<SEC-DOCUMENT>0001193125-11-100611.txt : 20110418
<SEC-HEADER>0001193125-11-100611.hdr.sgml : 20110418
<ACCEPTANCE-DATETIME>20110418120837
ACCESSION NUMBER:		0001193125-11-100611
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20110518
FILED AS OF DATE:		20110418
DATE AS OF CHANGE:		20110418
EFFECTIVENESS DATE:		20110418

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TRANSGENOMIC INC
		CENTRAL INDEX KEY:			0001043961
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				911789357
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30975
		FILM NUMBER:		11764885

	BUSINESS ADDRESS:	
		STREET 1:		12325 EMMET ST
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68164
		BUSINESS PHONE:		4027385480

	MAIL ADDRESS:	
		STREET 1:		12325 EMMET STREET
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68164
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>ddef14a.htm
<DESCRIPTION>DEFINITIVE PROXY STATEMENT
<TEXT>
<HTML><HEAD>
<TITLE>Definitive Proxy Statement</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SCHEDULE 14A INFORMATION </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Proxy Statement Pursuant to Section 14(a) </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>of the Securities Exchange Act of 1934 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>(Amendment No.
&nbsp;&nbsp;&nbsp;&nbsp;) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filed by
the Registrant: <FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT> &nbsp;&nbsp;Filed by a Party other than the Registrant: <FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary Proxy Statement </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B> </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Proxy Statement </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Additional Materials </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12 </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Transgenomic, Inc. </B></FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Name of Registrant as
Specified in its Charter) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>&nbsp;&nbsp;</B></FONT></P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(Name of Person(s) Filing Proxy Statement if other than the Registrant) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Payment of Filing Fee (Check the appropriate box): </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">No fee required. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">/1/&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title of each class of securities to which transaction applies: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">/2/&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Aggregate number of securities to which transaction applies: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">/3/&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and
state how it was determined): </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">/4/&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposed maximum aggregate value of transaction: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">/5/&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total fee paid: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee paid previously with preliminary materials. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.
Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">/1/&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amount Previously Paid: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">/2/&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form, Schedule or Registration Statement No.: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">/3/&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filing Party: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">/4/&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date Filed: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g176457g47i84.jpg" ALT="LOGO"> </P>
 <P STYLE="margin-top:48px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>2010 ANNUAL REPORT </B></FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="4">NOTICE OF 2011 ANNUAL MEETING AND PROXY STATEMENT </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4">2010 ANNUAL REPORT ON FORM 10-K
</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>TO OUR STOCKHOLDERS: </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">2010 ended with a transformative event for the company as we completed the acquisition of Clinical Data&#146;s molecular laboratory business. This acquisition brings us $13.0 million in new reference
laboratory business, proprietary assays for a variety of life-threatening inherited cardiac disorders and a state-of-the art CLIA lab facility. We also gain a very experienced and successful group of new employees and managed care contracts covering
280&nbsp;million lives. We are enhancing our reference laboratory cost structure by consolidating our current laboratory and improving our test offerings through the new tools and resources available to us from this combination. The acquisition also
brings us validated biomarkers with a significant potential for new product introductions. One of these proprietary biomarkers aids in the determination of whether cancer patients will respond to the newest of inhibitor drugs. A second should allow
doctors to determine which cardiac patients should be given clopridogel, commonly known as Plavix, the second most prescribed drug in the U.S. We will work to commercialize these new assays early in 2011. A key goal for this year is to drive further
growth in our existing testing and services businesses as well as initiate a focused commercial presence in the rapidly growing market for early cancer detection and treatment selection. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A second key component of our oncology market participation has been the refinement and expansion of our Cold-PCR assay portfolio in our
Pharmacogenomics laboratory. We completed the licensing of COLD-PCR from the world-renowned Dana-Farber Cancer Institute with the specific goal of developing and commercializing the most sensitive DNA mutation detecting technology available in the
market. We think we have realized that goal and have a rapidly expanding base of pharmaceutical company partners who are engaging us to apply these new assays to detecting, in patients&#146; blood rather than tumors, the presence of gene mutations
that may be indicative of cancer. We believe that this will provide a significant improvement in the method of and ability to detect developing cancers sooner as well as enhance accurate drug selection to treat such cancers. To further expand this
market, we also plan to make available to potential customers throughout the world the ability to use our recent discovery that enhances DNA mutation detection using standard DNA sequencing instruments. Combining these two technologies will offer
pharmaceutical company researchers, clinicians and patients the possibility of finding and identifying cancers earlier and detecting recurrence of the disease sooner and more accurately with no significant increase in cost. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are very excited by the potential for growth that resides at Transgenomic, and I thank you for your continued support. </FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px">

<IMG SRC="g176457g51p54.jpg" ALT="LOGO"> </P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Craig Tuttle </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Chief Executive Officer </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>TRANSGENOMIC,&nbsp;INC. </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>May&nbsp;18, 2011 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Annual
Meeting of Stockholders of Transgenomic,&nbsp;Inc. (the &#147;Company&#148;) will be held at our offices, 12325 Emmet Street, Omaha, Nebraska, on Wednesday, May&nbsp;18, 2011 at 9:30&nbsp;a.m. Central Daylight Time, for the following purposes:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To elect one (1)&nbsp;Class II director to be elected by the holders of the Common Stock of the Company as a separate voting group; and </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To elect one (1)&nbsp;Class II director to be elected by the holders of the Series A Convertible Preferred Stock of the Company as a separate voting group.
</FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Please read the enclosed Proxy Statement for important information about the Annual Meeting. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Only stockholders of record at the close of business on March&nbsp;21, 2011 are entitled to notice of, and to vote at, the Annual
Meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Please sign and return the enclosed proxy card using the envelope provided. You can revoke your proxy at any time.
If you attend the Annual Meeting in person you may withdraw your proxy and vote in person. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD WIDTH="100%"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors</FONT></TD></TR>
<TR>
<TD VALIGN="top">
 <P STYLE="margin-left:1.00em; text-indent:-1.00em">

<IMG SRC="g176457g16g21.jpg" ALT="LOGO"></P>
</TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Brett L. Frevert, <I>Chief Financial Officer</I></FONT></TD></TR></TABLE></DIV>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Omaha, Nebraska </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">April&nbsp;15, 2011
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>IMPORTANT: IT IS IMPORTANT THAT WE RECEIVE YOUR PROXY TO ENSURE A QUORUM AT THE ANNUAL MEETING. BY PROMPTLY RETURNING YOUR PROXY CARD TO
US, YOU WILL SAVE THE COMPANY THE EXPENSE OF FURTHER PROXY SOLICITATION. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY
MATERIALS FOR THE STOCKHOLDER MEETING TO BE HELD ON MAY 18, 2011. THIS PROXY STATEMENT AND THE 2010 ANNUAL REPORT TO STOCKHOLDERS ARE AVAILABLE FREE OF CHARGE ON THE COMPANY&#146;S WEBSITE AT <U>http://www.transgenomic.com/ir/docs/ar/AR2010.pdf</U>.
</B></FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Transgenomic, Inc. </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>12325 Emmet Street </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Omaha, Nebraska 68164 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROXY
STATEMENT </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>for </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>of </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>TRANSGENOMIC, INC. </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are sending
this Proxy Statement to you in connection with our request for your proxy to use at the Annual Meeting of Stockholders of Transgenomic,&nbsp;Inc. (the &#147;Company&#148;) to be held on May&nbsp;18, 2011. Only those owners (the &#147;Common
Stockholders&#148;) of our common stock of record at the close of business on March&nbsp;21, 2011 (the &#147;Record Date&#148;) are entitled to vote at the Annual Meeting for the election of the Class II director to be elected by the Common
Stockholders (the &#147;Common Stock Director&#148;), as a separate voting group. This Proxy Statement, along with the Notice of the Annual Meeting, the Annual Report to Stockholders and a proxy card are being first mailed to Common Stockholders on
or about April&nbsp;15, 2011. We are not soliciting proxies from the holders (the &#147;Preferred Stockholders&#148;) of the Series A Convertible Preferred Stock of the Company (the &#147;Preferred Stock&#148;) who are entitled to elect the Class II
director to be elected by the Preferred Stockholders (the &#147;Preferred Stock Director&#148;), as a separate voting group. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Your proxy is being solicited by the Board of Directors of the Company and will give the Board of Directors or our Chief Executive
Officer the power to vote on your behalf at the Annual Meeting. All shares of the Company&#146;s common stock represented by properly executed and unrevoked proxies will be voted by the Board of Directors or the Chief Executive Officer in accordance
with the directions given by those proxies. Where no instructions are indicated, the Board of Directors or the Chief Executive Officer will vote &#147;<B>FOR</B>&#148; the election of the nominee for the Common Stock Director to be elected at the
Annual Meeting. In addition, the Board of Directors believes outstanding shares of common stock owned by current executive officers and directors of the Company will be voted &#147;<B>FOR</B>&#148; the election of the nominee for the Common Stock
Director. Shares owned by these persons represent less than 2% of the total shares of common stock outstanding as of the Record Date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">You may revoke your proxy at any time before it is exercised by the Board of Directors or the Chief Executive Officer at the Annual Meeting. If you decide to do this, you will need to give the Secretary
of the Company written notice that you want to revoke the proxy or you can submit a new proxy to the Secretary. In addition, if you attend the Annual Meeting in person, you may withdraw your proxy and vote in person. Shares of common stock entitled
to vote and represented by properly executed, returned and unrevoked proxies will be considered present at the Annual Meeting for purposes of establishing a quorum. This includes shares for which votes are withheld, abstentions are cast or there are
broker nonvotes. The holders of at least a majority of our voting stock issued and outstanding on the Record Date must be present at the Annual Meeting, either in person or by proxy, in order for there to be a quorum. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>VOTING SECURITIES AND BENEFICIAL OWNERSHIP BY </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>PRINCIPAL STOCKHOLDERS, DIRECTORS AND OFFICERS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Beneficial Ownership of Common Stock
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On the Record Date there were 49,299,672 issued and outstanding shares of our common stock. Each share of common stock is
entitled to one vote on each matter to be voted on by the Common Stockholders at the Annual Meeting. Common Stockholders do not have the right to cumulate votes in the election of directors. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides information known to us with respect to beneficial ownership of
our common stock by our directors and all nominees for director, by those of our executive officers who are named in the Summary Compensation Table, by all of our current executive officers and directors as a group, and by each person we believe
beneficially owns more than 5% of our outstanding common stock as of March&nbsp;21, 2011, the record date established for our Annual Meeting of Stockholders. Except as indicated in the footnotes to this table, to our knowledge the persons named in
the table below have sole voting and investment power with respect to all of common stock of the Company beneficially owned and such shares are owned directly by such person. The number of shares beneficially owned by each person or group as of
March&nbsp;21, 2011 includes shares of common stock that such person or group had the right to acquire on or within 60 days after March&nbsp;21, 2011, including, but not limited to, upon the exercise of options or warrants to purchase common stock
or the conversion of securities into common stock. Beneficial ownership information of persons other than our current executive officers and directors is based on available information including, but not limited to, Schedules 13D, 13F or 13G filed
with the Securities and Exchange Commission (the &#147;SEC&#148;) or information supplied by these persons. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="71%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:25pt"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Number&nbsp;of&nbsp;
Shares</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Beneficially&nbsp;Owned</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Percent</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Of&nbsp;Class</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Directors and Executive Officers</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Craig J. Tuttle, President and Chief Executive Officer, Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">600,000</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chad M. Richards, Chief Commercial Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">243,800</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Doit L. Koppler II, Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rodney S. Markin, M.D., Ph.D., Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,000</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert M. Patzig, Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Antonius P. Schuh, Ph.D., Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,000</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All directors and executive officers as a group (6 persons)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">873,800</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7) </SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Other Stockholders</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">LeRoy C. Kopp</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,425,906</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27.2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">AMH Equity, LLC and Leviticus Partners, L.P.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,850,000</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Randal J. Kirk</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,517,228</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23.9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents less than 1% of the outstanding common stock of the Company. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of options to purchase 200,000 shares at $0.75 per share, 200,000 shares at $0.69 per share and 200,000 shares at $0.66 per share.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of 43,800 shares owned by Mr.&nbsp;Richards and options to purchase 200,000 shares at $0.69 per share. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Koppler holds unvested options to purchase 40,000 shares at $0.74 per share. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of options to purchase 15,000 shares at $0.70 per share and 5,000 shares at $0.74 per share. Dr.&nbsp;Markin also holds unvested options to
purchase 25,000 shares at $0.74 per share, 5,000 shares at $0.58 per share and 5,000 shares at $0.45 per share. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Patzig holds unvested options to purchase 40,000 shares at $0.74 per share. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of options to purchase 10,000 shares at $0.45 per share. Dr.&nbsp;Schuh also holds unvested options to purchase an additional 25,000 shares at
$0.74 per share, 5,000 shares at $0.58 per share and 5,000 shares at $0.45 per share. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes shares which may be acquired by executive officers and directors as a group within 60 days through the exercise of stock options.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of shares owned directly by Mr.&nbsp;Kopp, shares held in individual retirement accounts established for Mr.&nbsp;Kopp and his spouse; shares
held in the Kopp Family Foundation of which he is a director; and shares held in discretionary client accounts managed by Kopp Investment Advisors, LLC of which he is the Chief Executive Officer. The business address of each of these beneficial
owners is 7701 France Avenue South, Suite 500, Edina, Minnesota 55435. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of shares
held by AMH Equity, LLC which is the general partner of Leviticus Partners, L.P. The business address of this beneficial owner is 60 East 42</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">nd</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> Street, Suite 901, New York, New York 10165. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of (i)&nbsp;shares of Series A Convertible Preferred Stock (the &#147;Preferred Stock&#148;) convertible into 10,344,820 shares of common
stock and (ii)&nbsp;warrants to purchase shares of the Preferred Stock which are convertible into 5,172,408 shares of common stock. These shares of the Preferred Stock and warrants are held 40% by Third Security Senior Staff 2008 LLC, 40% by Third
Security Staff 2010 LLC and 20% by Third Security Incentive 2010 LLC, which companies are affiliated with the beneficial owner. Mr.&nbsp;Randal&nbsp;J. Kirk could be deemed to have indirect beneficial ownership of these shares. The business address
of these beneficial owners is 1881 Grove Avenue, Radford, Virginia 24141. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Beneficial Ownership of Preferred Stock
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On the Record Date there were 2,586,205 issued and outstanding shares of our Preferred Stock. Each share of Preferred
Stock is entitled to one vote on each matter to be voted on by the Preferred Stockholders at the Annual Meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
following table provides information known to us with respect to beneficial ownership of the Preferred Stock by each person we believe beneficially owns more than 5% of our outstanding Preferred Stock as of March&nbsp;21, 2011, the record date
established for our Annual Meeting of Stockholders. The number of shares of Preferred Stock beneficially owned by each person or group as of March&nbsp;21, 2011 includes shares of Preferred Stock that such person or group had the right to acquire on
or within 60 days after March&nbsp;21, 2011, including, but not limited to, upon the exercise of warrants to purchase Preferred Stock. Except as indicated in the footnotes to this table, to our knowledge the persons named in the table below have
sole voting and investment power with respect to all of the Preferred Stock beneficially owned and such shares are owned directly by such person. Beneficial ownership information of such persons is based on available information including, but not
limited to, Schedules 13D, 13F or 13G filed with the SEC or information supplied by these persons. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="72%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:25pt"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Number&nbsp;of&nbsp;
Shares</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Beneficially&nbsp;Owned</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Percent</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Of&nbsp;Class</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Randal J. Kirk</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,879,307</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes warrants to purchase 1,293,102 shares of the Preferred Stock. These shares of the Preferred Stock and warrants are held 40% by Third Security
Senior Staff 2008 LLC, 40% by Third Security Staff 2010 LLC and 20% by Third Security Incentive 2010 LLC, which companies are affiliated with the beneficial owner. Mr.&nbsp;Randal&nbsp;J. Kirk could be deemed to have indirect beneficial ownership of
these shares. The business address of these beneficial owners is 1881 Grove Avenue, Radford, Virginia 24141. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL TO ELECT CLASS II COMMON STOCK DIRECTOR </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Board of Directors and Committees </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Board of Directors consists of five
directors. The Board of Directors is divided into three classes with directors in each class serving for a term of three years. The terms of office of the current Class&nbsp;I, Class&nbsp;II and Class&nbsp;III directors will expire in 2013, 2011 and
2012, respectively. The holders of Preferred Stock are entitled, as a separate voting group, to elect two (2)&nbsp;of the five directors (&#147;Preferred Stock Directors&#148;). The Common Stockholders are entitled, as a separate voting group, to
elect the three (3)&nbsp;remaining directors (&#147;Common Stock Directors&#148;). There is one Common Stock Director in each class of directors. There is one Preferred Stock Director in each of Class I and Class II, but not a Preferred Stock
Director in Class III. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert M. Patzig is the current Preferred Stock Director in the Class I directors and Doit L. Koppler
II is the current Preferred Stock Director in the Class II directors. We expect the Preferred Stockholders to reelect Mr.&nbsp;Koppler as a Class II director at the Annual Meeting or by written consent prior to such meeting. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors has nominated Anthony P. Schuh for election by the Common
Stockholders as the Class II Common Stock Director to serve a three-year term expiring in 2014. Mr.&nbsp;Schuh is the current Class II Common Stock Director and he has expressed an intention to continue to serve on the Board of Directors if he is
elected. There are no arrangements or understandings between Mr.&nbsp;Schuh and any other person pursuant to which he was selected as a nominee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">A majority of the votes cast by the Common Stockholders is required to elect Mr.&nbsp;Schuh as the Class II Common Stock Director. This means that votes withheld and broker nonvotes with respect to the
election of the Class II Common Stock Director will have no effect on the election of such director. If Mr.&nbsp;Schuh is unable to serve as a director, the Board of Directors may nominate a substitute nominee. In that case, the Board of Directors
will vote all valid proxies that voted in favor of Mr.&nbsp;Schuh for the election of the substitute nominee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Board of
Directors recommends that the Common Stockholders vote &#147;FOR&#148; the election of Mr.&nbsp;Schuh as the Class II Common Stock Director. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board believes that the Class II Common Stock Director nominee possesses the qualities and experience that nominees should possess. Mr.&nbsp;Schuh&#146;s valuable biotech experience and extensive
executive management experience in the biotech industry makes him a valuable member of the Board. The Board seeks out, and the Board is comprised of, individuals whose background and experience complement those of other Board members. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth information about our directors, including the Class II Common Stock Director nominee who is to be voted
on by the Common Stockholders at the Annual Meeting. The Board of Directors has determined that Messrs. Koppler, Patzig, Markin and Schuh are independent directors of the Company under the listing standards adopted by the SEC. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:25pt"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Age</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1px solid #000000;width:91pt"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Principal Occupation</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Director<BR>Since</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Term<BR>To<BR>Expire</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8" COLSPAN="15"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" COLSPAN="14" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CLASS II COMMON STOCK DIRECTOR NOMINEE</B></FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Antonius P. Schuh, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">47</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Executive Officer of Sorrento Therapeutics, Inc.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">
(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2014</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8" COLSPAN="15"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" COLSPAN="14" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CURRENT CLASS II PREFERRED STOCK DIRECTOR</B></FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Doit L. Koppler II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">47</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Managing Director and Treasurer, Third Security, LLC</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">
(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2014</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8" COLSPAN="15"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" COLSPAN="14" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DIRECTORS CONTINUING IN OFFICE</B></FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rodney S. Markin, M.D., Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chairman of the Board, Transgenomic. Inc,</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">President of University of Nebraska Medical Center Physicians</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2007</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert M. Patzig</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">42</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Managing Director and Chief Investment Officer, Third Security, LLC</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"> (4)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Craig J. Tuttle</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">59</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">President &amp; Chief Executive officer of Transgenomic, Inc.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1997</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR></TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Schuh
co-founded Sorrento Therapeutics, Inc. in January 2006 and has served as its Chairman since such time and as its Chief Executive Officer since November 2008. From April 2006 to September 2008 Dr.&nbsp;Schuh served as CEO of AviaraDx, Inc. (now
bioTheranostics, Inc., a bioMerieux Company). From March 2005 to April 2006 Dr.&nbsp;Schuh was CEO of Arcturus Bioscience, Inc. In addition Dr.&nbsp;Schuh was a director of Sequenom, Inc. from May 2000 to February 2005. The Board selected
Dr.&nbsp;Schuh to serve as a </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
director because it believes he possesses valuable biotech experience and extensive executive management experience in the industry which brings a unique and valuable perspective to the Board.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Koppler joined Third Security in 2001 and manages the finance function of Third Security and is involved with several portfolio companies of
Third Security&#146;s managed investment funds. Mr.&nbsp;Koppler currently serves as Vice President, Treasurer and a member of the Board of Directors of Vital Diagnostics Holding Corp., a global supplier of products and services for the clinical
laboratory in the traditional in vitro diagnostics market with a focus on the physician&#146;s office, hospital and small-to-medium sized laboratory segments. Mr.&nbsp;Koppler served as Chairman and Chief Executive Officer of New River Funds, a
family of no-load mutual funds, from its inception in 2003 through 2008 and as the Chief Investment Officer of New River Advisers, LLC, the investment adviser to New River Small Cap Fund, predecessor to Southern Sun Small Cap Fund. Mr.&nbsp;Koppler
served as a member of the Board of Directors of IntelliMat, Inc. from November 2006 to July 2008. Prior to joining Third Security, Mr.&nbsp;Koppler served as Vice President and Controller of General Injectables&nbsp;&amp; Vaccines, Inc., a $120
million distributor of injectable biologics and vaccines primarily to outpatient physician offices, from 1992-2000. From 1987-1992, he was a Manager in the audit practice of Ernst&nbsp;&amp; Young LLP. Mr.&nbsp;Koppler is a Certified Public
Accountant and a Member of the American Institute of Certified Public Accountants. He has also held Series 7 and Series 66 securities registrations. Mr.&nbsp;Koppler received a B.S. in Accounting from Salem International University. The Board
selected Mr.&nbsp;Koppler to serve as a director because of his valuable financial expertise, including his public accounting and financial reporting experience. The Company also benefits from Mr.&nbsp;Koppler&#146;s status as a financial expert
under the Sarbanes Oxley Act of 2002. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Markin is also Professor of Pathology and Microbiology and Surgery, Senior Associate Dean for Clinical Affairs, College of Medicine at the
University of Nebraska Medical Center and Chairman and President of UNMC Physicians (the UNMC medical practice). Dr.&nbsp;Markin is also a director of Nebraska Surgical Solutions, Inc. The Board selected Dr.&nbsp;Markin to serve as a director
because he has valuable executive experience in the healthcare business. Dr.&nbsp;Markin also has extensive experience serving on other boards. His ability to communicate and encourage discussion makes him an effective lead independent director for
the Board. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Patzig joined Third Security upon the company&#146;s inception in 1998. Mr.&nbsp;Patzig&#146;s responsibilities include identifying and
researching investment opportunities for Third Security and its funds, securities valuation and portfolio management. Mr.&nbsp;Patzig is a Director of the Virginia Biotechnology Association, a non-profit industry advocacy group, a member of the
Virginia Tech English Department Distinguished Alumni. Mr.&nbsp;Patzig has served as Chairman of the Board of Intrexon Corporation and Cyntellect, Inc. and served as a member of the Board of Directors of Synchrony, Inc. Mr.&nbsp;Patzig served as the
head of the Investment Committee for Howe and Rusling, Inc., a registered investment advisor, from 2001 until its sale in 2006. Mr.&nbsp;Patzig served as the Chief Executive Officer and Chief Compliance Officer of New River Advisors LLC from June of
2003 until August of 2007. Prior to the formation of Third Security, Mr.&nbsp;Patzig served as Director of Market Research and Analysis at GIV Holdings, Inc. and Director of Research Services at General Injectables&nbsp;&amp; Vaccines, Inc.
Mr.&nbsp;Patzig received a B.A. in Philosophy and English from Virginia Tech. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">From 2004 to 2005, Mr.&nbsp;Tuttle was President and Chief Operating Officer of Duke Scientific. From 1999 to 2003, Mr.&nbsp;Tuttle served as President
and Chief Executive Officer of Applied Biotech, Inc. The Board selected Mr.&nbsp;Tuttle to serve as a director because he is the Company&#146;s Chief Executive Officer. He has expansive knowledge and experience in the biotech industry, as well as
relationships with chief executives and other senior management at biotech companies. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In conjunction with
the consummation of the financing related to our acquisition of the FAMILION family of genetic tests on December&nbsp;29, 2010: (i)&nbsp;the former directors of the Company consisting of Gregory Sloma, Jeffrey Sklar and Michael McNulty resigned from
the Board; (ii)&nbsp;the size of the Board was decreased to five members; and (iii)&nbsp;Robert M. Patzig and Doit L. Koppler II were appointed to serve on the Board as Preferred Stock Directors as required by the purchasers of the Preferred Stock
pursuant to the financing documents for such </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
transaction as well as the Certificate of Designation for the Preferred Stock. Mr.&nbsp;Patzig and Mr.&nbsp;Koppler were designated as Class I and Class II Preferred Stock Directors,
respectively, and filled vacancies created by the resignation of the former directors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">There are no family relationships
among directors or executive officers of the Company. Other than as indicated in this Proxy Statement, there are no arrangements or understandings between any of our directors and any other person pursuant to which such person was or is to be
selected as a director, director nominee or executive officer, nor are there any transactions to which the Company is or was a participant in which any of our directors has a material interest subject to disclosure under Item&nbsp;404(a) of
Regulation S-K. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Information regarding our other executive officers is found in our Form 10-K that is part of the Annual
Report to Stockholders that accompanies this Proxy Statement. The Board of Directors has adopted a code of ethical conduct that applies to our principal executive officers and senior financial officers as required by Section&nbsp;406 of the Sarbanes
Oxley Act of 2002. This code of ethical conduct is embodied within our Business Ethics Policy, which applies to all persons associated with the Company, including our directors, officers, and employees. The Business Ethics Policy is available on our
website at <U>www.transgenomic.com</U>. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors is comprised of four independent directors and one employee
director, Mr.&nbsp;Tuttle, who is the Chief Executive Officer of the Company. Dr.&nbsp;Markin is the Chairman of the Board. The Board believes that its structure with four independent directors (one of whom is Chairman of the Board) and its Chief
Executive Officer as its remaining director, achieves independent oversight of management and open communications with management. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors conducts its business through meetings of the Board and actions taken by written consent in lieu of meetings and by the actions of its committees. During the year ended
December&nbsp;31, 2010, the Board of Directors held six meetings and acted by written consent in lieu of a meeting eight times. All directors attended at least 75% of the meetings of the Board of Directors and of the committees of the Board of
Directors on which they served during 2010 with the exception of Dr.&nbsp;Markin. Dr.&nbsp;Markin attended 67% of the Board of Directors meetings and 100% of the Audit Committee meetings. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">None of our directors, director nominees or executive officers have been subject to legal or regulatory proceedings during the past ten
years which are material to an evaluation of the ability or integrity of such person to serve the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of
Directors has established and assigned certain responsibilities to an Audit Committee and a Compensation Committee. We do not have a standing nominating committee. The Board determined that due to the relatively small size of the Board, and due to
the policy on director nominations, which is described below, it was not necessary to form a separate committee to evaluate director nominations. Under the director nomination policy, director candidates are identified primarily through suggestions
made by directors, management and stockholders of the Company. We have implemented no material changes to the procedures by which stockholders may recommend nominees for the Board of Directors. The Board of Directors will consider director nominees
recommended by stockholders that are submitted in writing to the Secretary or Chief Executive Officer of the Company in a timely manner and which provide necessary biographical and business experience information regarding the nominee. All
candidates for director will be evaluated based on their independence, character, judgment, diversity of experience, financial or business acumen, ability to represent and act on behalf of all stockholders, and the needs of the Board. The Board also
values diversity as a factor in selecting nominees to serve on the Board. Although the Board does not have a specific policy on diversity, the Board considers the criteria noted above in selecting nominees for directors, including members from
diverse backgrounds who combine a broad spectrum of experience and expertise. Absent other factors which may be material to its evaluation of a candidate, the Board expects to nominate incumbent directors who express an interest in continuing to
serve on the Board. The independent directors of the Company review and consider all candidates to serve as a director of the Company who are properly suggested by directors, management and stockholders of
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
the Company, and the Board of Directors selects its nominees to serve as a director of the Company from among those candidates who are recommended to the Board of Directors by a majority of the
independent directors of the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Audit Committee.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee&#146;s
primary duties and responsibilities include monitoring the integrity of our financial statements, monitoring the independence and performance of our external auditors, and monitoring our compliance with applicable legal and regulatory requirements.
The functions of the Audit Committee also include reviewing periodically with independent auditors the performance of the services for which they are engaged, including reviewing the scope of the annual audit and its results, reviewing with
management and the auditors the adequacy of our internal accounting controls, reviewing with management and the auditors the financial results prior to the filing of quarterly and annual reports, reviewing fees charged by our independent auditors
and reviewing any transactions between the Company and related parties. Our independent auditors report directly and are accountable solely to the Audit Committee. The Audit Committee has the sole authority to hire and fire the independent auditors
and is responsible for the oversight of the performance of their duties, including ensuring the independence of the independent auditors. The Audit Committee also approves in advance the retention of, and all fees to be paid to, the independent
auditors. The rendering of any auditing services and all non-auditing services by the independent auditors is subject to the approval in advance of the Audit Committee. The Audit Committee operates under a written charter which is available on our
website at www.transgenomic.com. The Audit Committee is required to be composed of directors who are independent of the Company under the rules of the SEC. The current members of the Audit Committee are directors Koppler, Markin and Patzig. The
Board of Directors has determined that Mr.&nbsp;Koppler qualifies as an &#147;audit committee financial expert&#148; under the rules adopted by the SEC and the Sarbanes Oxley Act of 2002. The Audit Committee met four times during 2010. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Oversight of Risk Management.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Risk is inherent with every business, and how well a business manages
risk can ultimately determine its success. We face a number of risks, including economic risks, financial risks, legal and regulatory risks, and others, such as the impact of competition. Management is responsible for the day-to-day management of
the risks that we face, while the Board, as a whole and through its committees, has responsibility for the oversight of risk management. In its risk oversight role, the Board is responsible for satisfying itself that the risk management processes
designed and implemented by management are adequate and functioning as designed. The Board assesses major risks facing the Company and options for their mitigation in order to promote its stockholders&#146; interests in the long-term health and the
overall success of the Company and its financial strength. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">While the Board is ultimately responsible for risk oversight, the
Board has delegated to the Audit Committee the primary responsibility for the oversight of risks facing the Company. The Audit Committee&#146;s charter provides that it will discuss our major financial risk exposures and the steps we have taken to
monitor and control such exposures. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Compensation Committee.</I></B><I>&nbsp;&nbsp;&nbsp;&nbsp;</I>The Compensation
Committee reviews and approves our compensation policy, changes in salary levels and bonus payments to our executive officers and other management and determines the timing and terms of awards made pursuant to our 2006 Equity Incentive Plan. The
Compensation Committee operates under a written charter which is available on our website at <U>www.transgenomic.com</U>. The Compensation Committee currently consists of directors Schuh, Markin and Patzig each of whom has been determined by the
Board of Directors to be independent under the rules adopted by the SEC. The Compensation Committee did not meet during 2010, but acted by written consent in lieu of a meeting two times. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Section&nbsp;16(a) Beneficial Ownership Reporting Compliance</I></B><I>.</I>&nbsp;&nbsp;&nbsp;&nbsp;Item&nbsp;405 of
Regulation&nbsp;S-K requires disclosure of any known late filing or failure by an insider to file&nbsp;a report required by Section&nbsp;16 of the Securities Exchange Act of 1934. We believe all Section&nbsp;16 reports were filed in a timely manner
during 2010. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2010 DIRECTOR COMPENSATION TABLE </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides information regarding the Company&#146;s compensation for non-employee directors during the year ended
December&nbsp;31, 2010. Directors who are employees of the Company do not receive compensation for serving on the Board of Directors or its committees. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:25pt"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Fees&nbsp;Earned&nbsp;or</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Paid in
Cash</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Option&nbsp;Awards</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>($)<FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Total</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gregory T. Sloma</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,065</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30,065</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jeffrey L. Sklar, M.D., Ph.D</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,065</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,565</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rodney Markin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,065</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28,565</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael B. McNulty</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,065</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,565</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Antonius P. Schuh</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,065</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,565</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR></TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents the grant date fair value of stock option awards granted in fiscal 2010 in accordance with U.S. GAAP. For valuation assumptions used for the
fair value of the awards, refer to our Form 10-K for the fiscal year ended December&nbsp;31, 2010, Part II, Item&nbsp;8, Section B &#150; Summary of Significant Accounting Policies, &#147;Stock Based Compensation&#148;. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">These former directors resigned from the Board of Directors effective December&nbsp;29, 2010. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Directors who are also employees of the Company are not separately compensated for serving on the Board of Directors other than
reimbursement for out-of-pocket expenses related to attendance at board and committee meetings. Independent directors are paid an annual retainer of $20,000 and they receive reimbursement for out-of-pocket expenses related to attendance at board and
committee meetings. Independent directors serving on any committee of the Board of Directors are paid an additional annual retainer of $2,500 unless they are also a chairman of a committee. The Chairman of the Audit Committee receives an additional
annual retainer of $8,000 and the chairman of any other committee receives an additional annual retainer of $4,000. All directors&#146; fees paid annually or quarterly were pro rated for partial periods. In addition, any independent director who
attends more than four meetings per quarter, which includes committee meetings, receives $500 for each meeting attended over the four. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our practice during 2010 was to grant each new non-employee director an option to purchase 15,000 shares of common stock under our 2006 Equity Incentive Plan at the next Compensation Committee meeting
following a director&#146;s initial appointment to the Board. The options granted to a non-employee director upon initial appointment to the Board vested at the rate of 33 1/3%&nbsp;per year of service on the Board. Beginning in 2011, our practice
changed to grant each new non-employee director an option to purchase 40,000 shares of common stock under our 2006 Equity Incentive Plan at the next Compensation Committee meeting following a director&#146;s initial appointment to the Board, which
option vests after one (1)&nbsp;year. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Our practice during 2010 was to grant annually to each continuing non-employee
director an option to purchase 5,000 shares of common stock, which option vested after three (3)&nbsp;years. Our practice changed in 2011 to grant annually to each continuing non-employee director an option to purchase 25,000 shares of common stock,
which option vests after one (1)&nbsp;year. Additional annual grants of options will be made each year by the Compensation Committee in its sole discretion. All options granted to non-employee directors have exercise prices that represented the fair
market value of our stock on the grant date. Exercise prices on outstanding options granted to our non-employee directors range from $0.45 per share to $0.74 per share. <B> </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EXECUTIVE COMPENSATION </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2010 SUMMARY COMPENSATION TABLE </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B></B>The following table provides information regarding the annual and long-term compensation received by our executive officers for services rendered during the two years ended December&nbsp;31,
2010.<B> </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name&nbsp;and&nbsp;Principal</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:68pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Bonus</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All Other</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Compensation</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Craig J. Tuttle</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT
STYLE="font-family:Times New Roman" SIZE="2">President and</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">325,000</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">325,000</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT><BR>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT><BR>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,377</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,559</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">343,377</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">342,559</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Debra A. Schneider</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Chief Financial Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">96,737</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">209,333</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT><BR>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT><BR>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,055</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,568</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">111,792</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">212,901</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Brett L. Frevert</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Financial Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT><BR>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT><BR>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT><BR>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">96,225</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">96,225</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chad M. Richards</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Chief Commercial Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">188,708</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">182,250</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT><BR>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT><BR>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,476</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,340</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">202,184</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">193,590</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD></TR></TABLE>
<P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Figures in all years reflect new SEC rules where long-term incentive compensation must be valued based on the grant date fair value of all awards made
during the year as opposed to the accounting expense for all awards that has been in prior years. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Tuttle joined the Company as President and Chief Executive Officer on July&nbsp;12, 2006. See &#147;Agreements with Named Executive
Officers&#148; for a description of Mr.&nbsp;Tuttle&#146;s employment agreement with the Company. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts paid to Mr.&nbsp;Tuttle in 2010 and 2009 consisted of an automobile allowance as provided in his Employment Agreement, a 401(k) matching
contribution, group life insurance and long term disability insurance. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Schneider joined the Company as Chief Financial Officer on December&nbsp;4, 2006 and resigned on June&nbsp;16, 2010.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts paid to Ms.&nbsp;Schneider in 2010 consisted of a vacation payout, 401(k) matching contribution, group life insurance and long term disability
insurance. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts paid to Ms.&nbsp;Schneider in 2009 consisted of a 401(k) matching contribution, group life insurance and long term disability insurance.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Frevert began serving as our Chief Financial Officer effective June&nbsp;30, 2010 when we entered into a letter agreement with CFO Systems,
LLC relating to his service. All compensation received by Mr.&nbsp;Frevert represents amounts paid to CFO Systems, LLC for Mr.&nbsp;Frevert&#146;s services as our Chief Financial Officer. See &#147;Agreements with Named Executive Officers&#148; for
a description of the arrangement with CFO Systems, LLC. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Richards joined the Company as Senior Vice President, Sales and Marketing on October&nbsp;8, 2007 and was promoted to Chief Commercial Officer
in January 2011. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts paid to Mr.&nbsp;Richards in 2010 and 2009 consisted of an automobile allowance, a 401(k) matching contribution, group life insurance and
long-term life insurance. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END 2010 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides certain information concerning outstanding option awards held by the executive officers of the Company whose
compensation is reported in the Summary Compensation Table as of December&nbsp;31, 2010. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="53%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Unearned<BR>Options</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Exercise<BR>Price</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)
</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Expiration<BR>Date</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercisable</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Unexercisable</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Craig J. Tuttle</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">200,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8/31/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Craig J. Tuttle</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">200,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/16/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Craig J. Tuttle</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">200,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.66</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7/11/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chad M. Richards</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">200,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10/7/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Equity Incentive Plan and Other
Compensation Plans </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>2006 Equity Incentive Plan.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Company&#146;s 2006 Equity
Incentive Plan (the &#147;Plan&#148;) allows the Company to make awards of various types of equity-based compensation, including stock options, dividend equivalent rights (&#147;DERs&#148;), stock appreciation rights (&#147;SARs&#148;), restricted
stock, restricted stock units, performance units, performance shares and other awards, to employees and directors of the Company. The Plan provides that the total number of shares of common stock that the Company may issue is 10,000,000 shares under
the Plan; provided, that no more than 5,000,000 of such shares may be used for grants of restricted stock, restricted stock units, performance units, performance shares and other awards. Outstanding options exercisable for a total of 2,519,667
shares of our common stock are outstanding at the Record Date, of which 2,233,000 may be exercised at this time. Outstanding options have exercise prices ranging from $0.39 to $10.00 per share. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Plan is administered by the Compensation Committee of the Board of Directors (the &#147;Committee&#148;) which has the authority to
set the number, exercise price, term and vesting provisions of the awards granted under the Plan, subject to the terms thereof. Either incentive or non-qualified stock options may be granted to employees of the Company, but only non-qualified stock
options may be granted to non-employee directors and advisors. However, in either case, the Plan requires that stock options must be granted at exercise prices not less than the fair market value of the common stock on the date of the grant. Options
issued under the plan vest over periods as determined by the Compensation Committee and expire ten years after the date the option was granted. Compensation expense is based on the calculated fair value of the awards as measured at the grant date
and is expensed ratably over the service period of the awards (generally the vesting period). If the option holder ceases to be employed by or affiliated with the Company, the Company will have the right to terminate any outstanding but unexercised
options. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Employee Savings Plan.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Company maintains an employee savings plan that is
intended to qualify as a tax-qualified plan under Section&nbsp;401(k) of the Internal Revenue Code. This plan allows for voluntary contributions up to statutory maximums by eligible employees. We match a specific proportion of these contributions,
subject to limitations imposed by law. We may make additional contributions to the savings plan on behalf of our employees if our Board of Directors decides to do so. For the years ended December&nbsp;31, 2010 and 2009, Company contributions to the
401(k) plan were $105,131 and $73,933, respectively. For the year ended December&nbsp;31, 2009 we discontinued matching 401(k) contributions for the third and fourth quarters due to our expense reduction initiatives. We reinstated matching 401(k)
contributions for the first three quarters of 2010. Effective October&nbsp;1, 2010 we discontinued matching 401(k) contributions. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Agreements with Named Executive Officers </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">During 2010 the Company&#146;s employment agreement with Craig J. Tuttle, our President and Chief Executive Officer, was renewed for an additional year ending on July&nbsp;12, 2011. The employment
agreement provides that Mr.&nbsp;Tuttle will be entitled to receive severance payments from the Company if his employment is terminated involuntarily except if such termination is based on &#147;just cause&#148;, as that term is defined in the
employment agreement. The severance payment payable in such circumstances is equal to his annual base salary at the time of termination and will be paid to him over a twelve-month period. The employment agreement provides that the severance payment
provisions will be honored if the Company is acquired by, or merged into, another company and his position is eliminated as a result of such acquisition or merger. This severance payment is designed to provide him with an amount of cash sufficient
to provide for living expenses and other needs which would normally be paid from his monthly base salary payments in situations where the executive officer&#146;s employment was not terminated voluntarily or for just cause. In addition, the payments
are designed so as to not exceed the maximum amount which may be paid without imposition of the excise tax imposed by Section&nbsp;4999 of the Internal Revenue Code or resulting in a loss of the Company&#146;s income tax deduction for any portion of
these payments under Section&nbsp;280G of the Internal Revenue Code if such payments are made after, or in contemplation of, a change of control transaction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Richards does not have an employment agreement with the Company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Effective June&nbsp;30, 2010, we entered into a letter agreement with CFO Systems, LLC and Brett L. Frevert. Under the letter agreement
CFO Systems will provide financial and consulting services to us at rates of $75 to $150 per hour depending on the level of expertise involved. The services will include providing Chief Financial Officer duties and other financial and accounting
expertise on a time share basis. CFO Systems, LLC or the Company may terminate the agreement upon thirty days written notification. In connection with the letter agreement, Mr.&nbsp;Frevert agreed to serve as our Chief Financial Officer. We were
charged $126,459 for the services provided by CFO Systems, LLC during 2010. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>REPORT OF THE AUDIT COMMITTEE </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee is comprised of Doit L. Koppler II, Rodney S. Markin, M.D., Ph.D., and Robert M. Patzig, each of whom is an
independent director of the Company under the rules adopted by the SEC. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s management is responsible for the
preparation of the Company&#146;s financial statements and for maintaining an adequate system of internal controls and processes for that purpose. McGladrey&nbsp;&amp; Pullen LLP (&#147;McGladrey&#148;) acts as the Company&#146;s independent
auditors and they are responsible for conducting an independent audit of the Company&#146;s annual financial statements in accordance with auditing standards generally accepted in the United States of America and issuing a report on the results of
their audit. The Audit Committee is responsible for providing independent, objective oversight of both of these processes. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has reviewed and discussed the Company&#146;s audited financial statements for the year ended December&nbsp;31, 2010
with management of the Company and with representatives of McGladrey. Our discussions with McGladrey also included the matters required by Statement on Auditing Standard No.&nbsp;114. In addition, we received written disclosures and a letter from
McGladrey regarding its independence as required by Independent Standards Board Standard No.&nbsp;1 and this information was discussed with McGladrey. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Based on the foregoing, the Audit Committee has recommended that the audited financial statements of the Company for the year ended December&nbsp;31, 2010, be included in the Company&#146;s Annual Report
on Form&nbsp;10-K to be filed with the SEC. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:60%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Doit L. Koppler II </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:60%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Rodney S. Markin, M.D., Ph.D. </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:60%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Robert M. Patzig </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ACCOUNTING FEES AND SERVICES </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following fees were billed or were expected to be billed by McGladrey&nbsp;&amp; Pullen LLP, our current accounting firm, to us for
professional services provided during 2010 and 2009. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Audit Fees.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;McGladrey&nbsp;&amp;
Pullen LLP billed us a total of $205,315 and $188,607 in 2010 and 2009, respectively, for professional services rendered for the audit of our annual financial statements for those fiscal years and to review our interim financial statements included
in Quarterly Reports on Form 10-Q filed by us with the SEC during that year. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Audit-Related
Fees.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;McGladrey&nbsp;&amp; Pullen LLP billed us a total of $127,200 and $7,500 in 2010 and 2009, respectively, for audit-related services. Audit-related services generally include fees for the audits of our employee
benefit plans and fees incurred in connection with services associated with SEC registration statements, periodic reports and other documents filed with the SEC. In 2010 we incurred fees related to the audits, review and consultation for our
acquisition of the FAMILION family of genetic tests. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Tax Fees.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;McGladrey&nbsp;&amp;
Pullen LLP billed us a total of $34,055 and $34,760 in 2010 and 2009, respectively, for tax services. Tax services consist primarily of planning, advice and compliance, or return preparation, for U.S. federal, state and local, as well as
international jurisdictions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>All Other Fees.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;McGladrey&nbsp;&amp; Pullen LLP did not
render any services other than the services described above in 2010 or 2009. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee approved all services
provided by McGladrey during fiscal year 2010 and has determined that the provision of these services did not adversely affect McGladrey&#146;s independence. It is currently the policy of the Audit Committee to review and pre-approve all services
provided by the independent auditor to the Company in order to assure that the provision of such services does not impair the auditor&#146;s independence. Unless a type of service to be provided by the independent auditor has received general
pre-approval, it will require specific preapproval by the Audit Committee. Any proposed services exceeding pre-approved cost levels will require specific pre-approval by the Audit Committee. The term of any pre-approval is 12&nbsp;months from the
date of pre-approval, unless the Audit Committee specifically provides for a different period. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SUBMISSION OF STOCKHOLDER
PROPOSALS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to our Bylaws, stockholder proposals submitted for presentation at the Annual Meeting, including
nominations for Common Stock Directors, must be received by our corporate Secretary at the address of our home office no later than 35&nbsp;days prior to the date of the Annual Meeting. If less than 35&nbsp;days&#146; notice of the Annual Meeting is
given, then stockholder proposals must be received by our corporate Secretary no later than 7 days after the mailing date of the notice of the Annual Meeting to stockholders. Any stockholder nomination for a Common Stock Director must set forth the
name, age, address and principal occupation of the person nominated, the number of shares of our common stock owned by the nominee and the nominating stockholder and other information required to be disclosed about the nominee under federal proxy
solicitation rules. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In order to be included in our Proxy Statement relating to next year&#146;s annual meeting, stockholder
proposals must be submitted in writing by December&nbsp;15, 2011 to our corporate Secretary at the address of our home office. The inclusion of any such proposal in our proxy materials will be subject to the requirements of the proxy rules adopted
under the Securities Exchange Act of 1934, as amended. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OTHER MATTERS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Management does not currently intend to bring any matter before the Annual Meeting other than those disclosed in the Notice of Annual
Meeting of Stockholders, and it does not know of any business which persons, other than the management, intend to present at the meeting. The enclosed proxy for the Annual Meeting confers discretionary authority on the Board of Directors to vote on
any matter proposed by stockholders for consideration at the Annual Meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will bear the cost of soliciting proxies for
the Annual Meeting. To the extent necessary, proxies may be solicited by our directors, officers and employees, but these persons will not receive any additional compensation for such solicitation. We will reimburse brokerage firms, banks and other
custodians, nominees and fiduciaries for reasonable expenses incurred by them in sending proxy materials to the beneficial owners of our common stock. In addition to solicitation by mail, we will supply banks, brokers, dealers and other custodian
nominees and fiduciaries with proxy materials to enable them to send a copy of such materials by mail to each beneficial owner of our common stock that they hold of record and will, upon request, reimburse them for their reasonable expenses in so
doing. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders may communicate with any director, including the Chairman of the Board and the chairman of any committee
of the Board, by sending a letter to the attention of the appropriate person (which may be marked as confidential) addressed to our corporate Secretary at our home office. All communications received by the corporate Secretary will be forwarded to
the appropriate directors. In addition, it is the policy of our Board of Directors that whenever possible directors attend, and be available to discuss stockholder concerns at, the Annual Meeting. All directors participated in last year&#146;s
Annual Meeting via conference call or in person. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Form&nbsp;10-K, as filed by the Company with the SEC, is included in our
Annual Report that is being delivered to our stockholders together with this Proxy Statement. The Form&nbsp;10-K is not, however, to be considered part of this proxy solicitation material. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">None of the information set forth in this Proxy Statement under the heading &#147;Report of the Audit Committee&#148; is deemed to be
&#147;soliciting material&#148; or to be &#147;filed&#148; with the SEC or subject to the SEC&#146;s proxy rules or to the liabilities of Section&nbsp;18 of the Securities Exchange Act of 1934 (the &#147;1934&nbsp;Act&#148;), and this information
will not be deemed to be incorporated by reference into any prior or subsequent filing by the Company under the Securities Act of 1933 or the 1934&nbsp;Act. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors </FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:54%; text-indent:-2%">

<IMG SRC="g176457g16g21.jpg" ALT="LOGO"> </P>
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Brett L. Frevert,<I> Chief Financial Officer</I> </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Omaha, Nebraska </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">April&nbsp;15, 2011
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>TRANSGENOMIC, INC. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Wednesday, May&nbsp;18, 2011 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>9:30 A.M., Central Daylight Time
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Transgenomic, Inc. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>12325 Emmet Street </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Omaha, Nebraska </B></FONT></P>
<P STYLE="font-size:96px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt dashed #000000">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>
<TR>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">
 <P STYLE="margin-top:0px;margin-bottom:0px">

<IMG SRC="g176457prx_001.jpg" ALT="LOGO"></P>
 <P STYLE="font-size:4px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>TRANSGENOMIC, INC.</B></FONT></P>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>revocable proxy</B></FONT></P>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:1px" align="left"><FONT SIZE="1">&nbsp;</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="100%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF TRANSGENOMIC, INC. FOR USE ONLY AT THE ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON WEDNESDAY, MAY 18, 2011 AND AT ANY ADJOURNMENT THEREOF.</B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The undersigned hereby authorizes the Board of Directors and Chief Executive Officer of Transgenomic, Inc. (the &#147;Company&#148;), or any successors in
their respective positions, as proxy, with full powers of substitution, to represent the undersigned at the Annual Meeting of Stockholders of the Company to be held at the offices of Transgenomic, Inc., 12325 Emmet Street, Omaha, Nebraska on
Wednesday, May&nbsp;18, 2011, at 9:30 a.m., Central Daylight Time, and at any adjournment of said meeting, and thereat to act with respect to all votes that the undersigned would be entitled to cast, if then personally present, in accordance with
the instructions below and on the reverse side hereof.</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THIS PROXY,
WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED STOCKHOLDER. IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED FOR THE ELECTION OF THE LISTED NOMINEE FOR DIRECTOR.</B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">This proxy is revocable and the undersigned may revoke it at any time prior to the
Annual Meeting by giving written notice of such revocation to the Secretary of the Company. Should the undersigned be present and want to vote in person at the Annual Meeting, or at any adjournment thereof, the undersigned may revoke this proxy by
giving written notice of such revocation to the Secretary of the Company on a form provided at the meeting. The undersigned hereby acknowledges receipt of a Notice of Annual Meeting of Stockholders of the Company called for May&nbsp;18, 2011, and
the Proxy Statement for the Annual Meeting and the Company&#146;s 2010 Annual Report to Stockholders prior to the signing of this proxy.</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>See reverse for voting instructions. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">111605 </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>
<TR>
<TD VALIGN="bottom">


<IMG SRC="g176457prx_002.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>TRANSGENOMIC,&nbsp;INC.</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shareowner Services</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">SM</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">P.O. Box
64945</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">St. Paul, MN 55164-0945</FONT></P></TD></TR></TABLE> <P STYLE="font-size:120px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:120px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:36px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>TO VOTE BY MAIL AS THE BOARD OF DIRECTORS RECOMMENDS ON ALL
ITEMS BELOW, </I></B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>SIMPLY SIGN, DATE, AND RETURN THIS PROXY CARD. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I></I><FONT STYLE="font-family:Times New Roman" SIZE="3"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#242;</FONT></FONT><I>&nbsp;&nbsp;Please
detach here&nbsp;&nbsp;</I><FONT STYLE="font-family:Times New Roman" SIZE="3"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#242;</FONT></FONT><I> </I></FONT></P> <P STYLE="font-size:2px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="100%"></TD></TR>
<TR>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px dashed #000000">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>
<TR>
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8px"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="15" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Board of Directors Recommends a Vote FOR Items 1 and 2.</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px">&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1.</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ELECTION OF DIRECTOR(S)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>NOMINEE FOR CLASS II (term to expire in 2014):</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT><B></B><B></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3" ROWSPAN="2"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vote&nbsp;FOR all nominees</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(except as marked)</FONT></P> <P STYLE="font-size:2px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">WITHHOLD&nbsp;authority</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">to&nbsp;vote&nbsp;for&nbsp;the&nbsp;nominee(s)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">01 Antonius P. Schuh</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="7"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(Instructions: To withhold authority to vote for any indicated nominee, write the number(s) of the nominee(s) in the box provided to the
right.</B>)<B></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="7" VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="18"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="17"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote, in its discretion upon any other business that may properly come before the Annual Meeting or any adjournment thereof. Management is not aware of any other
matters which should come before the Annual Meeting.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="17"> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED
AS DIRECTED OR, IF NO DIRECTION IS GIVEN, WILL BE VOTED <U>FOR</U> EACH PROPOSAL.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD></TR>
<TR>
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="5"><FONT STYLE="font-family:Times New Roman" SIZE="2">Address&nbsp;Change?&nbsp;&nbsp;Mark&nbsp;box, sign and indicate&nbsp;changes&nbsp;below:&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top">
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2011</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px">&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Signature(s) in Box</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Please date and sign exactly as your name(s) appear(s) on this proxy. When shares are held by joint tenants, both should sign. When signing as attorney,
executor, administrator, trustee or guardian, please give your full title. If a corporation, please sign in full corporate name by authorized officer. If a partnership, please sign in partnership name by authorized person.</FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD></TR>
<TR>
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px">&nbsp;</TD></TR>
<TR>
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px">&nbsp;</TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g176457g16g21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g176457g16g21.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0M$4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````-@```)P````&`&<`,0`V
M`&<`,@`Q`````0`````````````````````````!``````````````"<````
M-@`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````"*<````!````<````"<`
M``%0```S,```"(L`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``G`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#U5)9F5D?6''+W486/G5AY+0V]U%NS38T5VT6T66_O;LJBM0;US)8T
M.R^D9V/)`T;5?SN[8.1DV>W;_HTE.LDL<?6SH8L]*^VW$LC=MRJ+\?3G1V33
M4QW]ARLXO7^A9I:,3J.+>Y\;6UW,<XS_`"&NW)*;Z2222D=-].0PV4/;8P.<
MPN:01N8YU5K-/SJ[&/K>B+EOJ9G!W4?K%TT[YQNHVWU[OH^GD%T^E_Z%X^7O
M_EO73O#BPAAVN(.UQ$@'QVZ)*9*-A<*W%FK@#M^,:+&ZQUO-Z/\`I,AF&ZAY
MBDOR'4VO=_H:<;[/D>O;_4N2Q?K%GY3&VU]!ZBVI_P!%UGV6IT3RZG(S:;F?
MVF)*<WZM_5S$?]7NGYW3\O*P<[*QJLB[)JN>\/NLK:Z^[(P\IV3@W/ML=^EW
MX_J?\)6M/]J=4Z6T_MJCU\=@G]HX3'.;`!+G973_`--E8_\`7QW9U7^E^S*/
MU-#:^A-Q09=A9&5BN$S'HY%];&_]M"M;B2F%-U-]3+Z'MMIL:'5V,(<US3JU
M['M]KFN4U6LPFC>_$(Q;GO\`4>]K06O?&R<BOV^K_+]]=O\`PR!3U-U5].%U
M-HHRKO;5:V?0N>!N<RBQWT+MHW_9;OTW\YZ/VFNFRU)3_]#U58-WUHLNNMQN
MB].OZID4.++G-<RG'K>"&OILSKG^D^ZO=^DJQ&Y3Z_\`"?I%O+D778?0[[<+
MH_7^FXK`]SATG.-9%=ECC=95COHOQ<C%KL?9_-6U9?I_X+_1I*="UOUXR"?3
M?TWI['`0(NRGM/\`QA^PU?\`@*Y[$^KWUDZ]TRIW5\S&RY+FV:!L/J>^ET68
ME%%WTZO?^LKH:.N=<=#OV75G4R`;NG9E5H((^GZ>8W`_S/54.@_6GI.7?=TU
MS3T[/KR+F#"R##WG<;BZM[OT5UEC;/7LIHMN]+?_`*-)3BX?U#S<`EV-5BA\
M`.LKS.HT.='#G^EDV?YJ?*=UKZL9>%FV,NRF9F35A-Q1U.[(:]]T_0QNJ8K=
MFS8_TO\`*5?_``UOIKMS=4VUM)>T6O:YS*R1N+6;18]K/I.:SU*]_P#QBXKZ
M\93;.J=.M]7T\+H&9BY'4'N+0SU+[JJJ*]Q=_.X^+Z^3?7M]E&1CV?X1)36Z
M!U;%IZYAY=N/=B?M&_J>';?>W96YS\NS.Z<S[4PV8=MC/2S,-E7VCU_7L_1>
MI1Z=B[+KG4K.F].?D4UB[)>^NC%J)@.NO>S&QVO=IMJ]6UKKO^"WKD+&UY'U
M+HZ;B=.R>J6TM;F4O^RN90ZUMAS:A8SJ3L=]U&3_`#5[,?[5^KW6?SB?I#NI
M=?Z<_I&-D8_3Z<#(::O6+\K-I=6:>HX=+JK7XWI6]/<[[%=]I^T_I,.W'L]?
M^=24]7TWHM6':<S)L.;U.QNVW.M`W0?<ZC&9JW$Q-_T,:K_KWKW?IE?MNJI8
M;+GMK8.7O(:!_:<N6MJS&YU5'UCZAF5UY%WIXS\6UF/B6V._F<<.PV4]6QK7
M^_93?EWU?H_Z9<]/E?5.O!RG9N'TW$ZS6XA]E&:-^6"-HG%ZEE^OZNW;N93F
M?G_]KZZ_T22D/3/K/]6NE9_7:K,VO8_.;DUBJ;BX7X^+ZCJJ\5MSW_K++_4V
M?]<6M9]:J=XKQNF]3RGN,`-P[:A_6]7J`PJ?_!%6Z-E>K]8KQC]*OP,9V%6+
MK;JG4@7577[<1L#['=L9D67>OB6W?SO\[^YTB2G#=UGZP/M#,;ZOW"LC6S)R
M<>H`Z_FX]N<__HJ&5B?6/K&,[#S*L3IN-:6^H^NU^3>`TE^_&<ZC#IQLMCVT
MV8N5^L?9K6>MZ5GL6^DDI__1]56/<WZI.;U(7?8()9^U]QJ&LN]']H?VM_I_
M:%\VI)*??3B_XK;QZ5;NCASM`:+:*[-?W+<=[+FN_J/6)^Q^C863U6JG,Z1;
MT6Y]=E3.I/9>!E.997D8WVUV2W*Q;ZVUMM;8]F2_T[_T?OKM7CJ22GW;$Z3]
M6<>LT_6>_IUG4FV/NK%V0;;68SG..-CVY>:^K+S**:[-C/5KKI_FOT?J4^LK
M%6#_`(M**[&NLZ98+'V>JZZVE_O(8,F-[]M3_P"9]7TO37@*22GZI$0(X[0L
MOK#?JPX,;UK[%J3Z7VHU@S+=WI.N]V[U/3^@OFI))3]&=/H^I-6=0<`X!SO?
M]EV/K?;]']-]G]S[/YO^<]+_``:WE\JI)*?JI)?*J22GZJ27RJDDI__9`#A"
M24T$(0``````50````$!````#P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H
M`&\`<````!,`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'``(``V`"X`
M,`````$`.$))300&```````'``@``0`!`0#_[@`.061O8F4`9$`````!_]L`
MA``!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`@("`@("`@("`@(#`P,#`P,#`P,#`0$!`0$!`0$!`0$"`@$"`@,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P/_P``1
M"``V`)P#`1$``A$!`Q$!_]T`!``4_\0`;@```@(#`0$!``````````````@&
M"04'"@,$`@$!`````````````````````!````8"`@`%`P0"`P$``````@,$
M!08'`0@`"1$2$Q05%A<8(B,D"B$903(E)A$!`````````````````````/_:
M``P#`0`"$0,1`#\`[^.`<`X!P#@'`.`<`X!P#@'`.`O&WDW?ZRU.V?LB**C$
M4HK[7BZIO&UA)Z9*:D?XG6TE?F=44J6')TB8PAQ0%C"8:866#./$0@AQG.`I
MXT@Z;*^J+7.G[)URVWW?U\NFQZSKJV)U*HOL-*+"K696_,8U&Y3,YO-M?[GQ
M850S0R3NIRDM2%>VC5X2*S,%*2E."U)8.6T[#[P:PA7)]TZ39[ZJEI+3Y+VF
MTEBDI>G9K;0&H6\3E<.HC@[2NW6U0(1^52M;`%$V2$E!...1-R4K(L`_]5VY
M5UY0AFLJG+!A]GP&0%C&T2Z#R!MDC$L$5G`%27"]K4*"27!`=XE*4QF0*$IP
M1%F@`8$0<!L3@'`.!__0[\B5"=3@P2<\D_!1QJ<W))H#<%*"!Y+/(,R`0L`.
M)'C(1!SX"#G_`!G'`]N`<`X!P#@'`.!3=V3[.S;5+<?J!E6++DT9HJZMK;"U
M,NBN6K+6*/V*^;`U,N:J(>)(6M;SEA(:ZMR/(51:E.J3>@E6J\&!-"9^@+D>
M!YG'%)RC3SS2R"""QG'''#"64246'(S#33!Y"`LLL`<Y$+.<8QC'CG@?&TNS
M4_-C>]L;FWO3,[(T[BU.[2M3.+8YMZLH)Z1<WKT9AR5:C5$CP,LTL8@##G&<
M9SC/`R'`@MH5Y'[=K2Q*HEN%68K9T%EM>2;"$24*W,?FC`X1MYPC$O2."$*K
M+<Y&>GDX@\K`_#SEC#XAR"#=-$Z?[$ZL=%GV5G^YDS5KY#:_?U&"$R<!SO5!
M:FK7`PDM&@;$OMQ*H<+)8BR<`&7X"P(S&?4$%F?`3Z?Z4U3(;52;!5DMD6O&
MP1"XU<_6C2RA#&,6V4>0T(SV+8J!F(5<`V#836QD(1)S9,W+'QA3"-''W-F6
M#PL`&QR[&E-611`MV$&PG#+=G8A]LZMHU(&ZL6*.$$NKLDELY;'IZE#O5["U
M-:()+LO6.+BSH18PL/7ITQAH$8;J:G9J?6]*[LCFWO+4N+]9$YM2U,X-ZPK`
MA`R:E6I##DR@O`P9QY@"SCQQG'_'`R'`_]'L]MC1362XG^5S*0PF21"?SEXC
MLCF%DTA;-O:ZV3*))#XP1#(A(9'/:&G=<RJ0O$4BJ0A`W'+E2G*5(F)*!X%E
M%A""^H.O*WX,Z(UE.=H'8#$&9$J=3R859DFHC9B.`(<DIJ8A&)^OZBYQ;3B2
MUC&$9`G"4+C<"+QG(LBR,0@F"ZM.SN)(Q$P;:[5*U_096)"C#>6J$YB[ZJ=F
M]#[=Z>WJ44WL,QQ\\Z0+`!4>BDC").D$(8"P9!Y,!"`Q^X>WB'29Z:;0TIU(
MN&*9=#P1N;Z][=RN$.OPY8!92'O]>7;224HIP6X\N3BTTA-+1F>8H`E0`A4C
M#](^PJ^HPJDZ"Z.KS=6,FQUZ;VXMVI170.S4<7H5S.!Y,<,!KRWT4Z3*FY*+
M`CT>&`PX0#2,$Y..."1@,"9W8Z#Q<*\N\I5=&JS@V+%*!:@VDUEV!I<DM4B+
M.&L"5(Y)7?T8M+39($$1A#F:6(?@$`A9SX<!AJ@[,>O2^V4+_4FZNLTQ09$K
M",I/<<(:WA/[$Q,2J&LCKZ\-<@1$E&+"L>H<E`#/J@\,Y\V/$&UC\]@TM-P1
M%9I$Y,?E'AQP3'Y&SO)N6_(B0878+;5BD>4>1J2\>KX>3Q,#CQ_5CQ#F%_M5
MPZRYW0.DK=3#T6S6W!=H[#V&@)Q#68[/0WS5O4+8K84D+.E3D&*A*%`JZPF!
MGS83EJE)!AX1%E^(0Z.M:[KC^R>N]$[#1098XW>5/UO;;)@L)I>"6ZPH@T2M
M.D,)4?R4RA$!U]$TDWP.),`(!F,#"+&`W9P*Y-_2-%*Q@)]R;1Y=(,_`6*"X
M;):.D]GUOM#/9>-E/:D<0J=TUW?XE>%@2Q8WGX`2UH5"DHL``J%`"R$XCB@J
MMC6K':S?;JC=M>+CVKZS:8D18%"MSVPVD_.&\3VII?D`&83505BP^8?:N0/T
M75KA+/D;3<O3/*3A4-V30".,"Q:I=$MW8"_Q=RF?<3M7:+`PR1H?G:'/%`Z3
MM;9,$:%V3+72+OKX'7]TFJ6/R!L2!1'8;W-$K3A,--3'DFC"(`17IC?C&6C]
MFM87!:2M>]+]^=NZ*.4B,-$XN<;D]G+=B8*^+L'KE0S0K8E>29.`TLI(F\R,
M9)9`/0'C@7`\`X!P$QFFO$OJAD?I/H\=!:KF!KDXRMTI:0LYA6NULO2Y:!T>
MRG9B8,HW"I)M*#,*`8E4;P6'WRW*UZ:W_P!`@@L-;?[(JO\`MYY_HN7_`)0?
M<C[$?A=[AD^^7W[^/^7^C?+[WX'[?_3/_P!+]=>M],?1W_K^OY/V.!__TN_C
M@+1LOMS1FH<7)G.P$L+K^#FIU8A3)Y"G01DMU"H0(&6*%NSBJ1)W":2]T<BT
MS2T),J%ZO(33LE`3)SSRPKX9.RW<'892D6Z1=6MR3RKWEK3K6._-N;8B6F->
M.>%>3_;NC/"W>.6E>,BCYI(2SDR@B,%!5@%_V(#DLT81BWJ`[[KPCJAN9-]]
M(M-CW0EN./!0FKTTNJ0L@O8FDO#`BL&^9@2WNR$]0JSX.A449W`62"S2`(A"
M&7P*BZ!ZI>U>6WWN55=_=A;=>A,,L2M9R![M=[W_`(;`+,Q;-9-B]8Z(*LU0
MWJU0AK8WLJJ,?%&-ZI*]-P1(AX(,`$U2E+!GTO\`7E?$$D;K"!&>H"139$\+
MGAS!9W75M#=C=-%*TD"<7UNZ7EV8V<XOI99(,A+`,G'I9'YPB\X"A%@Q1O5A
M?:2/CC7XP?U[Y8QC$602P&]8DS@<?1MI8A'`2C:OO?9*1Q$!2``P^!:4O&?'
M/E\<8\02C8[K(_&*%VGM,MZC^JI\.I.J;(N%SM#6?:S:+2R31U="J\>GZ1/C
M%6<-I@+.R1TEG1K$V&5#-DX5X!^8Q6BP,7E#3>.UR37Y>W1!>^TVFM]4["F>
ML=O]A[!?(16SAL/")E$9CK"R4FP3VLX]4,INFW'2H4:2\3CY*1(61,_-9AR$
M`P*?,?YPN#_K[6]`)CH>XT/7\L0S1HTFV"O#55IDR5Q=%)DIK^(S)5+Z@EP6
MV0(&N2,K:\U9-FDA.0M(P,`D1I>!CR6+P"SG;W9*-Z@ZT7'LC*&5PE*&JX>I
M>6N&,YX$SW8$R<5:2/5]6["H,3JRR)!8T\>&UC0#$48$*QP+SD(L?XR"PZ6Z
M2/D(?T>W^X+FAN#L'L&(F-\VGI@\*(70\:?SP.BC7_6^.!-/9H+747QZ2%8X
MI\&O4H/3"5N2Y2$1)9(66\`X%$>MMDTYJ]VN=QL6M.TZ]JYDM)%HQM%'U=C2
M9E@B`9<AH^95+/RD;[*Y$!(\)6MYI`#D>9CVH4OR^20E>FG]3(,.^]WO5.QH
M,.:?=&LIJB$+!99M2-L[NL1JG/K>"$DBH(C.%!SE^S_E*$&5&,F%?H_>*\X8
MMD[@:AL-6MQ0NI_8SL&P(SDA1<U@>EEH0B(.`%364XC4-[EL("DU)Q*4T8DH
M\"(`88I*%Z(32?*:(,.R]@'8#8;XH3UCTQ;%-L1&Y*DS9-=B-E-6J(!EN3)E
M9Q:]]AB":VC/VLYP/2X(()2-CD'!AQ8CC"2LC,+"7-EI=R$_E+(G1:B:.:Z0
M8IP2G29YL_;.T+XF*QG3EJ3%R".Q*K]?ZZ8D;P['F)R"3U3Z:G0%EG*!EJQ9
M*2Y#0G^HRZ_N'^:GYUR#_:'\?]-?DI]DH5]A_L][_P"5_&#\8_EO+]C_`'W[
MGR'U-]=^\_E?.^'\7@?_T^_C@5)]B^HMRV3=^F^ZE`P2N=@+%TMD5D.)NKMS
M2?$4AUFQBQ(P2C6R:K9,O:7N*PG9J$NS$C^DW9[(*:`%K58%"Q#^@_@?:C[>
MZ0B;J8P;2:^;MZ4.A1BQ-\IL+J_-W:L%BUN]V8N):[XU]%>=%K$Y*)":KP>.
M1DE>SQ@P609%@'`;ZKMWM,KN3(5=/;9:VV>6Y"R6D+@EW5M*%@U(2#%)R$U`
MT216N3.24DD>3TQI8%!&2QX,`'(!8P'M#V"KHYMI>#JWR6%EV_9]04:ZR.%(
M50TLV40JN'VV6!DF+NUJ)PYX=6_Y*6G-^%Z5@:0D@*3IU"I<+T`I09O@'`HU
M_L73ZRXWU6W95]-)W`VT-II!`]8(VH1@,RC0,EEOF%MJ'R`\"92%!&U5+1F2
M)%BD6`X(+4^;&<BP$`P4/I]97:6S[J)EKH@D![+5_026S,[FLCB9)%@26P;7
MUD0F`9)*%06K=)`@B5<%DK4V4^4Z9,J)'@T1QQP0!\6]>L3KKQVPI=GZ@V&:
M=.Y+NA0IRB!6])7%>R4$LW%U$']3"IK:6.IG9CADTI;:?7"0/&5YBT(9,UN4
M'$XLRXM6$)!@2'<CLKHSL-Z[`UIJPGO>WMIK4B=!7)!H?0&JUV7S%:QO:I[+
MKV\(>Q7%/HM'1T]%8.Q7E6[?&I,L-E)^6U,K$JP6J3`R,0-I5O9CN1LM)UU8
M4GHY5=*7#'(^G532LM_MKWG7NTVU]2*@A?E,'J.J-=-B7NT:L]KX90RY&Y(F
MX\1X0F`+.*-3X"8V+2'=-.80]/>=V]7JQDGQ+ZH)IC6_69:S.#DHRTK$K1'6
M/:O8J<WF@CRXY8,I1EX4U$I`$X/IX2DEB]8H$>IBI=.+YMQBIG=#<7M'2[-Q
M%.O&NU<W8VAD^N+?8('AN3">5=?)=:4M&4YL%!RG1UP64=%'1V+$!#@E67A'
MDP@X-E+NL_K8U\[4M7E!=-U<:_[`:R['P",UE;S$ZWL.S9!7,GJRTI':"22V
M\XSUQ;IS3[`VH&M.8K.]4]FE!Y2,02T9X.!?U#H+"*[9\1ZOX=%8-'\*CUV&
M.'1YHC+/A:JP7A2LPV,J-$B]THP4'SF>3SC\N/'.?#'`E7`.`<`X'__4[^.`
MG6\<CWIBM&NSSU[UKKS:E\I3CS$T6V.FLPAL4/:RVM>:#+"")H"BY))CG@"4
MDM`Y/D6;Q$&&F#="1%@+-"L*TKB_L65(C@SG&-:-+-MU$I8V]RDD2IV(!H]1
M6CD+*14ZL,KF-]=C8$3LZ%%"&C3Y8&IX0&&B,4C5@`F*3.`+64T;,[$MLG;N
MPC^K76[JVJD9+LIF=*;'=>MF3IV<4#HD>#22VU_L:JIDW&8.*/5`-0298J5G
MY"GRGS@P9N0I9E=L.L9[A]=()UNT=V']85MV32%F4:Z0+86.U!(U$WDL.?&J
MWT#'$:IVGVBDE4O5(*(RB/`G2LDIA)#BZ#)^$4^\];U`Z1H9VP;2:JI8S'NW
MS2N84&DF$P;:_K;:.@O@K8H^P)5)9,H8H1';(@L%G]JR+6R<2TDY'A,D6/\`
M)V,]5E1C#N2$!0#`W?%M[NQ`NX)NQV#U`[)XJYZ9X&\T6.NK8TP>YH0V$#>2
M;=/OB1R_;>%UA$)82:M9LQN-M2UQ,5%EKAG.`L8QA.%?1MG[J[W;ERBZ7#K2
ML684?K]6LFI?4.'3NZ];8O1RV<['EHH??>QEP[`5[>DX6OSE'*5"LC*)FK*.
MVBW-Q:]T3_+)70_(@!%.F'J]['J[J6R()O+L)>.LS969,0UII2O]:I51:=!8
M%+U,6]K&ZV#[+<8E;UHQ(Z7N4D)((3QUV@YYR1G)RZHU0O1"G!]=EN@#1C8%
MA8'!I57?6]XP&6-5C5K?KC=MG;!2=AL..+$CVQ.THB&STKN&OY]'SI(TH%#J
MVK&XH;BE2>S`I3$&&8R&0T_J#LHT#H/-?/-.:J;>9=+,L2XIC]AK6DNM<S;I
M5?=UN=A6+&ZUJVTZ\?:>D<;AQ\X<EK::IFL!(RW("T);=[@033`E^PLWE^R,
M$<F.SNE'<>PI%'6]2KA0WFX.N6`OS'(E(V_'J5[>,(["_N35ZQ;D&/5=V(:1
M>%(08`8<B&!.:#3==\>VUC6JL&1;KJ2<7HK=IF]*HZ9,VZRW^OH,]RIU<ZWK
M2;V@SM;,SV=/H!"U*-K>'](1[9S7)S#2S5`<^X-#<FQ.KNO.VU?GU;LG3T%N
M6"'*D[@2QS9E(<<M;FD/(4I7>/.@/1>8R])SDX,@6-RA*J#C'EP9Y<YQD$GJ
M[J2I*J=HJ3V?;;WV]F9^MC+<3!K_`$O:]V)K4J&I&R]&%IC,_2QA;.(>\W8J
M2J61A0D)4[E,UZ5)A(7D!7F\V1!:CP#@'`.`<#__U>_C@'`.`<"@OOMA>C,Q
M@ND1FZEPU#4:>);HUK,X$FOV,R&0TS;$=8_4S?\`3M@*FV)2^/Q-#-*/4.WQ
MKN[%)2$K^G;PE*DYAGJ!!7KXICJHL/6"?OBC;;M&HG0=JKA0.VH<Q1O=-XU<
MDU:D98Q*B3U6RVLMR#(3K1Y0A39B;JWK\'8Q[`19WJ9R'3BE^G/I]F\GI_3_
M`,61\;\C[KTOB_A3O)[[Y/\`D>G\/Y_5]W^KP\?4_7P))P#@'`.`<`X!P#@'
)`.`<`X!P/__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g176457g47i84.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g176457g47i84.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0IT4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````DP```DH````&`&<`-``W
M`&D`.``T`````0`````````````````````````!``````````````)*````
MDP`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````!]@````!````<````!P`
M``%0```DP```![P`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``<`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#T3J'4;*2]F.PO-0FY^C0V6[FM]2W;2UWY^]_\W_H[%R=^3EW5.R'Y
MA]%H+7YMKG-QFR?=]FKAM_4,K_K=>&S_``%2V#ZES,Y[V;VVL)W9!!H:1OM!
M-#3_`('9N]_I_P#&K)&^]PS:8N<P;AU7/&RFH#EV!AG9[/\`A?9_X8M4L*#+
MCH:_C_+^7]3(RQ_K%U7IS&V/#[L=[0S$Q\DQD7.&GJ`"?0K=_479XN53ET-R
M*'!U;Y@CQ!V/:8_.8]NQR\^?L-5F;2]S:W^V_K>9)M?I_-].Q='?\7M8N@^H
MUCOLV5C@-KIJ>UU5)_G6BQNXV9/\N^/41R1'#Q`41NORP!AQ`40=7ITERV=]
M9>J8.%US)L;CVGHKF5-:&OK%CK&8^0+'N=9;Z3&MRO3]/W_\:G?];LAG1\O+
M;35?F8N5DX]=#'EOJ-Q"Y^18^IP=;C6^A59LQW>K^E^S?I/UA0M=ZA)<UF?6
M]V/E8]C*!;TC+HI=7FC<2R[)]1V$W(J:'.;BY6QE3<C_``61_.H%OUSR,?J&
M;1D8S!5CUY;\9C'%YO\`L8+W-HRJ?6Q_7_1O^U8>0S%OPOT?]*24]8DN3L^M
MV93TVW((Q[<D58-]=;!:T!F=;7C\V#TLFJKU/9E8^1^FL_1V48VQ6>L_63-Z
M&ZNS,JKNPJZR[/R6`M=2;'.KP[?LV_(>_'=8STK_`$[++&;_`%4E/1I+F>H_
M6G,PW=4N;54ZCH]N-3=CRXW7.R!2[?4[VMH8W[4UN/NJO^U656?S*J]6^NV;
MTV_J6,[&I?;BL;DXC][@QV,+C@Y+LB1[+Z<AGIM97_.^O5_PB2GL$ES5_P!:
M,IN7?ALJJ:_]J5],IM>3M:+*!F^O<P;?4=]*FNEEE7J6>G^D1R>L=1JQ;Z<B
MD^B^VK*;B7'TGN:?2:_U=CGM]/;^EQ_YVFW]%ZEB2G__T.TSQ?@Y+_3%;*W.
M-E;[S-<N&QP]+^J]U?MLI]BKY];+L`7Y[Z<FVJMN11D97Z/'8ZQP:S]#O][6
ML=^?^E_P?K+H<W[)Z7ZU&V?;/TMW_![??O\`ZBPV;_7;Z/J_9MYW?:X^E'L]
M#\_;NV^E]A]_K_\`7$^-_P`MU\;Z?VO/Y;GM_7;?4LMVDLS\FN(`_P#*OIMF
MUF/7_P!WLQWI,_EKJ_JKTVS!Z9OO;&1EN]>R0?4`=_-LR+'[7VWM;_..<RO_
M`$>Q.W]C_;*_7GUY;Z?J>IL]3V^GZGJ^S[9_-^C]I_6?H?9UL)TR>';1?,RX
M-M.^G^#P_P!7_F.-=EXQR;:;,:IV-=:69!+6.%A;]FQV.N]VWU&V6>GZ=K?5
M?7C_`*-$;F8=5-?4*<-H=E/=L>P,#G![/7]5[O:[],W%I98S^=WUU?Z-:?M\
MN?Q0K/LV^C?$[CZ/.W=M/A[-VS>F6.S'<=-'+KS^F-Q@QN%75BQM],AC`/3%
M]WHNJ,-;;5;CV_HO^N*;<W%KONR:>GSE%XINL8*Q8]SGUU4_I):^RJRG9D>I
M_H*UJ_HH/T8D[N.8]TIQZ>X[8W0)B)C7:E<>WXJN/[OXN1D_LW&KNQ:>GTN-
M@'JTM96&NL_G:&VL.S>SU3_/._P]E?\`A/H1R,C#P6?86T4>FRJS[2P,8UI8
M&&UU;:-S6?I+KZ_I?H_TO_;>GD?9?4K];G>V/#=[O0]7_KG\QZG_`&H_F_TJ
M.=O>/-($=E`C31R;<GIQN^U7XU3\C%WQ>Y@WBND!UEE#GM-G^&_1LI>__C%&
M_J/3XL&5B--;&S=+6O\`:^RQN_81N?1;?C^IZG_7%JCT)$;9EVWCF?TD?]_2
M_0?R(V>7T/\`TFE<>WXJN/;\7*MS>G[;V9>$QM5CPW,+O2<QUOI#):+-?T[_
M`$F5?^!+5QZJZ:*ZJJFT5L:`VI@`:T?N-:SV>U#ROLWL]?Z&[O.R9&WU?S/I
M[-F]6$#704@D=!3_`/_9.$))300A``````!5`````0$````/`$$`9`!O`&(`
M90`@`%``:`!O`'0`;P!S`&@`;P!P````$P!!`&0`;P!B`&4`(`!0`&@`;P!T
M`&\`<P!H`&\`<``@`#8`+@`P`````0`X0DE-!`8```````<`"``!``$!`/_N
M``Y!9&]B90!D0`````'_VP"$``$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$"`@("`@("`@("`@,#`P,#`P,#`P,!`0$!`0$!
M`0$!`0("`0("`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`__``!$(`),"2@,!$0`"$0$#$0'_W0`$`$K_Q`#4``$`
M`@(#`0$!`0``````````"`D'"@4&"P0#`0(!`0`!!0$!```````````````'
M`0(#!08$"!````8!`P,"`P,$"P@."P$``0(#!`4&!P`1"!(3"2$4(A46,2,*
M03(D%S,T);5V=[<8.'@Y46%28C6V-QE"8U1DU&4F-E;76*A9&D.S1%65EJ?'
M2(DZ2A$``@`%`P(%`@0#!@,&!@,!`0(`$0,$!2$2!C%!46$B$P=Q,H%"4A1B
M<B.1H8(S0Q7!4V.QDJ)S)!;PT>&RLS3QPB6#_]H`#`,!``(1`Q$`/P#?XTA#
M2$-(0TA`1``$1'8`]1$?0``/RCI"(]9)Y.XHQHSD5Y&=0E%8I!=Q(!'.&P1T
M:DW()UEI2==+(1+-!$"CW-E5%$]AZB!K-1MZUQ42E1IEJC&0`$R2>@`&I)BZ
MDE2O5IV]O2:I7=@%502Q)Z``:DGP$5K4[RCSV?KQ;*UAZENHFD59)0BV4%FB
M#Z+=R@*(D2BHY26`I7JBZ*HJD,+%,W0F)S%`ATQ/U&8XE<8&PM+G)75);VL=
M*`)-0+KZFEH)=.IU,@200.NY%PR^XQBK"\R]]0IY&X.EL"6JJFOK<CT@`@`]
M=3($D,!U/-_*^0QI5'UQR9DNQHQY.LC*':2ZR#V?D!(84XN#@VSIBU>/E0,/
MY")(I[G4.FD4Q@\&&P=]G+U++'4-U0]6/VH/U.TC(?WDZ`$D"-)Q[CV6Y1D:
M>-Q5`O5.K,9A*:]W=@#M4?0DG106($5V8C\@5ARYD!W%S..QCZFV82+Y>61G
MGDU,,#`!AC$G!W31DQ<K23H.V)0[(AN90!$$S`,AYCXUIXW'I5H94O>EE$F4
M*I_41(L1(:]_#O$OYCX3%AC4J6><-7)EE$G0)3()]1T+,-HU_-/I+68S-.<@
MK6X44+64TJXB("0KHAO=R9B"/J`JJ%*U2*<-A$H)&$!#T,.O!9<1L:,FO*C5
MG\/M7^[4_P!OX1EQ'Q9A[0+4RM=[JM^D3IT_[%.\_7<`?TQPM)YCOL?WI%Y>
M^2%EKA(=NLLI#.;;8WZ;E5\F4K=HO76)WZ'MC=PK@2J-^WNF0=OS1#89/C-:
MXQII8?`J]1R`&"J)`&9.]I:_EZSU,;/E'$"^!:SXSQ6G4NZK*`Z4Z:E%4S+>
MXTC/38/5/U'P,6HXPYL6B?@8FS1LM7<D5262.JPE@;E9*NT$%U6BQ4'L8FT3
M36;N6YTE`6;**%4(8IPZ@'467N/N+"YJV=Y0:E=(9,IZB8!']H((\09Q\\W]
ME?8J\KX_(VS4KRF0&1A(B8!']H((/0@@C0Q*BL<P<-RBB3&UV&/Q[+*"4G8L
M\K'H1IE##Z$2EQ512(7I]1,Y3;!Z#K'3Q][7&ZWM*E1?X58_]@C/:8S*7R[[
M/&7%5?%*;N/[54Q)YD]9R3-I(QSMJ_CW[9%XQ?,ETG3-XT<IE6;NFCE`ZB#A
MLX1.!R'(82G*("`B`Z\K*R,R.I#@R(.A!'8B/(Z/2=Z=1"M12001(@C0@@Z@
M@Z$1]6K8MAI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"
M&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:
M0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(__]#?XTA#2$-(
M1T#(.2JKC6)&3L;T"K*E.$=$MA(K*2BI`]2-&PG+LF01#K5.)4D]PZC;B4!J
MJEND4+`=8@KGK*]LM>"[YF2NOIA[5L=M'3BUXJK3),EF4(V0:N%!3?!)%)92
M&:/2+]M4&9`2*<2(G4(`'V6-L&OKZTL?<2F:S2#N2$'F3(__`,^$>[%XVKE\
MA8V"7%.C[[[0]0E4'F6`.G;IUZRBDX<3YSY6/FLQG5P^Q'B!%PF\BL/0;HY+
M+.D3,FJW6N#PQ2^V4,(!N"Z8+I=(@FU;'-WAD3_>>/\`#Z;T./*M[FR)-<N/
M0GB*8[_@9'N[CTQ*'_N'BGQ]2J6W$T3(\D*R>\<?TJ<]"**]_P#"=IF"U1P-
ML=MR[R3PKQ,K"6.J'$14A9XMJ"$70:^H"3*%463ZR/K;)E[YVRRHB"JA%#*R
M3L3@<P`53OAXL+Q;/<RNSD\C6=;1S-JS]6\J:Z3'82DB]!TVQKN.<'Y1\B7[
M9K+W-1+"HTWN*@FSR/VT5TF!T!`%-)$#4;8JW;06=.85Z/:+"O(R"!U!03>D
M9.?DT-'@KO\`**K#H]1`10W^+I'83[J.5A5,)SS"'P'#,>+6W"4P-3,C<Q_5
M48]2?_HJ@``?1EM1XO\`'^)%K;>U;T%U)=@&=I?=4<RFQ[>`]**%``LWQ5Q/
M<52$;12)6E98#TK.U5S%DYV1<B0H&>/@;G3;BJJ4-MA5*"0?"5,I0Z=1GE^<
MV]:LSH&KU>@EZ4`\`3K_`':^,15GOEO$I4?]E3J7=<:`C^G3'D"P+'\$(/ZH
MCWR0SUC+$1']#Q9V+QD<G>93%IDU$Y&OTU7I%)=)FR0!.,F+`@81`$U"KMVB
M@;+"H<ID=;WC.'S><-/(9<FVQ6A6F@VO5':;&;*A\05+#[9`AHWG$;#EW*S2
MRV=J?L,"9,E&D"E6L.H+.9NE,^*E6<?;M!#16U2Z79\I68S%D=9RX<*B\FYQ
M\95=)DBJH(K/7RYC"=9=4V_;)U=:Q_0-@`QBR?=W=OCK?>X`4"2J._D/^)[1
M,5Q<4;*CN;0#0`=_(?\`QI%N-8E)6H4>O8\K\BYBZS7([V+9FP-[0SHZJRSR
M0?/ED1*NX=2L@Y5<+@)^T*JINDA2[`$55[&TNLA<Y.XH"I>56F6;64@`H`.@
M"J`!I.0U)B+ZG'L/7RMWFKJR6MDJS[B]3URD`%"@^E0B@*LA.0$R3K'4I>\4
M*J2$8G?+8TK+.07ZUG*R#^1>`S3-NZ<HQT4SD9%P(``E*()"4R@@`B'J(>Y;
M2_KT*S8^S-6JHT`(4$]@2Q51YZ](VM>ED/V=S4Q=@:]RB>A`54%NB@LS*H$^
MNHDLY>$61<8.?]#>V!&DXCNRTL#*/]W]$SL+/L(UW%L>VDY-&'D6;=-JY;)B
M3J%!4B@@(&$BA"F`(KSG$L_B:)R&4M`*3/(L'5O4VNH4DZZZRE_='S1R/A/+
ML!1?+YNR`H5*OJ<5$?UN2?4%8D;C/64IZ>$[I\79CJN467[FJ_+IYLB"DC77
MJA/>H`'251PS.'261CP4-L"I``Q=R]PB8F`!Y%E*_2..5@WUC+6K8NAI"&D(
M:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI
M"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(
M:0AI"&D(:0AI"&D(:0AI"&D(:0AI"/_1W^-(0TA$9.2'*/'_`!WB&Z$T]4DK
MU/-%EZG28B,EK#8)---4&HR00-?:/YA:,0=F!/J(F`*JCT`8H=9T]C88J\R.
MYK>F/94R9V941>_J=RJC37K/PC96&)O\D':TI+[*F3.[I3IIW]52HRHN@)D3
M,RT!BI1N'*/F+-W!"$]UA5XNQ;2<'8[<E#6*]V".1F&[26AXBI)2`P6/TR1S
M\RS59VY<*(@B8/;D,H"J70I3XYA6I5+FH,C<B<Z=,M3HJ9:3J$;JDCU"JJG]
M1E([ZE0XG@:E*K>UQF+\`SI4B]*V4R].ZL5#UI'JJ*JGH7($C(2V3N%."'&Y
MQAAMD07SV0E'T[EK(]KF!DYJR6Z63:'FS+/"I$<3EBD6T8@P1:MTE%T8YF5(
MQ>Z&X>2J^5Y=E4-M8`U-@5*5)=J4T'0`=%4$DDD@3),]8\UW6S?.<S3IV&,5
MKC8J4Z-!-M*E34Z*!.2("Q)9B!N8DD3E%&>4>9V5\Z3:^,N+]7L;-LZ!1)Q8
M6;3KN$BT`P(*.T#IG.RI<,)E`W=*J@X`!(856PB9/4H8C@N'X_07*\MNZ3..
MB$_TE/61[U6_A`V]1)M#$Q8'XQX]Q.U3.\\OZ#5%U%-C_14]9'\U=]/M`V]1
MM?0QWW!_CLBV:B5KSW*GLTXNL+X]/BGJPQ*;A4PK*'L4[N5_-NSJGW430%%$
M#@.ZJY3>FOS_`,G57!L^.T!2MP)>XP&Z0T]"?:H\"TS+LI$:KE'S57<-8<0M
MA1M5&T5G4;I#0>W3^U`!T+!C+\J$18@[<T#$M3<2#L]>HM/@FR??7$C6)C&B
M*>R2"8`F4G=64,($23*!E5#F`I0,80`8S49/-WJ4U]VYOJAT&K,?'Z#N>@`U
M.D0UNSG)\E3I%J]YDZID!,NQ[F7Z0.IZ*`)F0$4\\FN>L_D`LC2<0'?5:E*@
MHSD;.<#L[19D!`R:R;3H/UU^%<@(AT@/O%T]NLR)3*(#-G%/CJVQII7^;"UK
M\:K3ZTZ9[3_6P_[H/0-(-'TAP7XBL\.:&5Y($N,H)%:76E2/8G_F./'[%/0,
M0'B*N(,!W#*[YN=JR?,X`5`[D@FS5<NGP%.!3H0[,A1.[4$WPBJ(=E(?M$Q@
M`ANWRV<L\538U:J^[X$@`?S$]/IU/]\2IELW88BB]6ZN*:2[LP51_,3H/IU/
M]\6Y8SXMOZ[#-8EDT95.*(`*JG=&*^F'JYBD`[UXDV,7O.E"A\7=52$H`!0*
M4H``1#E>;6E2J]0,U>MY>E1Y`GM]`?&<0IG/E;"T:CFV-2\N.GI]%,>6YA.7
MFJL#UG'5<^Y'P[QJC3Q@$+D7*KQL)XNM/'?3%Q`JE`$9:RMX\2>T8D`>M-JH
M<[AW]A13((K)Y./VW(>6515!_:893ZG4>IO%4+=3V+``+WF?2?/QFMS3G]?W
M:;C&\<5O5419U'EU2FSSFW8NH54ZF9])IEMELGKQ8)"S6-V#Z7E%NXL=)!!H
MV2(``1!HQ8M$T6C%DV3`")(I$*F0H``!J:[2TH6-O3M;=2*2#N22?$DF9)/4
MDF9CZ!LK.AC[6C:6X;VD$AN8LQ\2S,2S,3J2223%C_#FJ-\.)2&2;%".GMZG
M(\T5`QCI0K)I78%R9%PZ>/-N^NM,2RB*9>UVTA;-R"`G$RQR)QSS0U<][6,H
M7(3'(VYR!-G<:`#H`JS.LSN)Z>D$QGS[&7?+1;XBG?+0PU-M[D`L]1Q,*H'I
M544$F<VW,?M`4$RZF>3^0:<@ZNC";:U4U;07EDG<2T1(NB+5,3E(DM(>^.95
MQMV@+]B@GZ=AWVURUIP[%/4IT#2>J[$#U,>_\NWIUCEK#XNXPC4Z3T*U>HQ`
MF]1A_P#CV:=_P^L68>+OR0J<P(27QKE@\/%YZIS()3N1C4L9&Y"J9!1;K6&.
M8%4.BSG(EVJ4DDU2`B/2LDL@4"&530T7.^&+QNK2O+#<V*JF6IF:;]=I/<$3
M*DZZ$'H">&^2N`+Q.O0O\9N;"UVVC<9FG4U.PGNK`$H3,Z,#T!-O6H\B+(:0
MAI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&
MD(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0
MAI"&D(:0AI"&D(:0AI"&D(:0AI"&D(__TM_C2$=#R1?HK&]5?V63^].ELVC&
M`'Z%9.46*<6K),VQN@IN@3J'V'MI$,;81``&JC<910F0G%2=HL\A;I>=N%NF
MX]@DF@[FI^?G'R497ZW!L$Q5<O7[YT<&\7!Q#0NP;CZ%`"E`RA@`WNH4*M>K
M2M[>DSUW("JHF23T``ZF%M;7-]<T;6THM5NJC!5502S$]``-3'T\2N2C/)V;
MZQ2<"8DNUMP>^&V0^4.34]`O:]5W[F/J$^\CHBI.)5NF=1NYM+5HV!DB*;T"
MJ@X7ZR`!4>DR7%7P^,K767R-&EDY*:=L&#U#-E!+R,E`4ENX,I3!CN,EP:KQ
M_$7%[G<K;T,M)#3M`P>LVYU!+[3*F`A9A]TY2)!TBK9;@;?;UD6;L'*3*LE;
MG$1.2\<SKD`X!,H-6<FNB1!1]V$HR!9N`;E,JTBVH%$3B)7!3!U#UM7Y`Q^)
MLEL.)8A*(*B;N.\NLIEG([-4;_"1'9W'RKBL!CUQ7`\`EN-HW5:@GZI:G;,M
M4(UD]5^VJ$:1.JC8[H^-(9.OT.KQ%7B2=`G;QC8$U7:B91(5Q(O5!4?RCL"C
MMWG*JJHAZ";4<9#)Y#*US<Y&[>M6\6.@\E'11Y*`/*(?RV:RN<NC>9>_J7%P
M>[&8`\%715'\*@#RC`7('E]C/!*#N).X+;L@%2_1J;#N2=;-4Y`.DI9),I%T
M()N)3`;H$JCLY3%$B(D$3EZ/C?"LMR%DK!?9QL]:K#K_`"+H7/GHH[M/2.OX
M=\;YWEK4[@)^VP\]:SCJ.XI+H:A\]$&LVGH:9+ODG.W+6\-(U1&5L[U5P<]>
MH]9;+D@(%(_P'709=PZ+<B29_OY!ZJ8X)_LBP)E`"SG88KCW#,>]4,E&F!ZZ
MM0C>_D3U/DBB4^BSZ_3F*P?$_CO%5*ZM3H4@O]2O5(]RH?`M*9F?MIH)3^U9
MG6P?`?CK@81-E9<XN26&9^!=*D13@0KS`1`IBDFY%,".)IR0?0R2!DFI1`0$
MRY1WU&_(ODZXK,]KQ]/;H=/=8>L_RJ=%'FTV\E,0]RSYKNZ[U+/BE$4K;I[]
M19U&\T0^E!X%@S'P4Q93%0M?JL<#6(CHR"C&:`=1&J"#)NBW;)[=:QR@0.A%
M(GJ8XCL4/4=M19<75W?5?<N*SU:S'N23,^'_`,A$(WN1R67N/>O[NK7N&.FX
MEC,]E':9[`#Z16;R<Y_,(4LA1L%.FTK+B"K24R(!2.(F+-L*:B-524*9&7?%
M-O\`IIP,T3VW2*OU`=.5.)_'%2O[60Y"A2CU6CT9O.H>JC^$>H]RLI&;^"?#
M]:Z-'+<LIM3MM"EMT=O`U3U1?X!ZS^8I*35%[6"X3IS":4L=CG'JBRRJAW$E
M*R;]R<RBRZZRAE7#A=4XB8YSB(_:)A^T=34!;V=!54+3MJ:R`$E50.@`Z`>`
M$?1].G;V5NE*DB4K6FH```554:``"0`'8")TX<X^-*H9K8[@FA)64!*JQC`Z
M5V$*<0$"F-^<F_DR[^A_5-(WYG48`4UQ^5S;7(:A:DK;]ST+?_(?WGOX1SN0
MRIK!J5`[:/<]"?\`Y#_M[^$3/;42RJQSJ;>,20<"P:K/Y"=L3A&#BF+!NF*J
M[UPYD#HC[5),HF,<I3``!OKBJN8Q]*JENM?W+EB`$I@NQ)T``6>OD2(X.\Y;
M@;2NEH+T5[YF"K2H@U79CH%`28#$]B1%8&>\RC=9!Q5:R[!2FQKSXGZ)5T0L
MSIL80(^Z'":#E.)34#J;)*$(<_HJH4I^DB<EX3%FUI)=7-,B[9?M,CL![:$C
M=XD$CL"1J9+P]DU*C3NKBB4N76>UI$H#V.TE=WZI$@=`2-3W;@,2\M^46.9^
MBK/F+JKN)*:F91H8Q$HZ#)%O&KD[LVPIF(Z<.DD4B&`P&<*)^GIN&J^0:MG3
MXMD$NR)U-JH.Y?<")?0`D_P@_2.3^5[C'T.$99+YAOJ;%I#N:N]67;]`"Q_A
M##O([OV&,IM,HU8CX_9;V&+%)G86"8@`)N1((I/VZ8B)@8R!2&,3?\TY3DW'
MHW'Y>9=I\H^.%;</.,OZMBZ&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0
MAI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&
MD(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0C__3W^-(
M135RKM^2LLWF18TO)4/5J1!J?+J^="C%G9HJJ::24Q*-Y&3L_P`A6^9/$1,B
M96*4Z$"D#XO7?=6%;%VZ(UWC7K5N_P#5V(?":K3WZ#0RJ"?E&RLKS"T`C7V'
MJW-43T]_VZ9UTFJTO<TZ&543\H^WC]Q'J"N)+W:+K*N\PS]NMT+'S$CF:.J]
M\C64%62DE6L97JE+N*G289FYM$B@Z,UZ#(++,FPJE4,DD9+W7?);UGMUQU&G
M8TJ0;:+<,A.X2)9R6=FVS`8F8!:4IF>UN>89%Q;C$6]#&4:6[:+4-38[AM+/
M4+-4=]LU#,TP"P$MQG*S&<(P2R+4&R98%^K"-G"+('=\K[B0K\<UB7P(M:U0
MZ(\0J\"P(02I`T3.](@F<5``"@`EYZK4>H7J5'9G8S),R23W).I/G'+O4J5J
MK5:U0O58S+,9DD]23W)^IB!?)3*-!Q1;LD6*_P!FCJ]'%O%Q]N5TH)W\BLG.
MR!A:Q4:@"K^3="'^P13.(!ZFV+N.MIBL1D<Q62UQMJU6KI.711XLQT4>9(C8
MX?`9?D-Y^RP]B]:M/60]*CQ=C)5'FQ'EK%)^;^?&0\G/#TG!T9,U*(D5_8H2
M31(SK(5A%3X4T8\D=[GZ?!81]"-#+/!$`$%R`)D]35@/CG&8E!?Y^K3K5U$R
MITHIYG=+?+Q:2_PG0Q]&<5^(<-@J8RG*Z]*YN4&XJ3*WIR[MNE[DO%]J>*'0
MQ^.$_'ID"\JHV/,3]U0X-RH+D\,0Z3N]2H*B"IU')5BN64#WQ.(B9SWW0'`0
M.W+N!ANS_P`EXW'AK7"4Q<7`$MW2DOTE(O+^&2RZ,>D7<I^9</B5:RXU26[N
MU$M^HH)+324FJ2\%VI*4G/2+=,:8CQYB&$"!Q]6(^`:'!/WKI(AEY6553`0*
MXEY9P*K^16`3")>XH)$P$2IE(78H0OE<UD\W<?N,E=M4?L.BJ/!5&BCZ"9[S
M,?.><Y'F>271N\Q?O6J?E!T1!X(@DJCZ"9ZDDZQ\N5LRX\PM7S6&_P`^A%HJ
M`J$;&(]+J<G'"1>H6L/%D.5=VIN)0,<>A!'J`55"%'?5^'P>3SMR+;&VQ=A]
MS'1$![LW0?34GL"8R<>XSF>47@L\/9FHPEN<Z4T![N_0#P&K&1V@G2*/.1O,
MS(&<E'5?BC+TK'`G$A*VP<C\PG$@W`JUIDDN@STI]Q,#-/H:$W*!BJG("HS]
MQC@V-X^$N:TJ^4_61HG_`):]OYC-CV*@RCZJX5\98?BBT[RX`NLW+_-8>E#X
M4E/V_P`YFYUD5!*QB_#?''*>;WB?TA7G9(`B_9?6R02,T@&G0;99-)ZOVDI!
MZD4!W01,8X#MU]`"`ZW&:Y-A\"A_?7:BO*8IC5SX>D3('F=(Z3D',>/<90G*
MY*FMQ*8I@[JA\/0LV`/ZB`/.+?L-<)JIC=DF>2D/=RRR1`D7S)(AI!T;8IC)
M!(NDS%9,Q-Z"@@B`"``(J','7J',W\AW-^Y6TH2I#INZ#_"#J?,G\!TB!N0_
M,]>[9J>'Q\J8.C53I]134ZGN"S_X>T9_L\CA_`E8<V^QC$5R/8EZ4WSHHOIJ
M0=]!CIL(D%S+R#V0==(]**/IL`F$"D*(EY:W.?Y-=K96[5*M1ORCTHH\6E)0
MH\3_`'DZQ_1N^9<YOTQM&XK7%1^J*=E)5_4X62!1^IM>VI.M)')OEU<,_/U(
M6/(YJV,V3KN1M9(L'O9<Z)A!"4M+A`XINW8_GIM2"+5KN`!W5"BN>=^*<+LN
M.4Q7J$5LJP]526BSZK3!Z#L6/J;R!VCZ8X)\<XWA]%;JL5N,ZRR:K+TI/JE(
M'4#L6/J?OM!V"--0IT_>)E"#KS(SITJ)3+K#N5HP;=92*/'RX%,"#9+J]1]3
M&'X2@8P@`];=75&SI&M7>2_WD^`\XD*O<4K:F:E5I+_>?(1;7A%FI@BI*5^G
MECD9B45([LEL4CD7$S,NR%Z44.MX+E!K$,"B(-FQ2;$$YSF$RBAS#%.<MJ7(
M+P7.0+M1022GN(11W.DB6/YFGK(#0`"(IY%Q^PY3D$O<RU6K1IB5.CO*TT'<
M@)M8NWYF+:R````$<]2O)'?.-7):H.9&1/;,;HM$(C*M>(UCRO31LTZ347>Q
M+ENV27^=5UD1)XB@8X(.##VC](F!1,?CW&Y3"W#VU'V<@232:;2,AT8$D;6.
MDY3$IB8F#X+[XGP.4PMP<9:BURDR:3AG*F0^UPS$;6.FX#<I`(F)JVVY7+%!
MV^O05KK$HSFZW9HB-GX"9CU078RT-+LT9",D6:P;`HV>LG!%"&_*4P:@JM1J
MVU:K;UZ96LC%64]0P,B#Y@Z1\RW%O6M*]:UN:92XIN593U5E,B#Y@B4<UK%&
M&&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(
M:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI
M"&D(:0AI"&D(:0AI"&D(:0AI"&D(_]3>)Y!W@U(QM*J-%A2EI\?IZ+,0W2HD
M=^DK[UV00$#D,UCDU1(</S51)_=U>@FWE%KF2Q5'KT1@B9?%K(M;9IR6+K6[
MC$"V:1%S6FLNJU]M-R"[,J4E`(HO!Z'3M9JP(NDW*!NX4BP[;A\5K4JCAGIH
M2%$S($R'B?`><>BA3J514]NFS!1N,@3(=R9=!TU.D2%KM-M%(R+9)U]*1JF+
M4:JZD(]-LQBXM[%S)G_>>,UX>#@FB3II'0[8QDW95!56%<4S)=1.XI;*DU%9
M.?W!>4I:;9==Q/6>DI><XRK3I>UN]X_N"\ML@%VR^[?/K/24I`:SC5+>\.,S
M<DLIV_+^?+4]I[&WV>>L+:OK2)+1<V49+RSN28PI#`X=0->:,VSLI"`"SHZ8
MD$IVY1W'4W5>>X/CMA1Q?';-:U6F@!>7MTRP`!;H'<DC719]0QCZ#N/E/C/$
M\90PW$<>MS7IH`U3;[5$N``SG05*C$@DF2@SF'(B?N)N/V*,*LBH4.JM&<B=
M'LO+(_`)*S2`"``I[F8<%%=)%40W%!N"+8!]2IAJ,LSR3,YZINR-XS4IS"#T
MTU^BC0GS,V\XA;D7,>0\HJE\OD&:C.:TE]-)?H@T)'ZFW-XL8S$NN@U06<N5
MDF[9NDHNX<+J$20002(*BJRRJ@E32223*)C&,(`4`W'6C56=E1%)8F0`U))[
M".:1&J,J(I9V,@!J23T`'<F*V^0GD(JM/![5\,D972RE!5LXMB_</489;<R9
MC1Y2]M2S.TA#<IDS$8@(E-W%@`R>I2XU\:WE][=WG2U"TZBF/\QAY_\`+'UF
M_4270Q-W#?AO(9(TK_DY:UL="*(_SG'\7_*![S!?J-JZ-%3KA?+'(&]G64"R
M9&O$VI^8DDJ^<$1`_H1)%(I&4/#L^OT`H(-&Y/\`!+J8U7#<;QP4>U:X^F.^
M@G]3JS'\68^,?0R)Q[AV)"K[%EBJ0[D*)^9/J=V_Q.Q\3%GN`/'5%Q!F5GSJ
MZ0G)`G;<-Z#$N5/DK14!ZR!89=`R:LPH0=NILV%-MU%$#*N$S"743\D^3JU8
M5+3CR&G2Z&LP]1_D4_;_`#--O`*=8@?F'S3<7(JV'$Z9I4>AN''K(_Z:&80>
M#--I'1483BT"-C(Z&CV<5$,&<7%Q[=-HPCH]LBS8LFJ)0(DW:M6Y$T$$4RAL
M4I2@`!J):M6K7J/6KU&>LQF68DDD]R3J3$#5Z]:YK5+BYK-4KN269B69B>I)
M.I)\3$5N1?+['N!FSF'243MN13H_H=2CW!03C3J)]:+NSOR`H2*:@`@8$0`[
MM8!+TIE((JDZ_C'"LER)TKD&CC)ZU&'W>(IC\Q\_M'<ST,@<+^-\SRZHERP-
MMA0=:S#[I'44E_.?XM$769)&TT597S'?\TV12SWV:4D7(=PD=&H=;>$@VIS`
M;V4+&]Q1-FAZ!U&$3K*B`&5.<WQ:^A,-@\;@K46F.H!5_,QU=SXLW<_V`=@!
M'UCQ[C6'XO8K88BU")^9CJ]0_J=I`D^`T4=%`&D<EC'#%FR.X3<D(>(K1%-G
M4ZZ1,)%0(;I40BT!$@OW("`@(@())B`]1P'8IKLAE;>P4J3NN.RC_CX#^_RC
MWWF0HV@*GU5OTC_CX?\`;%E6-<3MZ_'$@:)7'KD-R"^>(MSN7;UP4H_I,K(`
MF5,#_&/2!A(DF!NDA2AL&H\R>81G-?(W:+X`F0`\%'7^R9/>.%R^>LK3_P!1
MELA2I"6@9@-/!5ZG\`3'1>0M_3PHS&`4>1CG(D@U$R%?:.T9%>MI+I@*$G8C
M-P69-3&(?K;M>X=9;8#&*5(P''U<>HKG6-Q2IN,<I_S""H<CJ$G)CX%I`#I,
MG2*\9O*')B]S8T:IQ2&7O,I1*A'5:8:3M+HS;0HZ3+3`JV>/'4@[<OWSA5T\
M>+JNG3E<XJ+.'"YS*++*G'U,=10PB(_W1U):(J*J(H"`2`\!$CJJHH51)0-(
MW7/$79+4XX;X[I-Z.N6Q4]H\4BF[TP^^3HD_,RLI3DU^X/6/M(Y7MIDV_1VO
MMTQV$-@^6.>5+.MRK+5;(@TBX!(Z%U50\O\`$#,]S,]X^+?DBYL+KFV=J8X@
MT?<4,1T-145:A'^,-,]S,]XM"UR$</#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0
MTA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2
M$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$0;S7Y+N`_'>
MQKT[,'*S#]4M[)P+23JJ%D+:+)".BKI-C-K!!4]"?E*\X*HJ`B1ZDW,!`,<0
MZ"F,"*R)[1G#!?)WCQR;@WECX^YIQOE^)C#HI2ZE#MD3//()=P4QV[>PQ31R
M:5K[EPF43)I/4$%#E^(`$/72!!'6,Z:12/_5VG.<6;OE.06%(1I>2+%]+PY'
M@)U>K+RK&0DIENE(*@C)"X;0[<Z+!-!,/=N&YA5$Y2AM\1MUC\6;NF*O[^UI
M*3K[E0*1K+59%CX^D'2-K9X8WZ)5_P!TLJ%/O[M8(5UEJDBY\?2K:=8K=G;5
MROO0J,,>XWJV'XM8!*6VY1L,?8+""`FV%>/JE2--L&#\FWPD>J.4C?EZ=P$.
MCM[/AV/E4R64K7U8?Z=NC(D_`U*FPD>:A3'36F/^/<3MK9G-W&2N!_HVM-J=
M.?@U6ML9E\2@4CM/I'5*GPP.[N<%DC,&7LB9/R#!R3&4A7#"2=U*-AI)F\1>
MLODA(ITI-1PM'B!#)"P=,`[@=8)E,(;>ZYYXU&TK8W`8:VL[%P09J*C,")'=
MN&TS!UW*_A.4;.\^47M["OA^*\=M,?C*BE6FHJNP(()8L`C$@F>]:A[;B.NS
M_!(O7=7B(BZ&8/IV0KB2=A9"1`$GJAVB#>9*+0!%-5L"KKMJB4H)")P]"@8"
MZC4]9CI$8#I(]8JQS)028XOLK7VIE#Q2A$92%.J(F5^5ONL4D5#F$14.S<)J
M("<1W4[74.PCL'H5MPGWC`PD91!/./+#$V#$%V<U+%L-P*0?;TJO*HNY<%!*
M(D-+K=0M(%MN(;BX,"QBCU))*["&NMX_P[,\@97H4?:LN]5YA?\`".KG^73Q
M(CN>*?'O(N6.E2UM_9QO>O4!"?X!UJ'^7T@Z,RQ31F/D_FCDC*IUL@/F-??N
MRI1&.*:D^<D?J[[H)R`-4S2EH?\`P`;90O9`X=22"0B.IRP?$\%Q:B;H[6N5
M7U5ZI`EXRGZ:8^FLM"QCZ9XSP/C'"+<WQV/>(LWN:Q4;1W*S]-)?IZI:,[1(
M'"7CGNEH%G.9BD3T:"4`BP5J+5;.[@\3-L8".EC$=14`!R&`?C]TX*.Y3HIF
M]0YO/_)]A:;[?"4OW%P--[3%(?0:,_\`X1W#&./Y3\U8NP%6TXU1%W=C3W6!
M%$'R&CU/PVJ>H9A%M6-L38]Q'"A`X^K$?7V9@3%XN@0RTG*+)EZ0<2LJY,K(
M2*WV["JH8I-]B`4OIJ&<KF<GFJ_[C)7;5'[`Z*H\%42"CZ#7O./G;.<BS/([
MHW>8OWK5>P.BJ/!$$E4?0:]YF.TV2S5ZG0K^QVF9CH""C$17?2DJZ2:-&Y`]
M"E%54Q0.LJ<0*FF7J44.(%(`F$`'R6MI<WU>G:V=!JEPYD%43)_^@[GH!J=(
M\%C87F2NJ-EC[5ZUW4,E1`23^`[#J2=`-20(J&Y&^0F5G@?T_!8NX&',*K5Y
MD!RF=M/R*>PIF&MM#[*0390-Q*Y5#WH@("4K<P;C-/%_C6C;>W>\@VU*^A%$
M:HO\Y_.?X1Z?$L(^CN%?#=O9^SDN6;:USH1;C6FO_FG_`%#XJ/1XEP8K6B8>
MRW2>2C(6.F+19)ITJ=)FP;NY:7DG:QCK.%A32*NZ<*F$3**''?TW,8=MQU*E
M:O:V%N:M>JE&UICJ2%50-!UD`.P'X")PN+FQQEHU>ZKTK>RI*)LQ5$4#0"9D
M`.P'X"+,,'^.ZQN?:6#+JS&*`>A9&K$6"052WV,493V2H(.%"_E0*N0@#MU&
M4`1*$7YWY-L*6^WQ"M5;]<MH_`D3_':?PB'>1_-&#L]]OA$>ZJC\X&Q/P9A/
M\0A^HBS"L80H-90;I%BRR@MDTTD2ORI>R033*!2I-XMLF@P(@4"@!2F(IT@&
MP#J++WE&6O&:5;VU/Z>I^K&;3^A$0IEOD?DV4+BG="VHGM2T;\:A)>?FI4>4
M0GY/\Z(.A-WV.\'+1TG:$>ZQDK8T2;KUZK&*82+-H5(I#,YB9(.X"<`,T;&^
MWNGZB$[7B?Q_<9)Z>4Y`'6T.JTR3OJ>!8]57R^YO(2)[O@OQ5>YJK3SG+?<6
MR:3+28GW:O@:A)W(GE][?PB1-,\E)R,S(/9:7?O)24DG*SV0DI!RL\?/GC@X
MJKNG;MP=1=PX64,)C'.83&$=Q'4Y4J5*A3IT:--4HJ`%50``!T``T`'@(^F*
M%"C:T:5O;45IVZ*%55`55`T``$@`!T`B:?&#"<`:789"RU"R+Z#8';OJW4"D
M023GG1#=Q&0GQ76(JC#-S%*9-MVQ%Z;85.E`.E?C>4Y2]>W?'8:X1*SS#U#.
M:#P20^X]VGZ>WJU7C.8768NK*IC./7=*C7J`K4K-N+(O25,`$;SJ"Y8;!]H+
M&:7W<$>8&/KIR&DL;1RSJ%L"/O:V[B)([<"3+84D%4WL,HBH*3E2-GD$FRZ1
M@(LD4XG*!B";:#L_Q')X2RM<A6VU+.K^99^DGH&!Z;AJ#T/3KU^8>4?'^:XI
M;6F1N&6MCZVGN)/T,9R5P=1N&JG4'4:&0-[&N.CBH:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(IF\
MJ>8\V6JZ<9_'1Q>N;W'&8>9TY9U<@97AQ6+.X@XZ4!@G(Y%LD(NBZ8+,+%8F
MIUF\>NDL14Q&3INF=NX<-G"=#%RRU)[16UQYB'V'LP<GN+O`_P`1_'?/[7BC
M=8/'>0\W9BS71X_+&096:B',LPG;'+9&I+EXJYFUF3Q8[2/<$BVBGHDB@0Q2
M`_"+CK(EH^=EBZA\M<(Y1\AOCXPDX\?GD9X69`R'4,EXCHSN'4I%[L6,4&,U
M>L36N+K<17Z+>FEJKQCIH/4XJ.,_E@4:R!5D01=IHI.6A,Q&9/\`S(V#/^B<
M9_06_7Y_EW_\I?\`LX?G?Y,_XS_;7^]])PV'^^/_UMG/+LP:>R=>9(Q^LIK'
M(LT#[B/4TBUABV8AOZ@`M&1-@_)KTK]HCSL9L8QSJZ*1FKCY6D;/E:M-W1`4
M9Q2B\^Y()>HIOE"0N&93%$!**9I+L@8!]!*(AJQS)3%R";")CRN::>PY`UG&
M;J:KC:YSY)&+A:\YEX%W;Y",8Q3J;E7<=6H"-F[BTAB"P%55Y*.(N+`$/0#J
M`01STL;?5K*O?T[9S94Y;GE)`20`-QD"Q)'I$V\HVU'$Y.XLKG*4K)SCJ,M]
M4B2`DA0-QD"Q)'I!+>44.>7GD=EZ8Y0)<?,!+R2[J#QO5V-S4I,>Z?W`D_-O
M9V<-$FDFG?4@F3:O3,<N91$K==,RYA.N!/A"5N"<<P28?_W'R$)M-5O;]U@*
M>U9#=M,MY+!A([@9"2SUB:?CCB/%TP@Y=RP4]ONL*0K,%H[$D-VTR#L7#B3;
ME,A)9ZQ`_$WCAO5F73G<SV,M19N50=.8&(7;SMM?&5.*BX/Y4QUX6)65$_5W
M"FD3B;<#D*/KK=YGY0Q]HIM\%:^\X$@[`I3'A)=&8#P]`\"8WO(OFS$V"M:<
M8LOW-11(5'!IT5EH-J:.X'27],>!,6CXNP7BO#;+VN/ZA&P[E1$J#R;4(+ZP
MR)`V$P/IMX*S]1(Z@=?9*<C<IA^!,H>FHCR_(,OG*F_)7KNH,PG1%^B"0_&4
M_$F(#S_+.0<FJ^YF,D]1`9J@]--?Y462@]ID%CW)C+>M-'.Q#7/_`#5QCA8K
MR#BETK[?T@41^G89VF,?#N0W+O9II,%F[$R1RCU-406>=0`!R)%,"@=QQO@>
M6SI2XK*;?&G7>P]3#_IKH3_,9+X$D2B3.'_%V=Y0:=W<*;/#G7W'!W./^DFA
M:?ZSM3P+$;8I1S#GG)><IGYK>YU1PT05,I%5R/!1E6X0INLH%CHL%5"BN!#B
M47"QEG1R^AU3```$\X3CN*X_0]G'6X#D>ISJ[_S-X?PB2CL(^H^-<1P?%+7]
MOB+0+4(]=1O55?\`F:0T[[5"H#J%$9[P-P7RCEHS.<M**V.*.H9)49&:9J!8
M9=J8`4_<*`6[*P)+$$O2Z=B@ATG`Z0+](DUSO(OD'$885+>T8760'Y5/H4_Q
MN)C3]*S.DCMZQR'+OEC`<=%6TL&%[E1,;48>VAZ?U*@F)CNB;FTDVR8,7,8>
MP)C+!T/\LHD`DW>+I$3E;+(=M[9IHQ-AZI&5%),X(]0=16Z!46J9A$2)E$1$
M8,S?(\MR"O[N1N24!]*+I37^5?'^(S8]S'S+R7E^=Y7<^_EKPFD#Z*2S6DG\
MJ3.O\3%G/=CI'>[I=ZGCNNOK7=9UA78".*`N9"05Z""H8#=IJV1(!W#U\X$H
M@D@B0ZRIO0I1'6OL,?>9.YIV=A;M5N6Z`?\`:3T`'<D@#N8U.+Q61S5[2Q^+
MM'K7C]%4=NY)Z*H[L2`.YBDWDUSFM&5PD*9CCWU.QVKW6KUWU]BS6UN83$4+
M(+(',$3#N">GLT3"=4HB"ZABF[))YXI\?6F&]J^RFVODQ(@=:=,^0/W,/U'0
M?E`(W'ZDX+\46''O9R>;V7.:$BHZTJ)_A!^]Q^LB0/V*"-Q@9'1S^6>MXZ+9
MN7[]VH5%LT:(G7<+*&^PJ::8&,/]T?R`'J/IJ17J)21JE1@J#J3TB7G=44N[
M`*.YB=.(N.;2`%K8KXDWD9HG0NR@MR.(V*4_.*H^,`F1DGR8_84.IND8-P[@
M])B\?D\ZU;=0LR5H]"W0GZ>`_O/E'-WV6:K.E;$BGW/<_3P']_TC+.8\D(8O
MK?N#E_Y13#=0M;8+$$HK&'J2-*J$.`">-8G`1$P`)5%`!,!#<1+J\38_[E<%
M58>PA]9!Z?P_4_W#6-=C:*9"NZ4ZBM3IF3R(,CUVF70GP/;6*]<89/M&*,HT
MO+5;=J?5-*ML7;F2RRJ@>]>1[\CUPV>J%W44;2J8'1<!ZB=)4X#]NNYR..ML
MEC[K&W"?^GJTRA\M-"/-3(CP($=+EL5:9G%WN)NTG:UZ90^7@P\U,F4]B`8]
M$R!EB3T%"SJ39PS3FHF.EDVCPG;=M22+-%X1LZ3'U3<(%6Z3E_(8!#7QS5I^
MU5JTBP)5B)CH9&4QY1\%UZ7LUJU$L&V,5F.AD93'D>T<MK'&*,`\HL@YGQ9@
MN\WSCWAC^<)E^"^F?I'$'U2PI?U=\SN%?AI__E-)D48QOR"L2+V4^,![WLNT
M7XCAI%1*>O2*9+=Y+O+W1*I9[Q;?#LE#56FUZ:M=FF%^3U+71BJ_78US+S,D
MLBTC7#M9)C',U%3%23.H8";%*8=@&DSX1=M7]45PU'\5#F*]VNL4>I<%*C,V
MJY6&%JE9AT,Z2:"TK8+%)-HB&C45G>.F[1%5](O$TBF54(F43[F,4-Q!.*[!
MXQ9__K`_,W_X,?\`WHJ'_P`#TF?"*;5_5%T<_?9ZKX0FLH3U8)'6>NXJD;[,
MTQ21*HFQGHFHK6&1K"DNW16(H1K(-SM!<D3,`@7K`H^@:K%D:BM<_%699MMA
M@:K7^#=,D)ZS3,77X1A^O>2:^]EYE\A'1K3W3W'39DV]R]<D)W%E$TB=6YS%
M*`B%)QDV#QB>/(7S%^2;AS6RY"Y/>(AW5\<$51:/K56>3E<ML#$.WRR32-^H
M;3CVBY+AJPD\>K$01^8%;@X74(DF;N&*44SX10*IZ-$B?'SYY^*'.^^Q>&'$
M#;,#9MG_`'056H7EU%S-9NJ[1NH\4BJE>8KVJ+FP%9MU%`92#&-47`G2V%PI
MN0$XH5(UB\758MAI"-3Z^_B:(&H<X9C";/%--E^+=?S*TQK*9O1LDTI935=E
M(-:W:LBQT:@W-#/X9A,D=OFA">KJ*23V'N'ZM4G%^S2?>-KMLY;O&Z#MHNBZ
M:.D4G+5TV5(NW<MUR%507072,9-9%9,P&*8HB4Q1`0';58LC]M(1JC\T_P`2
M-=N)W*G-_'*/XGU:ZLL175U4FUK>Y;EH-U.)MV;)T#Y>)0H4DDP.<78AVRKJ
M@'3^=ZZI.,@28!G%HWBE\M&,O)G2+4D6OL<4YUQ\X4<W'$)K+]1**U%T[(VA
MKW591Q%P;F;KRJRZ;1_LV*I&/S$36V(Y:*+@9Q:R[?I$[.6F<'7&CC+G;D"Q
MKK>W/,.8OM^0VU8=R*D0VGEJQ$.)-.+7E$6<@JP2>&0Z!5*@J)`'?I'[-5B@
M$R!'2N!G)Q]S+XD87Y,R=0:4)]E>$FY=Q46,PM8&D*:(M]AK!4$9AQ'Q2SXJ
MZ<&"PF,W2Z14$NP@&XH$2)$8$\D'E4X[>->I0;G):<Q>LIW9H]=X_P`.T]9D
ME8IMDR.9LM8;!)OC"RJ-.3?A[<7RJ;A==8#E:-71D5P2I.45"DQ7EACR(>:/
MEAAY'DCQUX#\:X_#]B1F7E!B,BY7FUKY<&$(]>Q[EY"E^I*.B[:N'[%5NU4=
MLHPKLZ0JI`9!1)0S6*D*#(F,'\1/Q-].N.3V.'N;.#DN/4DYFRU1]DZLSDE(
M4^L6@CT8MXTR#3;(P;V.D0[&03,FY>E?R@LS"/N$4DDU%RIP*>!C:P343633
M614(JDJ0JB2J9BG343.4#$43.41*<ARB`@("("`ZK%D0+YZ>2'C/X[:'&VW.
MU@D75CM!7Y*!BZG-FLMD"\+1P(@]6C(YV]CF$;"1RCE('4B^<-FB0J%(4RBQ
MB(G14`GI%-?'3S*>3+R#6"T.N"_`+$Z.-*9(#%6"[YHRC+N85C(+(B\81JUA
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M\H^3V2X?#N"/'A6\AY*GVDN^AZK'9^/&NWK2!C',S+K)NYZC1,80K*,9JJF`
MZY1,!-B@)M@&DXO*`=3$_?\`6!^9O_P8_P#O14/_`('I,^$4VK^J+BN.%YRU
MDK"="O&=,2_J*RQ/Q\@XN6)_J-E;OHUZWG)1BR9?4<<0C*4][$M6[OK3``)[
MCH'U*.JQ:>ND4#>2?\0%<.!'+>]\9HCC'6\EL:="4:72MTCE"4K#M^:X5"(L
MZB"D.VI,TBW*Q4DQ1*8'!^X!.H0*([!0F+E68G.)2^)_S5XX\DDK<\:6FE1F
M#LZ5HAYV!H7U>:SQ]_I*227OYFKRKR$KJZTS771A"1CNR=1-J=-TF=1/W`-@
M,499?2+C<E6U2@XYO]Z18DDU:52K5;4HU1<S5.04KD$_F",5')4ES-R.S,P3
M%0"'$@&WZ1VVU6+8A1XP^<$KY">*T3R-F,=Q^+WLE=;E4C52,L;FTM44ZL\;
MM4WP2SJ'@U3G>@ON*?8`";>AAT$582,HF1EC+6-L%XZM>6LO7*$H&.:/%J3-
MHME@<BWC8MDF<B*8=*9%73U\]=*IMVK1NFLZ>.E4T$$U%5"$,BG6-9J<_$:9
M&Y"9LC\`>-CA9/9UMDVX>H5V=R;8/IXTRDQ1,9W,K4R&4;M:S560%[ZDE+V1
MB1-N(>X3:F$0"DXOV2$R8D-D[EYY^L'TV9RE=N!O$_(-+K[4TW/5S#]TMTS?
MH2`9,@<R9U(T,E3+NP.6YBG,(Q,>].F0H_<'*451:PDI[QS_`(_?Q"W%SF5<
M8+$&3:Q)\9LQV5RTBZLPL]B8V;&]TFWAR-FD#7[\FPKZ\?8I)T;I;,I.-9IK
MG.FB@Y<.#E3%.!0C7M&P)JL61KI^4SSFW3QV<ET<!U[C3"9;C_U4U/)CVUO\
MB2M768ELT_8(`63B.94R?02:-G,0B4K@ZY>M5R4G2`]/50F+U68G.,+<"?Q(
M:?+/E5BOCGDSCO7,.Q&69-Y58*],,H/[-[6ZN8]RM4(1S%/:7"$5):YE!.+1
M,5<#E>.T?02B;2<"DA,&-I758LC5V\@?XC@G$#E9DOC?C7CW7,RQN*UHF`L5
MW?9.?U@JEU/%M9"S0+2-94V=)T59X\".<',L!_?-ER=(`0HFI.+PDQ.<3"\0
M7E]L?D^L><X*=P9"8?)A^$HDNV<Q%[?W(TZ:Y/[0S5072>5>O`P*P"O%,4Q3
M*]SNB`@7I]0,X,NV6L63<T^0SSB=Q6S?R-CZLVNKW$5)=6UM5'DJK!M9Q1N\
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M-8J0HT)B-%`_$V77%.69["_/CAQ(XRL=1LCFLW>0Q7.NCSE.D6:PHKIO,;W4
MR@3+0`.1<KIK8P(LU$%6Z;@JB8BG%=G@8VGL19=QMGG&U0R]B&WP][QS>X="
M<J]H@UQ692#)83)J)J)J%2=,)%@Z24;O&;A-)TR=)*(+IIJIG(6L8^FABG;F
M'8F7'KS(>/CD!D`S&/Q3FK#.6>(I+?((D)'4W);R74N5-)(R:Y#H1KB\24VV
MBV0]2)C%]T8Q^RFMM3N(N&JM%=]/X3Y4Y;\P_-,]PER^Y+\7<K4G-=0;T5GA
M[+<]CS%UWL<M2;,[C$,PPU81;SLVR2=Q16J#QL]25C4'BZ@(N1'M&>,5G(+,
M1+[QD\J.,?&[Q=9UL[VE-\-Y*XDRF26G,G&UJF7\U:9?DHU[\4M(2\M/2,A+
M6%WF*9C&D?&=:ZB:;LIXM)0X,A4$.D&!+"-/+_5<<K/^A$G_`$(OY^'^3U/]
M$W_NS]G_`.=G_%W[?_WOJDHR3']\?__7V-I)Z#IY(2*QP(#ERZ>JG5,4H$!9
M51=0ZAOA(4"]0B(^@!KU@$R`&L><`L0`)DF(L9%Y?X,QXJ:-^J0NUF$PI-JM
MCY(MIE%W'QA[8[EDH$,S7*<NQDUG1%@WW`@^NNLQG">09,"K^S_;VG>I6_IJ
M!XR/J(\PI'G'=X7XWY7F5%?_`&_]K8]35N#[2`>,F&]AX%5*^8CO'"WDQGI]
MR(@;/=,*O,88"<0UAAYF1GNHMO36?L06@Y-6/D?82CQB$HQ2!1-G'E[:*QC]
MY;H*0_JSF#XOBL55IT,\+K.[ED$UI@3]0FNX`R/5G,R);1K+9Y_CG",!AJU.
MWY2+[DVY9"D)T0-WK$TW*#(]6J$DB019F5@L!CS+-)S;F/,U<S+;,PQ=O1=2
M.-\.Q\M%Q-1I4/:Q932ECL-/8/VLO;I"([BK2(.LB<3).5%%"@H")QT%YF+:
MZQ-EC:6(HTJE,#?6U:HY42T)'H!T+`=2!K*8/.Y'D5M>82PQ%M@;:C6I!=]?
M5ZM0J):$_P"6K:%E6<R!J!,&+'R5K%RU@>#%(L)V<F'LK:79V96TO+S[EPJJ
M_D)YP9,CU_*JN5#BHHX$RO4([CK7UKJXN12%>NSJB[5!)(51T"CHH\A(1SEU
M>WEY[0N[EZ@IKM0,20BCHJ#HJB6BJ`/*/HU@CRQB'+6=<8X3BOF=^LC9@X53
M,I'0+3I?6.7$!Z0".B$C@N=,3_"*R@I-B#^>H76ZPW'LMGJWM8ZU+*#ZG.B+
M_,W3\!-CV!CH^.\3SW*;CV,18LZ`R:H?333^9SI/^$38]E,4WYZYXY+RF#VO
MTD5\<4A<%&ZB,<Z$;5,MC")3%E9Q#MF8MUT]@,V9]L.DQB**KD';4X<=^.\5
MB/;N;^5U?C6;#^FI_A0]2/U-/L0%,?3'$?B3!X#VKS*2O<J-06'])#_!3/W$
M?J>?8JJF,9X9XB9FS49M(QD&-:J;@2J&N%J*O'QRZ!A`QE8EJ*9I*<$Y=^@Z
M"0MQ.'2=8GVZVV=YK@L"'I5;CW;P?Z=.3,#_`!'[4\YG=+HIC><G^1^,<7#T
M*]U[^17_`$:4F8'P<SVT_,,=TM0IBWW!W"[$6&/9RZS'ZZNS?L+?5%E;-U4F
M#Q+8W?KL)LJRA^E4`,FH8SAVF(>B^WIJ%.0<[S6=]R@M3]O8&8]M"9D'L[]6
M\QZ5/Z8^;^5_)_(^3^[;+5_:8MICVJ1(+*>U1]&?30@;4/Z(E[KBHCB(A<A>
M8^-L&(NX5JNC=,AE(9-&J1+M,48I<>H"J6F33!9*((F(;BW`%'A]R_=E(;NE
M[7C7!\IR!DKNIH8SO48:L/\`IKIN_FT4>)(E$C\-^-,YRMJ=U40VN&GK5<&;
MC_I*9%_YM$&OJ)&TT=9=S=D7-\^,]?9Q1Z")UOE,(U`S6`@4%A+U-XB,`YTT
M>HI"@=8XJ.%ND!44.(`.I_PN`QF`MOVV.MPLY;F.KN1W9N_D!)1/0"/JOCG%
ML+Q6S_:8BT"3EO<ZU*A'=V[]Y`259G:HCG\.<;\J9M=)GJ==>DKX+"D[M3Y`
MS:#0%,W2NDW=N#((/WB8`/W29_0P;',3<!U@S7)L/@E/[Z[47$M*8,W/AZ1,
M@>9$8\_S#CW&D/\`NN2II7E,4P=U0^'H6;2\Y2BW;#O":N8[9D%_($/)+$*$
MA(-$B.)9UN("=$LBZ1*C'M@V#[E%$Q-P`3&.8.H8>S7R)6OG(MK<[!TW:*/\
M(,S]2P/D(@K/_,[7+,F)QY*CH:IDH\]BF9^I<'R'2.)S_GG#O&9DM`U6$B;?
MEA5N(LXUZ<THA7SJDW0D[.Z,KNR``$#$9MA2<KEVW[29P5U=Q["<AY=4%Q>W
M52AA0=2OIW^*TQW\V::C^(B48>,8?FGR)5%UE<G6MN-AO44_I^X!U2DH'J\"
M[[E4_J(VQ2E=[Q:LC662M]SF7<[8)94%';YV8/A(4.E%JU1(!4&;%JGL1)%(
MI4TR``%``U.=AC[/%VM*RL:"T[9!H!_>2>I)ZDG4]X^D<5BL?A+&AC<9;+1L
MZ8D%']Y)ZLQ.I8DDGJ8GEPHXBO[_`"\5EC(T6=MC^)<)OJY#OT3$/=9)N<%&
MSH[=4H==79K%`YSF#H>*%!,H'3[NH[YYS2GC:-;#8NM/).).P/\`E*>HG_S"
M/Q4:Z&41'\H_(U+#V]QQ["UPV8J*5J.I_P`A3U$Q_JL-`.J`[C)ML;KM!="^
MHM+>B(F%Y4ZXZ$QBE*8PN(=FKN8I?A*(]?J`>@:^>#U/UCY?'01VS5(K#2$1
MHYH_T.N6/]6C.W\EMJTBHZB/+AX7?TQ>)W]9?!/\J55U9&<]#'K:ZOCSQAKD
M9_1[SM_$UD__`#(G-(J.HCR?>.?](3!/\<N,/\]X/5D9ST,>FWY8+YC;'_CD
MYD/LH2D3&PUCX_91HE?0E'#1%2:R!=:;,U_'\-#)NBJ^XG'-L>-5&_;3540%
M(7'3THF$+S&!>HCSPO%KA'*^=.>_%R"Q+"3,C)U#->,\E6>;BTGA&M(I-!NT
M%9++;IF3:@4L0RC6#`Q43G43%P\41;I"*RR936B,S&0,>J3JZ,$5(^:SFFYX
M7<&[[+U"0,VS/F=7]2F'$&B@C+M;!<&3I&?MD:@CUNO<4RJ$=NVJI4SIEEA9
M)*!LL`#0Q<HF?*//;YK<,<M<%,R,\*YA:D3L+_'6/,B,G[5!1&.?,[M664C*
MLF!U%%1=?1]P))U]RL`@19Y$K*$`$SDU2,H,Q,1O3?AYN;1N5'"*-Q=;YLLC
MEOBNXC,7SQ'*PJ2DIC99FJKB2RN.HQC'2"%8.8,3B(J**P1U5/54!-41B<2,
M7V:K%L>?IRZ\>N0^<O-_S#6C#IWDOE7C;D*FWF"QXV236-D>N3S&?1N$%$%*
MD9VI<FC2OMW,2B0VSTZ:K0"&6<(&3M\8R@R"SBCWC/R/RWQ`SI1L]8<FCUW(
M./)GW2*+Q)92+FH\_4TGZA:HTBK920KECC3JLWS?K25[:@F2427(FJ2D7$3$
MC'H#9AYMXIY^^%+EEGW%JQ6)W_&?+$)?Z,Y?(/9O&N0H^EKJV"G3*B)$17*W
M%RFX8.Q21"0C7#=R":7=%(EW:,8$F`C,_@V_LIN'G\#+G_*Q?]!TBC?<8U&O
MQ+<%?8[R83<Q:T)'Z6L.',6KXQ=NB*"P/5XV->1TTSC%A3*ETM;ZC+J+)`8Q
MB*..LVP*%U0]8O3[8E7XLOQ$=1XL8+QOQ=Y.8@LTW3<:HGKM/RQBQ:)=S;.J
MNI%R\9,+;0YIQ"MY$]?4>G*,@PD2KKLRD*+)1PF95R!@R3,Q&8*1XEO%]Y0,
MO9BS;Q]\A5ADK)E;(^0,N3>(8NHUBM6VC#?+3*6Q_$(4.W(0=O&O5US,BS2>
MD9J,CE2#H6,&PC60BFYAH1&W=A;'!<.X<Q-B(E@D[:3%F,Z)C@EJFDT4IFS%
MH]6BJR6P2R3<1;IR<R$7[E<I!$@*J&`OIMJL8S'F?>9'D98N2OD:Y-V27DG+
MR!QWD6PX0H#%1;NL8FFXBEW]-0")(`B"+*PS<<^FC@/Q&<2:AAVWZ0M,9E$@
M(WQ/"SB*"PYXQ^)41#1R3)Q=L:LLNV%T#7V[N8G<K.'%V/(OSF335>*HQ<NU
M9H*FZOT)H@0HBF0FJCI&-ON,8R\SGC$L_DOQ#B*LXULE`I.3L69(>SK.UY`+
M.%CPH=BK$E'VRO,UJ[#3<B#R4L#""<@4R141(Q.(F`P$`PB<%;;$??##XFN4
MWC0R9F"1R7FG%-YQ/E6BQK)S4*"XNBCY'(E:GV:]8LBJ%DJT,P2:-:U*3;58
MZ2W>.=PB`D.4O4F`E%68-VC*7XBS^RFS?_#/"G\K%4T/2"?=&IC^'DE(R'\I
MV%'\O(L8IBE3LT%5>R+MNQ:)F5Q5:DTRJ.7*B2)#**&`I0$?41V#UU0=8O?I
M'HP_K&Q[_P!/*9_\T0G_``[5T8I'PCN":B:R::R*A%4E2%4253,4Z:B9R@8B
MB9RB)3D.40$!`1`0'2*1H]^2+@?:_(/YCN=.*,=RY(_)V/.'%`S7C:)=+-&L
M5=+74XWC_6_H>5?O`!*-)8X&Z/DV;DRB"2,H5J9PH1L"XZH>L9%,E'UC63HU
MWRWQDS-"7:HOK'B[,^&KJ==HJNT6B[%4;A6)!9C)1,Q$2*!3IK-G2"S*1CW:
M(D53%5NX3,0QR#;&3J/*/1EXB^1F@>1[QXYER-$ECJ[ENGX9O]<SCC=LYZU*
MI;SX_GQ2F8E!=95Z>D7(K19W$+*"H)2D6:'447:+&U=&$B1$85_#6?V8-5_C
MER[^^\?H.D5?[HJD_%7<EK2:_P#';B)%R3AE3F=(6Y`7&.;*JD0L,[/6&RT*
MD?,R@/:4+5VE2F5$$_\`"DQ.<!$J0@,50=3&6?PH6&H!&B\K^0;EBV<6F1ME
M.PU"R1R`+R(@(:'&[69BU4!3<K:Q2,]$*+@)?B/%HB`^A@T$'["-OK58QQY9
M/E?P[#\=?)%RQQO36/TY!0V6%;?68Q@C\M0@(W(\/"Y1B8Z&0;D0!C&1"%N(
MDQ*F``FV33Z1$``1M,9UU`CT'O$OR2L7++QZ<:<SW-X>1O,C4)&G7>07/UO)
M6T8SL\YCJ0GY`P&,49"TEK"<JKML'4]]"E_-"X1A82)$4_<T^-%=YA>9[-W'
M"R>V10R?XF9.)A)-VC[A*O71CE9*:H=H%(!*=7Z:N4:Q>B0IBBH5`2;@!AU3
MO%X,E!\XTB7+>_82R<X:K!+4;*.([XJW5#8S.=I]^H-@,F<-C%$S66K]BB1^
MT-R+(_9Z:MC)'I@1WDUH"_BG)Y'W'R[MH8//8G=9,X[+4^<6R@T57&Q%?B73
M;NLS$^5(K"3K,T4(XZ.D=M73TG&';ZML:2W*GC18,;^,?CMRIRB=Y)YNYQ\G
MLBYFM4[+`H,R\I9*S)C2%'ZBP"==:ROYB7L??*;9="<1W#<F^J=HR`^H@=!%
ML'X3/_2%S8_@9@_]^\EZ"*/T$;%7F._LP>:/\34G^^\/JIZ18OW"//>\5G]I
M'P@_K+XG_P`ZX_5!UC*WVF/4;R1=H[&F.[[D>83,M$X_I=INTHD59)L96.JD
M&^G7J97"_P!R@8[9@8`.?X2[[CZ!JZ,$>2%D7(-^Y(YLM>2+Y-FFLBYER"]G
MIZ8D5E_;GG;=,B?H+TE<'90\>=V5%N@D04VK1(B21`(0I`LC/T$>M_CFAUS%
MF/J-C*GLB1M3QY4*W1ZS'IE(0C*`JL.S@XAL!2%*0.RP8IE'8`W$-7Q@C66\
MQ'@JY"<]>7+;D1QXMO'NDPLSB>F5J^H9/LV0(&R3N0:O)V>/-.IMJ=BB[1[F
M,"A_(6*2RSPKD3L3D%(J9$S'H1%ZL`)&)\^%3@+RG\=N&,KX9Y$9"Q/>*Y.W
M^.O.,6>+;'>;&WK2TC"C&7AL_4NM%HQHYM)N(J-7;MVB2R0K^Z5.)3JCU!%&
M()F(L8Y5<6,-\RL*6K`^<JY\^IME(FY:/&BA&=BJ%E8D6"#NE.EQ26/"VF`6
M7,9NN!#IJ)G40736;++HJ5B@,C,15)2^/GFRXE`O1\(9MX><P<6DW;0%GY3P
M.1:3G9A&M&JJ<*RM=EQXH*5W6C!.4BDE*R,G(.RE,`>V*<@)4UBLU/72/\5_
MQ><GN5^2ZUE+RFYMQ;<J74K-&W>!X?\`&2KRE7P-*VV-[BT=-Y2L-B:L+=D@
M\>=VNG[.1(]$"KK)IOO:N'#==+QAN`$EB]SY='_[@9?M+Y=^U4/\G_[@_,_:
M7^U?F?WM5BV/_]"\>6X[8DE1*UL%5=33=F<2)Q4]:;C,Q#<R7W8))PLG8'<2
MFFCT[%(5$"$V#8`V#744N2YJ@2;>[%-SU9*=)6/U94#?C.-]0YER.U+-:WZT
MJIZM3I44<_5UIAR3W.Z9CO%6H%%HZ(MZ;3:O541(!#EKT#%Q`J@`!ZKG8-4#
MN#FVW,8XF,8?41$=:^[R60R#;KZ^K5F_C=FE])DR_"-3?YC+95M^3R=Q<-/_
M`%*C/+Z;B9?A$J,*4N$D`L&0+F1I](4E!(X(R9UTHR6L3LQ4XF.>*-T'*IF9
M%U$Q6*5-3<5$P,0Q#&*.O<G11U,>!0-2>@CF:A7L@2&6:U=&;Z/LIG=QBG4O
M-U&4;RS=DP<R+=O))OX]LLE*Q46E%J&3$CA%%,&WP@.P>E"1M(/A%1/<#'V^
M0"?QMB2/K.4;G/1-3;21I"%D7;Q0I5I=RP0;NHY-DP;@I(RTH1J*Q1(@BLJ9
M(A=]BD#7NQ.,R&7N/VF.M7JUNLAT`\6)T4>9($;;&8/*YZ[6SP]A4KW)ZA1H
M!XLQDJCM-B!VG&N7FWR/6"9%U`80B#UMB8RB`W*?;MGD^Z*.Y`/$0A@<QL24
MXAN51P+I8Q3`/;1.&IGP'Q?;4-ESGZPJU.OM(2$'\SZ,WT&T>;")_P"+?"=G
M;>W><JN17J]?9IDK3'\[Z,_F%V`'NPC`^/.(?(O/DH>UV5&1@6,NL5R_NF2G
M4B$I)E$2E,NTCG0+V&54%`-T3J$1:J%``!<H;:Z+)\UXQQRB+.U9:E1!(4J`
M7:OD6$D77J`2P_3'79GY'X7Q"W&.L62M5IB2T+8+L7R+"5-!/J`2P_28M!PU
MP<PQB<S:5DF!LBVM`2*%F[6V;J1S-<FP]R)K0"M&M!*<H&(=<7;A(P;D5#42
MYWY`SN9#T:53]K9G\E,G<1_$^C'S`VJ>XB!N3?*W)^0A[>A6_98\Z;*1(8CP
M>KHQ\"%V*1U4Q,H`````````````V``#T```/0``-<-$9=8Z?>L@TO&D`YL]
MZL4;6X5J`@+J06V4<*@43%:Q[-(JCV2?*%`>A!NFHJ;8=BCL.O=C\;?96Y6T
MQ]JU6N>P'0>)/11YD@><;+$X;*9R\2PQ-D]>Z;LHZ#Q8F2JOBS$`>,4[<A/(
M+;;O[ZK8>3?4>K*`HV<V98Q4[C-)".PF9G0,=.L-%`WV[1U'9@V-W4MS):F[
MC7QM96'MW>;*W%YU%/\`TE/G/_,/U`7^$Z&/I7AOPYCL5[5_R4I=Y`2(I#_)
M0_Q3UJD>8"#IM;1H@93Z3<\E6%&OTV!EK58)!0RGM6")W"OQGW5>/G2ABMV;
M8IC;J.'"B:1-]S&#[=2)>W]CBK9KF^N$HVRCJ3+\`.I/@`"3V$2YDLIC,'9M
M>9.\IV]F@ZL9#R"@:L?!5!)["+:\`^.R"@!8V?.#IM9I<G;<(4:,64^G&*FQ
M5"%G)$O9<3JZ1M@.@EVV?442F,Y3-J&>1_)MQ<^Y:8!#2H]#58>L_P`BZA!Y
MF;>`4Q\Z\P^:+N\]VPXK3:A;&8-=@/<8?]-=13![,9OW`0B+,"$B*[$@1,D;
M!0<,QV*0A6L9$Q4:R1^P"E!!FQ8M$$_\5-,A?R`&HJ)KW-:9+U+AV\V9F)_$
MDD_B3$&DW-[<$L7JW=5_-G=F/XEF)^I)BJCDWY`B)A(4;`CL#J""C26R2*0"
MF3?<BR%.;KD$%#;")?F*I0`/46Y!^[<!,'$_C<GV\AR)-.JT/^PU2/\`[!_B
M/58^@>"?#Q/LY7EU.0T*6T_[#6(__&#_`#GJD5,.'#^6?+.G2[N3DY%T=9=P
MX56>/G[UTJ)E%5E5#*.'3IRL<1$QA,<YA]=Q'4RJM.C35$55I*)`"0``[`=`
M`/[(^B:=.E0I)2I(J444```!5`Z``:``=`-!$QL-<=E4G#"UY"9I[(*).X^H
MO$$UR+&()5$5+$@L!TCH;AN+(Q1`_P!BWIU)#RN6S@9*EK8N=1(N#(C^0C6?
M\0Z?E[&.?RF2%6G5M;9V`8$%U)4B?78PD0?X@01U761B65-YQR,'GAMC^UO8
MZ0QHX^65$9)!A%QPU>P`<Z(2**D:U:(JPR+E=-F\24^%`B/=2$O0<BW"Y7X^
MMZV"J9#'TF3)KNJ;2S-[B]2IW$D-(%E(ZD[3U!6(N4_$V.K<>KY/!6[T\O3#
M52I=W]Y>I4[V8AY`LA'W$[6!F"NW=C5(Z&.:`BH&RB-*JJ2@`("`'3@F!#``
MAZ#L8-0>WW'ZQ\YCH/I'==4BL-(1&CFC_0ZY8_U:,[?R6VK2*CJ(\N'A=_3%
MXG?UE\$_RI575D9ST,>MKJ^//&&N1G]'O.W\363_`/,B<TBHZB/)DPM"(V7,
M>)JXX>R<:WG\F42$7D85X:.F6",K:8IBJ]B9`A3G82;4BXG06`!%)4I3``[:
MLC.8V4//!XCT^*>)Z;R=QUGCD)F>I?7C>CWV!Y`WPN2IRI+VM@]=0-GKUF&.
MA%DH->0A/E[Q!PBY<F<NVIRK"3K*6I$6*T])1]'X>WRA6JH\B*GPPR16\2L,
M<YJ-*1=/ME.Q3CS&%FB,CQ\4^F*\SLTICNNUA*[,;45DM&)JRJ#V23?N6@$=
M$;E43T!@ZZ3C>HU=&*-'OG=S*K_*#S3XV._Q5G?/W&+QYVDS1[1^.M!6RG:;
M%D&G2?SBS68]<&:A85.#>YABHB">K+O4V[J'@RF*"AU^R:WO&4"2^9CJWG2Y
M(8^Y\XOQMD*D<)N?^(\H8.DY8LOD+-G&IO2J`KB*=:'<3T98[3#7FSN&:T+9
M&+)W''<MO:H%</@ZTS+B)A@H([B455^'CG"IP1YNXZR%/2AV.(<@'+BC-J2B
MIBL6]$MCYD5&V."")B%/0+&W93!E"D,N9DU<MT]O<&W"*L)CSCT_DU$UDTUD
M5"*I*D*HDJF8ITU$SE`Q%$SE$2G(<H@("`B`@.KHPQKL>,'^V`\U7\,L1?\`
MK;GJ@ZF+V^U8K&_$,^(P*3)6'GWQMJROTC.OCR/):B030RB=7GY!Q]YF*'8M
MP$4:]/.E@+/I)D`K)\8'P[HN')FXB*HW8QK7<?\`E=ECCE7<[4JC2O<HO([$
M-LP]E.GOU7!H6;BI^(D6$+8"MTE"D1LU,D)`SF/=``G*11=N(]ERL`VQ>1.4
M>BIX-O[*;AY_`RY_RL7_`%<.D8F^XQB+R29(\-G)9I-\9N;F=<<5V^8QFUR-
M'*$W)UG*V)[(]8M3NU("<3@I%N@62CE4#.&3I%]%O2E046;JG10.FT@-PU`C
M7FR+^&WNF1,>QF<O'QR@QOR;Q-;&SZ5I[.XMG..K',1[%\^B5FL%9D0EZ?9'
MB<K'*I"L]"NH;E,&P=(">DHOW^(C7UM=3SOQ$S>[K=GC[M@_/.'K,T7.D1TY
M@+=3[$R*A(Q<I%RL8Y]2+METG3-ZT74;.VJI%D5%$5"F-2+]#](]/_QL<A;=
MRKX*\:<^7\K?ZYON.T37!TU10:MY6S5F7E:=-SZ3-JDBT8EL4C7E'_MTB%2;
MBX[9``I0#5\8")$B/-K\D..YS%?/SF/2;"W60?,>1N69=H+A$R"KROVVXREO
MJDJ*)OV,DS5YUF[(`"8O0N'28P;&&V,PU`CT;?$]<FU[\:W"2;:.R/4F/'7'
M%-.LF5$I2.<=0B./GK00;F,GUQ[RL*(&$1ZQ,F(G`#]0!<.D86^XQKT<W.??
MX@?A:PMN5\KXZQ#1,"'RD_I5&MCF/P=;7#UO+/9]W2VZ\/4LF3UJ36D*]#'5
M,JX8I%3,005%,Y@*--8O`0_6,W^"[R[\P^?'*_(^&N0TIC^3J%=X\V?)L2-5
MH[2KR2%D@\D8JJK?NO&KM8'#%6,NSOK3,7]D*0P"&P@(&*,H`TB=7XBS^RFS
M?_#/"G\K%4T/2"?=&F=X7N-V%N67D#Q9A'D!3/K_`!?9*SE"0FJQ]16NJ^\>
M5W'M@G(9;YU2IVN6%O[.48I*]*3M,JG3TG`Q!$HT$7L2!,1NR?\`E^_$7_V2
MO_KSR:_ZY]5D(Q[V\8MZKE?B*E7H&JU]I\O@:S#1=?A&'N'3KV41#,4(Z-:>
MZ>K.7KGVS)L0G<6445/T[G,8PB(UBV->[!/_`/3!S1_J!U7]]>)VJ=XO_(/K
M$7?Q"OB+#)L)/\].-U655R36HX'G(JB0+0RJM[JD2T32#*D.P0`3FM51C&Q2
MS*291]_%I`Z`"KM%A=B(JC=C&HQQ5Y89:X@Y$DK_`(JES($M%.L^.;]5W:SD
M("]4&XQ:\5.5Z<;(*$!0R0+$>,%Q`YF4DV0<%*?MB0](O(!ZQO=_AK/[,&J_
MQRY=_?>/U4=(QO\`=%$?XJ'&TM`\U\)90%HX)7,B\<XVO,WZH]2#BT8\OUT-
M8F380(7I!C!7&$4.41,(&<[[[&``H8N3H8LD_"C6:+=\9>4E-16*::@<[5ZS
M2#?K3$R47;<?QL5#K"F!A5*5=W2GQ0$0`INV(`(B!MJB*/U$;6&JQCCS&O.A
M;8^Z^5SF#,1JB*K=G;*'4E#('.H0)"@8?QW1)9,QE$TC`LC*5Q8BA=A*50I@
M`3``&&T]8S+]HC=7\!=!GL?^*KC,VL;=5D^M2>1K\T9K(G142@;CDZW2U9<"
M)QW62EZZJU?)'```4G1=M]NH:CI&-_N,85__`-(O_P"M+_[K:=XK^3\8US_Q
M)?#XN`>;;?.]8B_9X^Y6P:]S5.@BH1HRRU5Q90^2F)1'N$ZYE%U%SASB<#*N
MY5R!2%*D`C0Q<AF)1"C@S-YZYA,<+>)F"EG"6%LI<JX?-MH<-?<JRT!$PM0<
M,L@N$E>HZ(5Z(IL8ZF$F)NVW5F4$U!$%#]8/**F0FW>-B+\4O6H&E\5N%M.J
MT6VA*Q4\D3]:KD*R*8K.(@8+'+&+B(MH4YCG*V81[5-),!$1`A`W$=5,6IU,
M8$_"9_Z0N;'\#,'_`+]Y+U015^@C8J\QW]F#S1_B:D_WWA]5/2+%^X1Y[WBL
M_M(^$']9?$_^=<?J@ZQE;[3'IV<B:5)9*X_9TQS#`8TO?\.9.I44!0*8PR5J
MI,W!,0*!SID$PNGY=@$Q0_NB&KHP#J(\CVKO25JY5V1E47*"<!9HE[)-^R)7
MB)(J5;KO$?;JBD8'*94#%Z#"4>L-AVU9'HCV'VSEN\;H.VBZ+IHZ12<M7394
MB[=RW7(55!=!=(QDUD5DS`8IBB)3%$!`=M7QYXJPYT^8GB/X],J5K#F>6F67
MMSM6/X[)D>GC^F15AC4*Q*V.SU9@=Z_E+37@3?+RM/?!V4RJ=*9"F,(=90&D
MXN"D](R/P&\FO';R.M\IN^/T5E)@TQ"M3&UH=9&J4;6F[IQ>26E6*0@EXVQV
M%.169IU)<SPIA2,@59`=C`KZ5BA!'6+#M(I#2$-(0TA'_]'96O,8,-=+;$B7
MI^766;9E#;8!3;R3E-(Q?0/A.F4!#^Z`Z]0U`,><]3'5M5BD6#XW;I1_&4LI
M!G<K.VZ\Q/3@1MS;4)8AV4JX1D#OK.Z$&\.VCH)JFLJ98Z)3H(@/64I@'6,(
MU2LE,`[F(`T)G/02`U.O@"9QZ:-*I5-*E34FH[```&9),A(`$G720!)Z#6,$
M\=N05@RMF6+KL96,?2=/8.)8CV[,^:&)<PVYL+6`E'*!28VI\;;Y57JD8]N@
MJ/SYJ=!)<5S=94U$3=%DL#;XS'BM<WM=<@P$J1M:M-#,B?\`5J;.BDG2F9RE
MWG'797B]KA<8EQ>Y*X7+,!MHM9UZ:-,B<JU;VR9+N;2D9E9=YQPWE+XQ_P`Y
MVI84KRLW*Q+2`OLP^<-X.'^;3$P=_`BU1CH[J5!-FY-VC'!047.X%$`3'[0R
M\2Y14XO5R%>E:+5K5:84;FDJR,YD`3/T!7ZQGX;S6MPNKDKFWL%KW%>DJ+N8
MJJD-.9`!+>$@5^L8]XT^*S&^.F[*;<UYI791/MJI2LVBC:L@*F*`![GWSP0C
M*JHJ38>EDDF.X"!T2CJS-<RSN;+)=WK"W/\`IIZ*<O`@:M_C+'SCS9_G7*>3
M;TR639;-O]&G_3IR\"HU<?\`F%SYQ+];`_'ED1LV<WJ747>2AX!!RC889R8T
MV4&QCQHF9PJS1!\F#Q,>TH`&`#!N`^HZYG>_A''[4\8Q'?>/K:+C9JP8\MT?
M<XRNBZ-/Q0+L_GT&FR%0'9W(-5127%KV%#*%,FV5*4OPD/L(ZO5BQ5=IW'IY
MQ3VRQ`IZDF4AUBD[/7D(HU&][7<2HM,@VE+NMU)TYU0I,4X+N4#$<H'2<68Y
M#>NS4Z;8P>H.1'<NI1X[\:Y#(>W<YEFMK0R.S_58?0Z4_P#$"W\/>)FXC\-Y
M7*^U>\B9K.P,C[>GON/H9BE_C!;^`=8J+MUWRGGBXH/+%(3][M4BH+6*C&;5
M9V9$J@]81\#!1B/89H?#N*;=$O4(=1MS;F&:;*PQ'';%DMJ=.WLU$V8D"?F[
ML9D^;'R$?1F.Q6`XEC7I65&C:8]!-V8@3E^:I48S)\V/D)#2)R8.\<UMLHM)
M[,\BI2H4PE5+4XI1J[MCY+I`Q2O7OZ3%U]-3J`=MG3G8#$,FB;8P1_G_`)/L
MK7?;X*D*]?\`YC3%,?0:,_\`X5[@L-(BGE?S5CK'W+3C%$75UT]UP114_P`*
MZ/4/_<7H0S#2+:L>8NH.*8-.O4"L1M<C@`@KBT3,H^D%2%Z0<RDFX,M(2;G8
M?SUU3F`/0-@V#4,Y/+Y',7!N<E=O5J]I]!Y*HDJCR`$?.V:S^7Y#=&\S%^]>
MOVF?2H\$4251Y*!'6<QYYQM@R#^;WJ;(B[<)G-$5QAVW=CG#E$2],=&]Q,00
M`Y=CN%C)-DQ]#*`82@/KP?'<IR"X]G'V\T!]3G1$_F;Q\%$V/81[^,\1S?++
MK]MB;4FFI]=1M*=/^9I=?!5!8]A*9BC;D/RYR+GMRM%**GJF/TU^ME38QR8Q
M'?;/U(N;'(%(@K-NBB`&!,Q2-4C%`2)`<!.;Z`XSPO&<<5:P'O9(C6JPZ>(1
M=0H\]6/<RTCZLX9\<X7B*+<!1<9@CU5F'3Q%-=0@\]7(T+2T&`Z5C^U9`DBQ
ME9BU7A@.0KEZ<#)1S$#C\)GCSH,1,3!N)4R]2JFP]!##Z:Z:[OK:QIFI<5`!
MX=S]!_QZ#N8[JYNZ%I3-2O4``'X__'GT'>+2<(\.).M$;2@PPO)]1,!/8["F
M$<U8BH`@8L,P7*H]13$AA#OE2454+O\`$4INC47YSG%DQ:D;G^D/R4_43_,1
MZ?P)`'X3B*.0_)G'[4O2?(AY?Z='^H3_`#,/1/R+"7X3C#O)3,D#15GF/L>6
M1*RVM(RS2SV6,2($#7C=)TEXF&>=]525G4U-P67`J:+,0Z"]:W5V-SQG'W62
M5<CD+,T;,ZTT8^M^X9A(!5\!J6ZZ++=O.)C(YNDN5O\`%FUQS"=)',ZM0=0[
M+("FA'VK-F?KZ5ENA#C7'5KRY>8"A4]BI)6"R2";5'?N"BU2.<!=RD@L4IS(
ML&"/4JL?83=)=B@8XE*/993)6F'L+C(7C[;>FL_,GLJCNS'0#^V0UCKLWF;#
MC^+N\KD:NVUHK/S8_E11W9C(*/$ZR$S'HEU.$-6:M6JX=T=\:OU^&A#/E"@5
M1X:*CFS`71RE`"E.X%#K$````1U\>5J@JUJM4(%#,3(=!,SD/ITCX.KU!6KU
MJRTPBNY(4=%F9R'D.@CL&L48H:0C`'+"OS=LXL\E:M68I].V2RX`S)7Z_"1;
M=1W)3,W,XZL<=%14<T1`RKI](/W*:**90$QU#@`>HZ0'41YUW$_QF>0>I\IN
M-5ILW#7D3!5NM9_PW8+!-RF+[.TC8:$ALBUR1E961=K,2I-6,>P;*++*&$"D
M3((CZ!JV1C,6$CK'IH:NC#&*L[14E.X0S)!PS%S)S$SBK(<5%1K)$[AY(24C
M49=HQ8M$$P%1=R[=+%33(4!$QS``?;I`=1'FM8)\8/D0@LWX;G)GA=R-C(>&
MRKCR5E9)[BVT-V<?&QUNB';Y\[748`1%LT:HG44.80`I"B(ZME&8L/&/0.\F
MO'9URJX&<GL)1,6>:M-CQA+3=$BT&_N'DAD*B*MKY18UB`?>)NI>TUMJS`Q/
MB`K@P;&`1*-QC$ID08\]G%7CS\H^'<GXYRW3N%')5I;<7WJI9"K#D^)[6)$+
M!3)YA8H=10H1_P`219".3ZB_88NX?EU;(QEW*>\>AGS2S3F>D<(\D9-X]XDR
M?<\\6?&[-EBS'=<J4E)WRN7;(#%M'1LO.5Y)HLNP/C098\G(HN"$#KCC-A$%
M%"@-T8AUUZ16#^'=X'Y"XI<=\I99SW1;'1\]9^OZA)"$N\>Z87"#QU0C.V%?
M0EV4JB64C9"QVJ4F9)?J-L]9G8*FZND@A01<YF=.D7Z7BEUG)%+MV/;I$MIZ
MGWJLSM/M4(]("C27KMDC'4/,QKDA@$#(O8YXHF;^\;58LCS.>0/AJY\8GS=E
M/'%$XPYVRM1J?=Y^&I62:MCN<F(2[U!!\J>L61L^C&:C`7$G"*(*.4DS"#9T
M*B.^Z8ZME&8,/&-Z;P]7[DA:>$N.Z9RPQ/DW%>9\+E#%$@.3:Q,5R0O=3K;)
MF%&NC$\L@FI)F4K2R$<_6$ZBRDE'+K*;`N3>HC&TIZ=(CIX\\%9DQYY1/+/E
M&\XRNE3QUEJU8Q=8RNL]`OXZMWMM%J6L9%>KRKE(C6729`[2[@HF,!>X7?[=
M.Y@2-JB+PYB'BK#$2D!/1K&9@YR.?0\S#RC5%]&RL5)ME64C&R+)R11N\8OF
M:YTEDE"F(HF82F`0$0U6+8\];RN^#O/7&WD([E^(N$\MYQX\Y16E+%3(S%E#
MN&3[!B9Z19%28Q[;&M5BYN5:Q,<L]*:#D792@]8&!$ZJSIJY4-:1&56!&IUC
M<&\.%"O6,/&CQ4H>2Z7;,>7BNU.V-K!3+S7)BI6N"<.<FW=^W0F*[/LX^7C%
MEV+M)8A5T2&,DJ0X`)3`(W",;=3%&OG@\*F<<Z9HE^9_$>KI9%E;E#P;7,^)
M(QTT8W(T_68=M7V%\I3-\LSC[$TD:Y$M&\C'(*%D@>H`X12>>Z7]M0B+U:6A
MCY_%1Y-[SP$XPUWA_P`M>#'-F(E,8S-W7QW-47`,^^=SD/<+;-7IY!3\!;W-
M*?LYQM:[,]3;.$#.6RZ"R)%.P*0G4`P99F8,00Y"<->>?FGY]V3-T!Q0R7Q<
MP[9SU.J-[OGNJR=);UG']/C&T-]3R;>;;PKZ]6F0!)58(^#3>II+J)LS.010
M4>A3K%00HE.-XSCE@JF\9,$8HX_X_*X&HXEI$'3(IT\$!?RHQ;0I9">DN@12
M^:6&4.N^==L"I`X<'Z"E)L4+HQDS,XHY\T_A*<\]95ER+X[RU>JW).#KS>O6
MBNV108NL9B@89,_R`J\VBDJ6!O4(W,9FV>.4SM7K/L-W"K9-LDJ%"(N5I:'I
M%>/C2Y:>0;Q2T][Q2Y5>.[E?D7#L99)><I-FQ1CZ3N,I1W4^\-(V.OP$I#-7
M^-KY`R4LHXD2$0GVJS1TX6,)U4UR@DZ14@-J#K&0/*WRHS1Y2^-L/QRXT>.'
MR%Q<FVRQ4;X]N&6L`JTJM-DZ[#V>-<1!GT?.V:+2>N#69!0AEWB``F4YA#8-
M]#K!1M,R1';OP_\`XHN9W"_D5D#D-R5H];QK6;5Q_LN+X:J+7>O6:]JS=AR'
MBNX,9%U'4YS88&.B$HJD.BK`XDDGR2ZJ)!;>JHI`(.P(D(M0\ZN(,I9U\;F7
ML;8;H%JR;?I>UXE=Q=/I<,\GK`_;1&2JW)2:[6,8)JN5DF$>V465$"B!$R"8
M?0-#%JD`ZQJ0>-?CMY$.!'+>B<F9?QQ\I<EL:="7F(5J,;1K'6';\UPJ$O6$
MUR3#FM32+<K%23!8Q1;G[@$Z0$N^X4$7L01*<;,_^MYYP?\`@D<R?_C#_P#Z
MI-5GY19M'ZHMIXHYJO\`R"PG7,HY-P'>>,]PFI"PLW^(<C+J.+7`H0TV]BF#
MY\JK"P!S(SK-J1XANU)LDL7U-^<-8H=.\5=8;P7F2&_$`\L.0$KC*Z1^$;9P
MJKE*K.5'<"_1HT[;6TEQJ4<5R+L)T@CW<PBG6I`3($.)P!FMZ?`;:G>*S]('
M><7HF*4Y3$.4IR'*)3%,`&*8I@V,4Q1W`Q3`.P@/VZK%L:'?FJ\(&3L5YI'.
MO"7#-\R?B#,,R\=6#%.)*38+Q8,0WUR5Q(R2<=5:G'2DL3&EB[:CEDLFB+:)
M="=D<44C,"JVD1E5M)$ZQL&_A]L492PQXZ:W2,PXUO\`B>Z(98RE(KU#)5.L
M5%M",?(2C%1@_5@+1'14JFR?)D$R*HI`14`$2B(!JHBQ]3$KO)5X\,9^1_CX
MYQ%<Y$]1N==D%+3B7)C1B21>T:X`T.T.9VP%9J:8JT\T-[:48=Y+OI@FJF=-
MP@@JG4Q13(SC5%XAX*\I_@XY-6BX.>)-]Y)80NL.%4R03!#:7R#6[?78MZ:1
M@KM"/:O$2T]4+#5G!W`M@L$2S*=L\=('(0%R.4[=1&0[6'76+H,G>=Z]2E'F
M(WC1XQO();\W*-%(R+ALDX"EH:EP-F=1Z:K5:44HDK>+58&\<HN5P+`C*+7?
M(%`H+M>[W$ZS\HMV^+"44H<*_`'S$Y<YK>9ZY[L93#&.[7>I+(^1X^PN6"&:
M,N2MCF5[+8VC&MPRIQQ^E8I1XN1X]D_9O&G=$S9DKZ&)247%P!(1O<5BLU^E
M5JO4VI0\?7:K4H.)K-9K\2V39Q4'7X%@WBH:'C6B0%2:Q\9'-4T$4R@!2)D`
MH>@:NC%%.7ZE<M_Z^K]?7ZN;?^I;^8#]`?K0^1O?HGZV_61\R^E?J#M>P^>>
MP^^]OU]SM_%MMJG>+IC9+O'=O-IPID>;7!&_U:E5]S8<QXJ>-,P8ACHUO[B7
MF)^LH.F]AJ4>@02N'SJVTN0D&K5J0?OY/V@])C$*41@ID?**L?PW_C6ROQXF
M\X\G.2F*+9B_(CQLUP[BVK9!KKR`L+&MKA&6J^VY".E"D7*VG71(J.9NB)D,
M!6;](#F(J<N@$7.TY`1F[\2AQKS_`,E,(<:H/`&'<A9AF*UE6VRM@C<>UB3L
MSR&C7=12:-7TBA&(+G:MEW0"F4Y@`!/Z:&*(0)SC`'X:/B7R:XT7CEN^Y`X)
MRAAQG;JIB%I6'.0ZA+UA&><P\O?UI1"+4DVZ!7BK!*00,J!-Q("I1'[0T$5<
M@RD8O3\J&/[ME3QY\L,>8WJLY=[S;,52$56:G6HYQ+3T[)*2<6J1C%QS0BCA
MVY.FD8P$(41V*.JF+%ZB-(3QP^.'GKCCGKQ#OM]XAY_J%+J&?\:V"T6BP8UL
MD9"0$)&61DYD)65D'+(C=FQ9MR"=10X@4I0W'5H$9&8$'6/1ZU=&*-+KR]_A
M],O6;+U\Y/<&(&,NT)D>9D+CD'`:4G&0%GK5NEE59&S3V.5)MW'P<[69Q^99
MZI$>Y0?,72XHL$7+<Z2#6A$9%?L8F!Q,\Q^=>.7'N@81YI^.WGPMF;&%?B,8
MPUJH>#)23A<G!7V)X>I/I=:XOZ@\CI^3CXY%%RLP";2D54U7J'PJ@W(G%"LS
M,$12IR,XK>4;S/<R+%G%/B'D#"-4FF\'3Z>OF:,F\;47'.-:Z*[:+([LMUAH
M:8N3CWSQV_DC0D;(.#OWBX-VI4BE2)34Q<"JB4XW(?&9X]Z+XX>-['#%;F?K
M*Y3\RO=,KY#.P^6FMUT>LVC`0C6!UW2T968",9(LX]L94X@4BBY]EG"V]PC&
MQF8L/TBD-(0TA#2$?__2V>^8=5R3$9BDWU,EZ5'Q-DA8N82:V6K3LJX+)"*C
M&0=EDHJW0R"C951@/Z*+8JA#F[@KF*8$R[>Q?%BE*^H7#5-W6G411*73:U-M
M9Z[MTB--HZGW6CX55(R=K=/5W3G2JTT&V0TVO1<[IS.[=(B0V"6XP2FL-9HN
MX&0N7(V:A(EP)A<0N(J?'T%0A3;!VD+-(RUKL72`;AZJ@40'82C]H]#0SF"Q
M\FL>+TZE8=&N:AK?VTU6FG]WXQTMKR;C&*D^,X52JW(Z/>5FN!]325*5/^[\
M8EGQ4=Q_%"I3^/ZPTDKI2K3*NYRP1-YGGDPY>RD@R1CY)TBX624CVGS5FW3(
MZ3!F9)P"8"8O5N8=1FLU>9V[I7ET*:5J:A5]M0@`!F`):Z$Z3)EVC39[E.3Y
M%?4;^^6BE:F@5!204PJJ20!*;:$F4R9=I1G:!R?B&I6.#LM-P^I3W40Z$R;&
M`L232";,W:"[.11901(@D>@4S-VH":2`-4NL0'T]=]15:M69GK52]1NI,R3]
M2=3&CJW%2O5:O6=GK,9EF)))\R9DQ/H9QKDRF.GF.;@W8/W38AF$PW09OG$0
M\'I4]K)1SQ)<[-18A135*8A52D,)B>H%$?/]I]0BL]PT,1'R?7\XQD=CIQ()
MSUI?5Y>3E)IS%JNY>/4EF]G4<Q:SA!B@D8&81+=H*9E$RB3<X;$$!UD4IZHQ
MD-I'3SV;&;^P*MH[*>&DE'>;*C?/IB;RY1(R52CGAEC6Z"<1C>6?R3.<K2BQ
MT?;&;?I!B`4I@V$P;*GB,DR^X^/N11V$[A2<@Z3$C("1TUG(`SUC=4>/9BHO
MOU,5=K;;2P84:C`Z3$C("1,A.<@#/7H8G6'A-Y))+/\`5LV5S/6&(>IP62$;
M>WIM-M=^BROZHK9P=KL)(BM"(PN;B:JZ@@[1D'I&1E%%$TMB"!S=I8YK@5GB
MKK'OA[I[VK1*FK46FQ#[?R_U)TP'Z;5W2`+3,2+B\Y\98W#7V-?`7E3)5J!1
MJU5*3$.5ZK_4G2"O]I1=T@"TR(JN8^*3-4;:Y&0Y"$1Q?#OYB1<LXJLN6%F>
M2J)WBBQB1DZT[U:8-@15**8B+EP0NP*MDA';799/Y2QUM0IT<+0:XKA!ZW!1
M!IW'WL?$>D>#&.[SOS7BK"WI6_'K5[NYV#^I5!ITP9=U^]R.X](\',6$8JP1
MBS"[#V=`JC&,=*(@B^GG(?,+))AZ";WTTZ[CPR)U`Z^PF*;8AA^!,H>FHFS'
M(<OG:F_)7C.@,P@T1?HHTGYF;'N3$"<@Y;R#D];W,QD'J4P9K3'IIK_*@],^
MVXS8]V,94?/F48S=2,D\:Q\>R05=/7SYPDT9M&R!!46<.G*YTT6Z"*91,8YS
M`4H!N(ZU%.G4JNE*DA:HQD``223T``U)/A&@I4JM>K3HT*3/6<@*J@EB3T``
MU)/8"*Q>0GD/A8$'U5P8FVL,R43MW-\?H"I7H\Y3&35^0QZQ2'GG)!#<CA7I
M9`(`8I7)#>DL<:^,Z]Q[=YR`FE0ZBB#ZV_G8?8/%1ZO$H8G;AOPQ=7?M9#EA
M:C;=1;J?ZC=Q[C#_`"QXJ/7V)0B*DY:8NF3;4>0EG<]=;A87::13G!W+S,F[
M4$$V[-FV1*JNIL&Q$4$2=)"@!2%```-3-1H6&*LQ2HI3H6-)9]E51W))T\R2
M=>I,?15O;8O!8\4;>G1M<;16?9$4#J23(>;,3,]29Q8O@3QTSL\#6QYQ=N:Q
M%FZ56])B'#<UC>%ZBG(,U)$!TSAFZA`]4$NZZ$#"!C-SEV&,>1?)UO;%K7CZ
M"M6[U6!V#^5="Q\S)?`,#$+<N^:K.S+V7%:2W%<:&LX/M#^1?2SG^([5\`X,
M6B0M.Q)@VJ+.HV+K5&K,`U.X>2KHR2!6R)0`%%W4H^.=RHLN?;?<XG54$``!
M,(!J)KC(YSD-VM.K7JW%S4,@@[GP"KII]-!$&7N<Y3R^]IV]Q>7%U<U6DM)>
MA/8"F@"Z>,M!J3%3G*/G?+Y`))4+$"SVO4E8%F4O:1!1I8;2W-NFJW8E^!:"
M@G)=P.'H[<IB`'%(@J(GF'B/QY0QII9'-JM6_$BM/JE,^)[.X_[JGIN,F$_<
M"^);;#FAE^2*M;*"3)2T-.D>Q;M4J#M^13J-QDP@#5:I)VV1]FQ,W9M&Y/<R
M\W(F61AH".*(BO*3#M%%<[=H@0HCL4AU5!#I3(<X@49)NKJG:4C492S_`)57
M5G/95!(F3YD`=20-8F2\NELZ#UC3:HX'I1)%W/95!(!)\R!XD#6-FGQ_\5Z%
MC6>HC*KN&MNF+*ZB9^RWLH-UTIN)C$23QFT.JD*J+.KK$:[H)E4.*QE"F.=0
MW1T_,G+N39+/WE1;M#1MZ3$+1U&TSD2\Y3J=B2!+H`-9_&/.>99CEF49+^DU
MO9T'8);ZC802":@,IU>S$@2Z*!K/88UQ<<9#2$-(0TA#2$-(0TA#2$-(0TA#
M2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(
M0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#
M2$?_T]T/EO332]/B[<U1$[JK/3(/A('K\GES(HF4/MZF!M()H[?X)53C]F^L
ME,ZD1CJ"8G%=.L\8H:0C^"(``B(@```B(B.P``>HB(CZ``!I#K$3,K<Y\/X7
M.[;1%F<W"XH$,D6#HK[N%15,`AVI2RH'^41Y"G+TJID4<.DQ^U`==KA.`Y[,
M[*KT/V]F?SU!(D?PI]Q\B0%/ZHDCC7Q;RGD)IUGM?V>//^I6!4D?P4_O;R)"
MH?UQ7Q;LY\T.9RIX:H1-FCZ0LJHW4:5YW(Q\$JB)E2=JRWF9=MT9`Z2?64Z!
M5D$5-AV;";TU)=KA.$\)`KY&[IU+\`&=23.#XTZ2@E?(R)'ZY1,MEQOXX^.%
M6YS%_3K950"#6D]0'QI4%!*]B&VLP_7*,VX)\6#^QS$.TR19%IB7DETRMZ71
M!%)(QN@5CDDK/)-R'!!%,HBY[#5(J1"&,5QT_$&CS/RLTGI8.QD/^95Z_4(I
ME]"S'S7M'-<@^<G;?;\8QDNWNU]3]5I*9#Q!9SYIVB^2C*4WA3'U7"F*XQ%:
MOP3@TKD%J1T\>(N).622%:/AE9!VY6;.8]OLJ=8YS*+JB0JH@!!3+$F1R%[F
M+JI?9"N:ERVDS(:#I(```>0$H@W+9G)9J^J9#*W35KQI`L9#0=``H"@#P``B
M?TS$5;*E*]JY!&3@+'')/&#LI0%5N9PAW&4BT,8.MN^:&4W#?82F`2'#83%'
M6`E3YQX3)AY1KM\F.46,N-$W8Z9-O_JS(4#(2$6--KRR1W*;MBLH@52<D?OV
M=?:K"4I@!3NNA3.!TT%"[CKN..\+S'(=E:G3]G'GK5<&1'\"Z%S])+V+".XX
MG\;\AY6R5Z5+]OBIZUZ@(!'?VUT:H?I)9Z%Q%'^;^4.5L\O#H6.6-%U8JX*,
M*3`G6:P2(E$.RH^)UBXG'Q-MP5=&4Z#";M%2*82ZGC`<2P_'4#6M'?>2UJO(
MN?&79!Y+*?<F4X^G^*\"X]Q&F'L;?W,A*35ZDC4/B%[(ODH$Q+<6(G&4\(<$
MLM94]I,V=`^-:<MV5BR$^S5&P2;8_P`?5#ULQT'12'3V$JSPS5(Q3@9/NAN&
MM1G_`)"PV'WT+1OW5\)C:A]"G^)]1^"[CI([8T'*OEKCO'_<M;!_WV3$QMID
M>VI_CJZC_"@8Z2;;%Q&&>..*L%L02I4`0\VJ@"$A;ID4I&SR)1V[A#R`HI$8
M-51*`F;M$V[<PE`1()@ZM0CG.49CD%2=_<_T`9BFOIIK_AGJ1^IBS><H^:^3
M<UY!RRKNREX1:@S6BDUI+X>F9W$?J<LW8&6D<;GCDSC7`46)[*_&5M+EN*T/
M2HA5)2;?]6Y47#OJ$4H:*,H'Q.5]MP*;M$6.7H'+Q[BF5Y'5E:T]EH#ZJK3V
M#Q`_4W\(\IE1K&?B7!<YR^O*QH^W8*9/7<$(OB!W=_X5\MQ4&<45YVY)Y(S]
M+^XM,A\OK;-<RL)3(I59*"C-NLJ;A9,3`>5E02.(&=K]1PZC`F"28]L/H/CW
M%L7QRCMM*>ZZ8>JJTM[>0_2O\(TZ3F=8^L>)<(PG$+;984=]\PD]9P#4;Q`/
MY$G^1=-`6W$3CDL,\9KYEAP@]"*E8^N"9,PNTF*JC^02,(#^YZ)TQ200.3_V
MI?I1#<!*"FQ@"[,\EQV(0K4N$]_P)``^O<G^$:_2/=F^3XG!TRU[?4D>7YF`
M_P",R?X5F?I',YHM]6J,0YPWCE!BFQ;.$RVN7CG2#Y-\[:G(<[`LJV46)*K]
M](ON5RJ&3#H!$@]`&*6S#V]Q>.F7O2VYAZ%8$2![[3(J)=`0#W/:+\2M2^%/
M*URTG$T#*5,CT.U@"HET!`.LXV&O!3"7"4P59[G:VKD8&$M$K3,:2#SJ$7<0
MHG&RMB(S!0>L[**F3B@DL&Y.I59`HAV3%U"WRE2LJ7(E-JP]]Z*M5`[/,@$^
M;(%)'64C^:/FOYEML;0Y?[EDR_NJENC5E':I,@$^#-3"$CK*3'[HOAU&L1/#
M2$-(0TA&'5>0.%TLO,<!ER-6G>8W[%[)!CV.=GE+!'LF$66;77GD(Y)TC6^N
M).1PB60.V.X24(9(#@<N^R&'R9QSY?\`9.,:"![A$E))V^F<MVNAVSD9SE*-
ML,%ESBGSG^WU!B58#W2)*23M`4F6_P!6AVSD09RE&..6^;,JX`Q3;LHX_P`:
M4V^Q%(J4]:[,YMF1W5*-&-X9`'!4HZ*:T^P&LCETD!NVC[Q@)U0*F!]S@(>W
MCV+L,OD+>PO+ZK1J5:BHH2F'F6\277:!XR;37M&PXMA\9G,G:XV^R-6A5K55
M1`E(5-Q8RU8U%V`=SM;366D=,\??(K)O*SCLQSCDVMU:JN+9<;<VJ,74D95-
MA]'UU^2O(+NU9>4E'+R3&PQDBFJL44$S@F7I2)MZ^GE^&L<!F7Q=C7J5!3IH
M7+RGO8;M)``#:5D-?K'KYU@,=QG/U,-CKBK56E2IEV?;/W'&\RV@`#:4(&IU
M.IB;FN7CCH:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0
MAI"(V\D>4./N-,%7UK(E(VB^7^82J^*<4U8K=U>,EVQTNT9M8B!8K*ID19)/
M9!N5X_6$K9F5<G4)E%$DE-WA<%>9NK6%`K3M**[JM5M$I()DECXR!DHU,CV!
M(Z#C_&[[D->N+<K3LJ";ZU9YBG10`DLQ'>0.U1JTC+0$B,-"O_DW><E:+#Y1
MQ'@JJ<>K2VG'D^]J<A.7*9I;.-C%WS**E;)\]BN[<9"0%!J18D;\I4(90Q"B
M<GKO+NSX,N$NZEAD;NIF*94*'"H'),B0NT^@"9ENW])]8Z.^L?CI./7M7&Y6
M]JYZF5"APM-:A)`+*FUOZ8$VEOWSE/0Q9AKB(CR&D(IZSYSQY58LY/8"XV(X
M-Q%`2&<++4&S*:4OUDR>NRJTI;D("PR[J-C8+&HQ:T:R1=KEZC.DP31%3<PE
M,F$CXCB>`O\`!9?-G*W#I:HY*^VM*;!-R@$M4G,R'8ZR\XE;"<)XUDN.9WD)
MS5TZ65-R5]I*(+A"R*"6K3!.T=%,S+P,6KW^TJ4:B72ZHP4O:5JA4[%9TJS`
M(&=3MA4@8AW*$@X9L0ISN)65,U!!N0"B)E5"@`#]FN`M*`NKNVM356F*E15W
M-HJ[B!N8^`G,^41G8VPO;VSLS72D*M54WL9*FY@NYCV59S)\!$3>`W*/(O+C
M#LOE'(6(CXD,G=I>`K+4'4DZ9V:`8,XY8)MB:681[LY&TBZ78JJE(*"J[4_0
M)1`Z9.AY;@;+CV2IV%GD?W'](,QD`58D^DR)&H`8#J`1/L3U'-^-X_BV6I8V
MPRO[H>RK.9`%&)/I.TD:@!@.H#"?8F<&N6CC8:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"/_U-^:9B&,_$R4))H]^/EF+J/>I;["
M=N[1.BKT&V'H4`I]RF#U*8`$/4-`9&8@1,2BBS+%B88@NMGI%AA,CO9&N/4T
M"+U_$N3K(PF&CMJ5]'/XJ4K]3DXAX@Y:J`!Q(X$J"P"FH)3!L.]M<5<WE.E5
MIU[54<'[[BA3(D9&:O45AY::C43C96F`O+RG2JTKJR5'G_F7=K2(D9>I*E97
M'B`5U&HGK$:9O.69I[K:8BXW79XJ;8@3^5G,7CB(:]8")'9860D!GY-``$.I
M+]$7#<0$H"&P[^WX_@K>3YKE-NJ_HMPU=CY;P-BGS]0CI[7BG&;253D?-[55
M_P"7:![ESY;U7VU/GZU\XP_.<;>3V;Q$N;\YQE4K*X@9:B8P8OC1JK<QNLS)
MZJN>&(Y,0VPE,[-*@40]!^S;=V_*>)X#7`<?>M=CI6KD;I^(ENE_A]N.EM.;
M\#XKKQ7BE2XOATKW3+N!_4H&^7T04I]XRYCKA+QZQWV'!:<6YRR(!^ZU[6)8
M3&,`@8#!#F1;5M(Q3AN4Q60*%_PAUI<GSWDN3W*;[V*)_+1&S_Q3+_\`BEY1
MSF:^4^99K>AR?[6W/Y*`]O\`\<S4/F-\O*)7H((-D4F[9%)NW03*DB@@F1)%
M%(@`4B:228%(FF0H;`````&N.9F=BSL2Q.I.I,1Z[M49G=BSDS).I)\28L>P
MO2H3$6-7F1[.(-)J4B"R3MZHV,Z6AXASVS1D<V;`)5#+NCJIJ+$`2&.H8J9A
M`$P'7G8EFVCI%Z@*)F(RR;2BG%S8([&?([+\I*/5U")14(S:M9N3='.X.JM(
M1[)XUB4'2PB/NGSUFU3Z_O#D';?V6MNUS4]OWZ5)0)EG8*`/QU/T4,Q[`QZK
M&R-]6]L5Z5-1J7J.$4#QU]3'^%%9SV4Q)'B/D]_=8.Z5&<KV-,?SF/YMFD3%
M=+R[%Y<M]$K=@1=K1*>57L(L_B(&V3,Q%RBQ&C=VY3!`@!U;E$Q_7F<73QW[
M-Z%6M5H54/\`4:DU)'92-WM;_4R*"OJ(74]!&ZSN$I8A;![:K7JVU9#*J]%Z
M--V4C=[/N2=T4,LW*K,G[1T&L'FSB-E;DIRRY"9&4;-<=X^L&9;VM$3EA:F3
ME9B":V)['1\K#U9L1L\7&18-4G(*.S,TU@5ZP54-N(S+:\YPO'./XBP1S=9!
M+9`50^E6V@D-4,P)$D27<1*1`B>+;Y.XYQ'B^#QE*H;W*T[2F&2D1L5R@)5Z
MIFHD25D@<B4BHB9>&.(>&L+`UD(J""RVU`"'&WVDJ$C)HKAZBI$-12+'08%,
M(]!FZ0..@>DZI_MU&^=YKG,]OIUKCVK(_P"G3FJD?Q'[G_$RGT`B&^3_`"/R
M;E'N4;B[]C''_1I352/!S/=4\PQVSU"B)&3D["UF)?3MAE8^$A8Q`[F0E)1V
MBR8LT"?G*+N7!TTDPW]`W'<1$`#<1`-<Q;V]>[K4[>VHM4KN9!5!))\@(XJT
MM+J^N*5I96[U;JH9*B`LQ/@`-8JAY"^1,RA7]3P*D9(HB=LYR-*-=E#%`3D.
M-6A7B7W8'``Z7;TG4`"8"MRFZ%0F+C7QD![=YR(S/44%/_Y&'_VJ?JQU$?0G
M#?A<*:.1Y<TSU%LAT_\`^K@Z^:(9=)N1-8KOI..<L9]MKI&M1<]=K`_<D<SD
M](.%W"#4RX](R%BL,BH*+8!*0=A65[BG3TIE.;8NI,O\GAN.62-=5:=O;*)(
M@`!,NR(NI_`2'4R&L3/E<UQ[B&.IM?5Z-K9HLJ=-0`3+\M.FHF?\(D)S)`UB
MV/$O";$&#(%3(>=9B$L\M$-ROWJ\PJ+2@UHZ>PE!JS==E2?>"H/00[L@E5.)
M`2:D5`#&AS,\]S?(+D8WCU"I1HN9`*)UG^I$]@[D+TUFY'3YZY!\J<EY3>KB
M.(VU6WH5&VJ$&ZXJ?4B8ICN0AFNI:H5Z13Y,\WW]\:O<=8:17I^.>E9B_ET$
M`C)JU-3`9)5!NV0!,8"ON2B.Z(;.7*8AW12*8Z&NQXKP%,?43*9UQ7RNA"D[
MEIGQ)/WN/'[5/VSD&B0N$?%R8RM3SO*JO[O.F3*K$NE(]02QG[E0?J^U3]NX
M@/'P</\`@Q<N0,]7IJSL9"$Q_(2#-*-0Z%&TQ>E5ETB),XCK%-1C!K=0]Z2$
M.GH`01ZAZE$?1S#G=K@DJV./9:N6E(]UI>;>+#LGXM(2#>KG_P`GV7&DK8O$
M,E?/D2/=*'F_8N.U/MU>0DK;L>*,;5S$&.JEC>J1[*,@JG#MHQHUCFJ;-H!R
M`*CI5%NF&R9%W1SG`!$Q@`0`1$0W'YQN;FO>7%:ZN:K/7J,2S$S))[DQ\JW-
MS<7EQ6N[NNU2ZJ,69F,RS'J28R'K!&"&D(:0C'&5,O8RPA4G%[RU=X"@U)NZ
M08&F[$]*T;+2#HBRC6.9)@"CF0D7*;=0R;=`BBQR)G,!1`IA#VV&.OLI<"TQ
M]J]:X(GM43,AU)[`"8U,AK&PQF*R.9NELL79U*]T03M03,AU)[`"8F20-1&M
M/Q)YJ\6JKSUYD\JLP9*6@(2ZKRM;PTX=46_6&1LU=>V-`Q7C(L!7)E2OJ,JU
M3XI($7X-%!3D"D#I!-4I9MY#QG/7'$^-8#'60>K2`:M)Z:A6"]#N9=TV=S-9
MZK/N(^AN4\/Y+<\(XEQG$XX/6H@/<`5*2A'"'0[G7=-ZCF:[A-9]P3:OY<LF
MHUCQ]Y)=QRAT5LG*T*GQ!G*(HK"VL5ABYN325:.2`HFNM5XAX02"`'2,;?T$
MNN`^/+$U^7V2N)BA[CF7BJE1J/XBOUB,OBS'&YYUCEJ"8MA5J-+Q164:CMO9
M?K^,=WQ[E#%G!3BEQWQE=23<C?8_$59.VQ7CB!D;UD2TV,(EK*7M_`UB(2,[
M&+"TR+M51ZZ%LR2Z^DRP&V`?->6-_P`KY!F;ZU*"T-PTZM1@E-%F13#,=)[0
M`%$V/A'CO\;D^:<FS^1LRBV+73SK56%.DB;B*89VTGL"@*)L>PE'<>$7.&I<
MX*WD&TTZB6JDQ=$M#*N%&T.HITK,E?Q@223E((I9=)HY0)Z+(=:H$`Z8E4/U
M"!?-RCBUQQ:O9T+F[IU:E6F6]((E(REKU'@=.^D>3F/#;KAMQ86UW>TJU6O2
M+^@,-LC*7J`F#V.D]=!+7*>5N3%-QO:6>,H&$L^6\V2L4,Y%8=QJU82-K+!@
MH#?ZCLLC+R$15:-6"NE$TQ?3#]FFH=0I405,/3KP8_!W-[0:^JU:=OC%;::U
M0D)N_2H`+NTM=J*?.4:S&<=N\A;/D:]:G:X=6VM7JDA-W78@4,]1Y3.VFK$2
MUD(C/@WR$NLA\HI_B+EW`=GP3ER.BGDU#-75SKV08>88LXE*P;.I6OLV#:-<
M/:^K[QMVA>-SD(<AUDU0(0^[RO#UL\%1Y%CLO3N\<6"L0C4R"3MT#$D@-H9[
M3T,B-1T69X(MAQNARK%YNG>XIF"L13:DRDMMT5B20&])GM/0@$3(LEUQ41]%
M=G+'R486XN,K$BE!7'+UFJLDV@[1'8_C%5JO2YY^B"T=!WW(*Z)ZS5YEZ0=R
M,`,ZD@#U,V`-A'LN/\)R>>:B35IV]"HI934/J=1U:G3^Y@/U:+_%'>\8^/<Q
MR5Z!-:C:V]52R&J9/44=6I4AZW4?JT3^*,BR7->CQ]"Q/-,J3D*ZY4R]C.GY
M-@L!XU@SW/(L7$6ZOM)LBME.E\NA*Q#1JKDS522E'#!NLJD?M`<2G*7QIQBZ
M>[R%)KJC2L+:N])KBJVRF2C%?3U9F,I[5#$`B<H\%/A]Y4OLG1>\H4<9:W+T
M6N:K>W2+(Q7T=6=C+<$0,0")RF#'4^%G/:L\PYG+E/\`U<6G$E_PY,-(VRTR
MVO6SV1[+IW*Q:R@B@T8*LY&'F85=J_:*I`9LH9+XS]8@3/R?B5?C=/'7/[VG
M<6ERI*N@(&@!\3,$,"I!UUTTU]7+^$7/$Z.*N_\`<*5U8W:$I40$#0*W<F89
M6#*P.HGH):Y4R+RIKE:R(XPGC2H6;.><6D.G/2V/:*O#,&E-AG`ID92V1;O9
M9"+JM,9O3K$[2*BR\DL4Q3)-%"F*)O!98"M7LQE+ZY2UQ1;:*E3<2Y[BFB@L
MY'<@!1W81K+#C5Q<6"YC(W5.RPQ?:M6H&)J,.JTJ:!GJ$=R`$'=A$>*3Y%DV
MW(V$XN<C\$6[CEDVY^U_5^Z?VJ"R#2[>>276:PR+2T0+2.226FW;=1LW%-%P
M@#PAFZJB2NQ1W-UPPMA:N>PN6IWMC2G[@"M3=):M-6)^T&9F09:@$1OKS@);
MC];DO'\U2R&.HS]T!&I5*<A-IHQ.B@@G4':=P!&L=BS!SZ5QSE^T8EHG%WD=
MR`/0213:^VO#=,&SP%;GYR#86*-K1UT#F26ERP\F@LY355;F0*J78J@[].#'
M<2%YCJ&0N\[968K3--*S[6958J6^DP0"`9R[1Y\3P<9#%6V4O>28^Q%?<::5
MZFQG56*%Y?IW`@$`SD>D91XI<L`Y5,;O+1^%LK8JB*/8%JB\=Y/90<2O(VN/
M.<D_!,(QA+R$@#FN'Z"/#*IIII+G[.XJD4*3PY_C_P#L#6M-\G;W%2JF\"D6
M,D/VL20!)ORRZC7H1&MY/QC_`-LO9TGS%K=5:U/W`*)9@$/VL25`D_59$DC7
MH03Q6`^;>/N161\_T:C52Z-X?CK*.H&WWJ6;1AX2;F&TO/194:DR@Y"9EI9H
MZ)6'KA(YDD5CHE3V1ZE0*&3+\7O,-98BZNKBD:EXH9$!.Y00I]98*`1N4'4B
M<]=(RYSAU]@,?@KV]N:)JY!`R4U)W*I56]98*JD;U!$R`9ZR$8>P5Y.,<9IY
M+O>,KW%>5L6VA^UF'V/Y'(\&>O*W5E"Q[R9666K4@BSGJT:2@8]P^8@NFJ59
MN@<%#(J]*1MCE>#7N,PBYQ;^WKT`0*@IMNV%B!]PFK28A6E*1(E,:QMLU\=9
M##\=3D:9.UN;92HJBDV_VRQ"_>)J\F(5I$2)$IC6)>9AY#X]PNZKM?FS3=GR
M'=C.DJ#BFBQ*MER)=EF1!5>GAX-N=))I%L$2F4=2+]9G&M4R&,JX)MKG<;AK
MS)K6K4@J6=*7N5:AVTTGTFQZD]E4,Q[".5Q.!O\`+K7KT0E.PHR]VM4;92IS
MZ;F/4GH$4,['HIB&T3Y&IB"Y0T;C%GKC/=<&365$F!\;S[Z]TZ^)RXR[ATRB
M"S;&H%<1\(5W(L569Q;R,B+=T``H`)#W@Z6IPRG5P5UG,3G*5U2MY^XHIO3E
M(`G:7U:0(.JK,=-=(ZVKP"E6XW>\CPG(J-[1MB?=44ZE/;M`+;34D6D"&U59
MCIKI'Y<K?*M@_C68\;`UBXYKG49Y6KO%Z2U,SH$79FASA(5>0R0\:.8->TL4
MD3BK'QZ<@X1,'2N"([]-<!P'*9N3UJ].UI%-PWF=0J>C"F"&VGLS;0>TX<8^
M,\SR&52M<T;.@4WCW#.J4/1Q2!#;#V9MH/43CMO(;R/XMP9FC%/'>-K<KD;,
M>2;31Z[*U6&E&+!OCQ.\RL5&QQ[3)@A*@,V=.5(X1CD$CJ*(`!U%$"*HG4\V
M'X7?Y7&9#,O76CC:%-V#L"?<V`D[1IZ=)%B=#H`2#+RX'X_R>:Q&3S]2X6WQ
M-O2J.'8$FK[:DG8-/3Z9%R9`Z`,00+%=<;'!1U>ZW:I8XJ<_>KW8(RJU"KQR
MTM/V"9<D:1T8P0V`ZRZIO4QCG,4B:9`,HLJ<J9"F.8I1SVMK<7MQ1M+2BU2Y
MJ-)5`F2?_CKV`U.D>FSL[K(75"RLJ#5;JHVU543))\/^)Z`:G2((7'G#E5OC
MYUF;%7#'+.1\,L(Y2PJ7":ME1QU89BGHM"2![A4\:203=ZF(-2/,*Z/NFD>X
M70#N$2%,0-KK+;BV/:\7&7_)K>CDBVW8J/44/.6QZHVH&GH9%@#H3..UM.&X
MQK]<1D^76MOEV;;[:H]5%J3E[;UAMIJT]#M9P#H3/2,RX`YI8)Y"X(D.0M?L
MI*E1*XM(,KT>^+Q\`XH4G%-F;Q^RLC@7KB+1*5G(MUDEDW"B*Z2Y.DW6(D+K
M,OQG*X?+)AZU#W+MP"GMS;W`20"ND^H(((F"#]8U.<XAFL#FTP->W]V]J`&G
M[8+"J&)`*"08Z@@@@$$'ZQ0UF'G'QOOOE6QAFRRY`][Q[P#2U(NOV.(@;-*-
MYVVI0=ED2.8R+:0JLHL9.Y69)/OF23;*)193E4$@D$\LXWBV:M.`WV+H6<LQ
M=U9LI91M3<HD26E]BDRG,%I2G.)LQ/#.0V7QEDL/;V$L[?5MS(S(I6GN02)+
M2^Q"93)!>4ISELGXARK4LWXWJN5J(>45I]T8KR=><3,2\A'[R-2?NV"+\\8_
M(F[;MG_LQ6;B<I15;G(?8`,&H3R-A<8N]N,?=A?W-(R;:0P!D#*8TF)R/@9B
M/GO*XRZPV0NL9>A1=T6DP5@P!D#*8T)$Y&70@CM&1CG(F0ZBARIIIE,<YSF`
MI"$*`F,<YC"!2E*4-Q$?0`UX@"2`!K&O`)(`&L0$M/.*7G2RRW%;CID?E=#U
M^3?Q,S>JC-5BE8S/(1`IDF(ZL6^TN#+W>0CEE2IF^5,7310X&*FX.8A@#KJ'
M%J=+VQG\S1Q]1U!%-U9ZLCT+(OV`_P`;`CN!..XMN&TJ/M#DN?M\95J*&6FZ
MO4K2;[2]-!*F"-?6P8"4U$Q%<''^X6/EYY?5,G7#&5PQ:ZXX8,>Q[RAW91F[
MD:O/"@[KB+%=9JF5JJD_<Y/?2+(P%`RA2=XNP`&W:9>VH\=^.OV-M?4[A;VZ
M!%1)@,NC3UUT%)5;PZ1(&=M+?BOQ4,;:9&E<KD+T$5*<P'71B1/73V55O#I%
MEO*[R&X&XGL)=.P#8\A6Z$,P2EZ?CF-+,KUI:5,4L66\3ZJK>N4H9$#=2"+U
MR5ZX)\2+=4/77$<?X=EN0/3-'91MVG)ZAV[I==B_<\NY4;1W(B/.,<#S?)ZE
M+V/;H6KSVU*IVA]O7VUU>I+N5&T=V$2%QOG&L7C`50Y#3R1\<T^RXXC,FR);
M<[;-@J]??PQ)Q1Q*O]TVHM6S`_=!<.DJB0E.`!U`&M/>XJO:Y>YP](^]<I6-
M(;`3N8-MT'6<])=CI&BR&&N;/.7>!HG]Q=T[@T1L!.]@VV2CK,G278Z1%FV<
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M,`1K(S$SUC%>3.9<#`3MKHF$\9Y!Y.Y,I"J;.X5C$[1B,!2I-<BPMHJZW^9<
M-*S"RRIT#%,Q;G?2*/285&Q0`=>^QXU6K4K>[RE]1L;&KJC52=SCN4IB;,/X
MCM4]FC98[B5>O1M;W,9&AC<=6$Z;UR=U0#JU.DH+LNOW$*A[,8ZYQ1YDW'D#
MD+)>)\E<;KQQZR#C&$KMBF(JR6*-LT>XB;4LY2@CH2"457G9G#\C-90G;:+-
MNE!0!7`Y>@<V?XW;8>SL<A99JE>6==F4%5*F:2W:382$QU(.HTEK'HY/Q*TP
M5ACLIC^04;^PN7=%9%*$,DMTQ-A(3`U8'4:2UCNMOY:1IK[9L1X*QU9^1&4:
M25N%YBZ?*UVNTK'SIXF].SC+SD>TR#.!BIQT9B<I8YH20D""`]:!`*;;S6W'
MG_:4,CE;Q+.PJ_87#,]0"4S3IJ"Q43^X[5\#'CM>+U!8V^4S5_3L,;6_RS45
MVJ50)3-.D@+,HG][;4\&,8AP5Y"XG(?("2XJ9EP];>/&?FK9P]B:K/3T-<Z[
M96S:)-/"2$M\&BR;N72T&FH\1_1O;+()'`BXJAVM;'*\/J6>(3/XW)4[S$$R
M+JK(RDG;ZD:>F[0ZS!(TEK&US7!*MA@J?)L3EJ5_@R0&=5:FZ$MM]5-ID#=)
M3K,$B8EK'S9`\AZU9RI?<=X^XG\F\\PN.)I6I67(>'Z*K9:LE=V;..=S%6;+
MAVD57D`+\4'O4LFHDY3Z03,0Q5!NL^'"O86EY><@L;2K67>M.L^UMA)"L?)I
M3721'>>D76/`Q<XRQO[_`)/CK&M<)O2E7J;']LDA7(\&E-=)$&<YZ1WO$_.2
M%RA@:^<AE<)9MJ5.ITD]A(F%D*NVGKO?YJ,>'B)&/IU6J;Z:D'16MAZ(XSA<
M$6P.P6`RA2-ESD\F0XM5L<M:8<92UJ7-10Q8-M2FI$P7=PH$U]4A,REIZA/Q
M93AE;&YNQP(S%G5NZRAF8.5ITE8;@:CN%`FGKD)G;*0)90?MX4<X*+S6K5YD
MZS4[-0K+C>PMH"XTZU'9K2,:>2*_/#O"+M!()TGH1;E,Y%44547#95,2F`H'
M-9R?BUUQBO:TZ]PE:A70LCI.1E*8U\)@Z$@@@^46<PX;>\/N+*E<W5.O;W%,
MM3J).1E+<-?"8.A(((/D.UWWE7$1EMG\7X8H-JY%9;JW8):ZACYY7XR"HB[Q
M)55BWR+D.U2454:H[=E1.)60+.I02E$0:"&V^"TP%1[>C?Y.[IV6/J?8]0,6
MJ2Z^W30%W`_5(+_%'EL>,U:EK0R67OJ5ABZL]E2J&+5`.II4D#.X'ZI*G\48
M0XO>1JF9VF,YT_)U"?<=+UQW]ZODR+N5MA)RM1$?%R[N!EW/UBV;P[,%8:69
M]IP4Z!$1[J9D%5RF,)=IG>&7.*IXJYL;L7MK>2]HHC*Q)`8#9-CZ@9C6>AF!
M&YY)P"\PM+"W>.O5R%E?R%%J:,KL2H91[9W'U*9C6>AW!>_'TSR<8KR5RKI?
M&&@X_P`AR(6F.L<NXR99HM6C5UO#PE2F;6TGH2$L;5O89ZORR,,9)-XJDP3-
MW"*)=\@ZON>#7]E@+K.W=Y17VRH]I3O:;.J%693M5ANG(%CI(RC)=_'63Q_&
M;ODE]?6Z^TR***-[CEF=4*LR$HK+NF5!8Z$':8_QC_RAX,R;R#R3B*K))$QQ
MB*BV.Z7S/\]9(Z#H[0M;FH2ON$85FNU64EXMU+3R*"#X[EL#A0!["2Q#)J'7
MG!,K8X>RR-<_^MN*JI3MU4LYW*S#<9Z$!22LC+N09@+[XWS6-P6.RMR?_P#0
MNZR4Z5LJ%JAWJS#<0?20JDE9&0^X@S`Y+"?DLQ5GKE')<9J91,C,'#.K2%C9
MW:VQ'TLVE/8,HZ6("%4ERM[,SB92%DDW+-VZ2147()1]N5,Y%1LRG"+_`!.!
M3.7-W1(-0*40[B)DC[QZ20PDP!('C,2BS,?'F3PG&J?(KN]MV5JH0TT;>5F2
MNKK-"P8295)`U]4P1$KN1^>Z=QCPQ=,W7MM*/JW2F\8HYC8,K)2:E'4S-QM?
MC(^,2D7D>T4<N)&42WZU2`5,#&'T*.N?PN)N<YD[;%VA45ZI,BT]H"J6),@3
M(`'M',<?P=WR/+V>&LF5;BL3(M/:`JEB3($R`4]NLA'U<>\O#GO#=$S&2H3-
M&8Y"BE;%"5VP.&KF82K;I^\+6Y1Z=ENT(-B@DV\@1-,RA4TG12@<^W6-,QCO
M]IR5WC?W*U7HMM9E!`W`#<!/7TM-?J.@BS.XK_9,M>XDW25GH/L9U!"[P!O`
MGKZ6FLS*9$Y#I&9M:R-3#2$-(0TA#2$?_]7?XTA$9>26)3WFODLT$U%6TUMN
MI]PD43+2\*43KKL2$`!,J[9G,99N4/4W4H0`$QR[9$:1D>D6.LQ,=8K/$!`1
M`0V$/00'T$!#\@ZSQAC^:0AI".)A[WC=ME7&N-++;89E8;[=*S6HVN`Y]U-O
M334HT:EWC&9'#MJV427_`&=8B:`;^IPUL;?$9.[M+F]M[)VLZ*%F>4D`43/J
M,@3Y`D^4;FQX]FLC:7>0M,=5?'T$9WJ2DBJH);U-($B7VJ2WE%G?,*3RA%85
M?$P]>:#C6XOIZ"9(W'(%>>VR,A(Q%5:2?KPU685ZU'G;,5*.#V3<\>X2`>HY
M@+T`<MF!_P!K&05LQ;U*MDJDE$8(6/0`L622S.I#`^'A'NXX<(N26IR"UJ5L
M<J,2B.M/<V@4,[,FU9G4A@>@$^D4^GXQK9.7(GR!Y?\`+GDHYD>\=2A55V?%
MU">*N3'*LQ""6E;HK[)P00`0:QK!4Z8%`2I[=LO9/S>VL9K@.,6-L1TJ,/<?
M3ONDAG]2P^O6.WJ_)ECC2:?%^&X^U9>E1E]VIIT.[:AF/,L/KUBQ_CGB&F\7
M\996>8]PU5,+QZU<9R*4<R?2LU?IQ\P:S2<$_N\Y8)&4GW;9!V]5*S37,@1`
MRCD4D"`<W5QV7SF4SM>E5REZU9EGM!D%6<I[54!1.0G(3,A,F0C@\YR;.\DK
M)<9N_:LR`[`9*J;I3VJH"B<A,@3,A,F0B'PB(B(B.XCZB(^HB(_E'7@CG8A7
MGKF_BW#WO8*"63R%>T.Z@:%A':0P\0[)N3IL,\F"S=!1%0!`[9N"[DIRB10J
M.X&UW?'>`9?-^W<7"FVQYUW./4P_@30F?9FDLM06Z1*'$?BO/\E]J[NU-GB3
M([W!WN/^G3T)!'1FVK(S4MTBH2\Y2SQRLMK6-=%F+2Y%8582C5-@Z""B"C]V
M=RWBT#+@7ME4'N/GBBJI2#L=8$P``FK'XCCO#[)ZJ%**2]56H1O;R+&7X(H`
MGT6<?1^)P'$OC['5*],TK>G*3UZS#W'\BYEUEHB``GHL^LU\&^-Y=;V=@SM+
M"V2$"+%H-;=E,Y,/4`@C8+(W,=)$H@40.C'B<P@8!*Z(("77!\@^457W+;CU
M&9Z>\XT^J(=3Y%Y>:&(MY7\VHONV?$[?<W3]Q5&GUITCJ?)JDNFM,C6);Y1S
MU@KB16$JE!Q<46;0;=R'QQ42-F[LQU"`";ZP.B%5+%(.!V,=RZ[CI<-S$(L(
M&VXS$<=Y#S.[-[<5G_;D^JO4F1]$'YB.RK)1T)6(ZP/$>6_(M^V1NJ]3]J6D
M]S6F1IU6F--Y'94DB]"5TBF[*^<,P<F[2W;RIW;MH#DYZ]1J^1P6#B2^I`<>
MVZS"Z>$2./=?.C&.4IC;&32V(6<L+Q[#<6M6-NH%0CUU7EO;RGV'@JZ?4ZQ]
M.<8X?@.&696QI#]P1*I6>1J/Y3_*L^B+(=)S;4_XL6.H[#$*DZNATWV291JD
MYKU7!$JT?`I*'((3DP1P049(42@8$$SD,U56#;I6(!C$SV^0.8J,EF98]20[
M@ZL?TJ1JOF9[@/`RGM:%]3S)J)9U`;%25=E;4F6J@J9J?&1##KH91MN^,B'F
M<AX*Q]R$OL06-LEE@W;*&9"U(T1%&.D'T"\MC5H4A"M4;(G'BHT(0"D(V6-T
M=29TQU\T<LQ]#$Y_)8ZUJ[[>F^AG,C<`VTGN5GM)ZDC76/C3F6&M<#RC,8RS
MK>Y:TZGI,YD!E#[2>[)NV$G4D3.LXM"USD<U#2$-(0TA&/,N7EEC#%>2<DR(
MH`RH%$MMS<>XW[(DK4"_F!(?8IS#W!:=.P`)A$=@`1]->S'6KWU_9623W5JJ
M)_WF`_XQ[\79/DLGC\?3GOKUTIB7\;!?^,5@>$^CN8OA[(9&G#$D)W-F7;]?
M'DDX;@#UPV8KLJ65%RN=,IG!!F*P^=%$!$H&>'V]1$-=U\G72OR-+*EZ:5K;
MTZ8`.DS-]/P91^$2/\PWBU>6)CZ(VT+.UI4@`=`2#4T';TNJ_P"$1AKS*SUB
MO>1>%7&.B0,;;+7<LJ#?_IR5<JH1KQ>)<Q]8K3:9,T/[MM`/R3,P+UP`$%%L
MV.8@B(&Z=E\;4:-I9<GSEW5:G;TK?V]P&HF"S$3T+"2;1W)$XV_Q)0M[*PYA
MR.]KM2M:-K[6]1,@,"[E9Z%AMI[1W)$^TYP99@8OA_Q3Y(9ODI@]NSG)XTGY
M2YY=DF!`FK3?Y"-5@Z7',FY#G&N8^KUDEVK6(A6R@-HR/*'JHN*RZO+X^L_(
M\_A<6E/V\4M=0E$'TI3!W.3^JHR@EW.K-X"0'&8NM4Y7R;C^&ITO:PRW"K3H
M`^E*0.ZH2?SU6169ZA$W;P62C"/C8AHOBQXR&F6+`Q41.ZJ.2^15J1*V(DZ>
MQ[=E(OX/M;&*H[,_H]9CA1$P@)NZ`%]-M;3FM6IG^<-CZ+S`J4K=-=`9@-])
M.S3^D;GY"K5>2_(SXRW><JM&U370&8#?251WG](C'XL[)GR:HV9^0D+@65R9
ME_DCE&:E7^7KO=ZC0\3,H"#$[)A#%?EE+?E-RVA+.XD0.VCJNHU!NDB@5P!D
M2@7><\HXFE=8S#U<LM#'65!0**(]2J6;4F4DI`LNW5JH,R3+6.C^2[?!T;W$
M8&KFUM\5C[95%"G3>I7+-J6EMIT060)JU8-,EMNIBQ;CGPK=X^S9?>5^<+LS
MRCR2R0Q+%N'\+$*PE`QO7^PR:A5L?QCUP\E7"+>/CF[+YD\.5TLT1V!)(RSH
M5^-S/)UO,7:<?Q=J:&%H&<F.ZI4;4[JA$@-26VKH">IDLN!S_+UO\/8\8PUF
M;;CUNVX!FW5:K3)WU6`"@DDML4;0QZF2[9]ZY&.'BC+SB*'-@3"F&J6R8(V/
M,'(=BX9U^/;-VCFQ/T(B<2=K@":2:)W+RUVZ/,X6.8%%%URF,)NHPZE3XM'_
M`/K9/)73GV+:S(+$DA1-9?@$1I#P$3/\-`#.9C+WCL;>TL#-B20@W++\`B-(
M=`!%GW'S"==XWXO[,Q+-9:Y.XMK8<PY0DTVK)U:9^,ATDGT@Y6`J:413ZQ'M
M?9PL:02M(:';)-T@`"&,;A<QE*V:OITJ96V#%:-(3(52=`/%V)F[=7<DF(XS
MN8K\@R4Z-(I:!BM"B)D(I;0#]3N3NJ/]U2H2QZZ4I>.RX+5VN>3CR-*1!DX:
M?GLFV>B1#\PM6,JZCW=RRH_B5S";W1@<2%AAF)#E,4"G,J7<Q_S).YE;"M6X
M-PP5/ZB)26H1J0"$I`^'17;^SMUF#GUJ*]Q\<\`%7^LE.BE1AJ5F*=$-X:!:
MC?270=9;>%JMO'W&N[9XM3A:<R1R!S%=;9;;;(=A25FT89V$*V17<I_>&;(3
MR<JY(0P%Z%7BO24""77/?)E=4S=KB;<!;*SMD1$'1=PW'\=NP?0".6^7KA$Y
M#9X2V4)C[&TIHB">U=PW'3Q*[!/P4=XP%Y)Z^[R/Y*_'ECZMD<A8V4C7;9)N
MV*8&=,*U'Y.2G7<D0R1@6`8>+IDDY^+I*7HW`?4VVWX566RX3S&\KD>R0R`'
MH6-+:!^)=1&\^/:ZX_X\Y[?W!'[=E9`#T+FB5`_Q&H@B5_D2S*]X[T*EX2X_
M,(^H9HYGY;=U**GX=N5H]C'UIDH*-OF1#'0*11[:5EK#',4%U%4E$?=`LFH'
MM"$US_#<:N9N[G*9AS4QF,MPY4Z@A0QIT_)?2S$2(,I$>HQS'`L0F>O;S,9U
MVJXC$6HJ,K&8(0,:5+R3T.Q`!!VR(]1,2IMCN@<&N(5@>5QHVCZA@C%LBI!-
M'._5,SC-FK\L+(*%,"CJ8N=P>$%RL8W6N\>G4,;<PCK06ZWG*N145K,6N+NN
M-Q'Y5)UEX!$&@[!0(YFU2^YGRJ@EPQ:[O;D;B/RJ3K+P6F@T'95`$0V\*F.@
MJ_#)GD-Z0JM@S?D*\WJ5?J)B5\X;14TO1V"+DY@`11!:KN720!L39X8P?GB(
M]+\G7O[CDK6:_P"3:T4I@=IE=YE_W@#]/*.M^8+_`/<\N>P0_P!"SH4Z:CL"
M5%0R\_6%/\LNT?T*.TS'Y?7N3V";52M<2>/4/6K'.($.BDEDZ_)W):-@'KWM
M`W>N&E%N[IRH4%!!KVRE-L<1*#]TV-^.EL7)]_(WA95_Z5/9-@.P+H!YSBG[
MUL3\5)C7)_<92_9T4_\`)I>W-@.H!J4P.FNO:(?\`<LY5SIR1Y7<R8+!ETS1
M-6J<3Q;BJ6<62C4F@XZI+-T68&NS-AMEF-8HYR$`6"%5*$@)=8#'654*47!@
M-T7+L?88K"\?XU6RM*VI4T]VJ-KO4J.1+<%1=I&[W)%ZB#H!TCK.<XO&87C_
M`!CB5;,T;.C23WJRA*E2K5J$;=ZJB;"-WN2-2K3'0#[8LDQWPTMMFY*,N8?*
M2UURUY6KD*:NXMQK06S\<78BB`-(%34934^V96&\6/IDW*WOG#.-32<NU3E;
MCT-A;\5>\EMZ&$;CF!MWIX]VW5:E0CW:QTZJI*HN@&T%B0!K]TX]O^6VMOQY
M^)\;M:E+&5'WUJM4CWJ[:=54E*::`;0SDA0"VK;H$^7LLY=,X<$>,F'FD,2Y
M2%WF+VUKIF:2,*P7<3E<C:K-23%NHS1^3-SQD^N[`.DQD4%!`=Q'?K?CKVK;
M%\KSF29OVPI+3+3]1DK%U!U]6M,#S(CM_BKV+3#<VY%E6?\`:+06F6GZB-KE
MU!,_49T@OF1%PV(N-F,<2U%I7T8./M\^XL*-[N&0+=%QTQ<;UD[WY)AUD:PR
MCINLN>R#-$!PT.0P%C2D22:]M-),"QQD<W?9"X:L:K4Z(3VTIH2$ITI;134`
M_;MT/ZM2TR3$497D&1RETU=JS4J`I^W3I(2M.G1EM%)%!ELVZ-^N9+3),9_U
MJ(T<4/\`D]M+K-/+[A5P<,X.:B6RY5;)&6(E%RJV"?A%[.ZC$(UPJD!^DS"L
MUN;42*8IBBN[2..W040E?@M!<9QSD_*9?^KITFITC*>U@H,_Q9D!\@1WB:_C
MBV7$<4YAS/;_`.MI47I4&E/:VP$D?5WI@^2D=XNUN;^,KU'MDI(`V;0T'5)U
M^^!4"(LV\9&Q#IPY!0.GMI-DFJ)M_38I`^S;486R5*UU;HDS5:HH'C,D2_&<
M0[:4ZE>\M:5.9K/54#QF6`'XSBEOP-U)\AQ-R7)S<6F:#MV:I=2)*]2270EF
M<34:A&O7`(*E.15JG)HJH`)@]54#AM\.XR9\L7"GD%BE*I_5IVHG+L2[D?C*
M1^A$2_\`-ETC<HQU.C5/O4K-=TM"I9W($_&4C]"(X7Q>4^#RWRL\@?)&5JL4
M:,=90<XWHA5H]BHR:Q(V6=EIEB5ETJMDG:$3!UPQSD#8QE#=([".^7G=S5QV
M`XAA:==O<%`5*FIF3M4`S\)M4C+\D7=?%\9X+Q^E<M[HMA5JZF9;8JJ9]9;F
MJ_W1?&W;MVB"39J@BV;()E20;MTB(H(I$#8B:2292IIIE`-@````#43DEB68
MDL8A-F9V+,Q+'J3UBJ+S$9OL^,N,#+&U!5>IWOD7<H_%$;\N540D/IYX@JZM
M"3-9-5(P*3"8-HDY?4#HR1P';4@?'&+H7V=>]NP/VEE3-4SZ;AHL_IJ_U41)
MWQ/AK;(\D?(7P!L<?1-<SU&X:),?PZO]4$35ID'C7A?Q@K\'*2C>(Q[@K&[1
M&9F_;]I214B&0*S$LFP2$RCJ>MU@656(V2ZE73]X"293'.4H\Q<U;WDV=K5:
M=,M>7=<[5\)G03[*BR$SH%$SH(X^\KY#EW(Z]:G3+W][<':L^FX^E9]E19"9
MT"K,Z"*PO#(68RK(<P^7-DCW#.3SEFI1DP*LY]PDS9Q?S&VO8IB<2HG79QHW
MAJT(KVB$$&@$+L)#E+W/R7[=@G'..T'!IVMM,Z=29("?,["93[^8B1_ESV<8
MG$^+6]0&G96<S(2F6D@8^!/MEI3_`#3/41]?F1`MRA>,?%"EMF+*U\D.0L3)
M281H,F;ERTAD&]7.^F2E0$3)N).ZM7`NUO7:+'U,4AP"GQM_Z:IG,_<L3;V5
MF0)S(!/JD/H$(D/U><6_$W_I*W(^3W;%K;'V#`3F0"Q+R77PIL-H_7VG$U.<
M_&>U9KX5W/CYAI5HPG&\%2FE1BY%_P"Q:2S&@R\'(MJPO)**)-VRDG'PH()*
MN!!N"_1WC$3ZE"\QQ7.6^,Y/;9C)`FD7<N0)D&H&!:7>1:9`UE.4SI'(<+Y%
M:X?E]GG<N"U$O4+L!,J:JL"X'4R+3(&LIRF9"*]('R2\M.+&.ZU`\I>`U]CZ
M[0H^#I\UE2J3+IG7`;139K"L79D#UVQU=5V]*@4`4)8$6JZYMDND#%*'85>%
M<>SUY7JX'EM(UJI9UI.H+:DDC[E:0\/;)`ZQW=?X^XOR6_N*_&N<4&N*[-46
MBZ@O-B6(GN1Y"?\`RB0.LY1)G._*?&>*?&$^SGQ;*:K5BUU1&`Q"W;,E6[VK
MV2\V=W"SA5D#/7!6-BJ$LO+++'!PX0)(LC"0RY.GN:/$X&^O^<IBL[_4KTZF
MZL9S#*BAE[":N-@&@.UM0#TYW"<9R.3^1TPO)?ZES2J[JY)F'2F@9=9":5%"
M`:`[&U"F<LX>-3#L9AGA?A"-:M>U-WNHQ>6;B\5!4'TE9<D,&ME44DA7'N"\
MC(EVTCQ`0#8C,N_KN(ZOFV2J9/DV4=F_I4JAI(.P6F2NGD2"WXQIOD/+5,OR
M[,U&;^C0JFA3'8)2)33R+!F_Q1^W,VRU[BQ@KE'RKJ45[/*TWCJI512Q`X=.
M%#2S>3<4?&3DK)P9PS0;UJ>R&=VH1)-,'(`/=-Z`8M.-4*V>RN!P%Q4GCTK.
M^V0Z2#U1,2/J6G+4F7:+>(VU?DN;XWQFZJSQB7#OMD!Z2!4K">AFZTI"9,NT
M8T\1N.&M'X1XZL:QSO+3E^3M65;E,.3F7?R\O/3SV/CW+UXJ91RZ6)7(AD4Y
ME#F,*W<-]IAU[OD.]:ZY1>40)4+95I(!T`503(=!ZBWX2C8_*>0:\YCD+=1*
MVM%2C34:!5502`.@&]FE+M*(7\@X-7)_G'XW1-75,FXQEBZL3EV=()&,#!*N
M#DN['2>F2.02EE(R>C60&,.V[U,!`0]!Z;#U18_%F:J5QI7KLJ#QW>VFGT*L
MW^$QU^"K#&_#/(:MR/3<W+K3![[O9IZ?RE7;_"8DKSPR(:E/\&<%,!+,,=6W
MEMD"7"YSU>%)A(4_'=ALRDGD>RMNC=8MEOLE*21B.A*H9;VST-RJF3.&DXG9
M_NDRO*\N#6M\=1&Q6U#U%65-3_#3`73M->TQ'.\)L/WB9KFF<#7%KBZ"^VKZ
MBI55)4D/\%(*DQVFG43$6>5JN4S$]#AZQ7V<94J'0*TWC8YJ4R3.+@J[7V`$
M`ZRR@E320:,VPG664'<=C'.(B(CKA:]:YR%W4KUF:I=UG))ZEF8_\2=!^`B.
M;BXN\G>U;FN[5;VO4))ZLSL?^TDZ`?010_A.^2O'KAGY!.?;1JI6YCDWE_(%
MRPXV>)MQ?HQ]BN\]6\:S8I*]SWI&=JO3UZ5$Z)2K,V?>#=%4#ZE?*6E/,<EX
MAQ)FWT[&VII6(G*:HK5%\IHBB<]"TNHE$UYBRI9[EW!>#NPJ4L=:4J=<B<II
M35ZR^4TIJLYZ,TNHE&4O'+#\E*!Q#IL%B7`";&YY75E\K6C.N>+Q7(BE2\A>
M%BO8&SQ=:I3^[Y4NI/HQ*/[:4FT@"N%Q$_N`3,8VO!S.IA+OD5S5R&7G;6\J
M2T*",7`31E+.$I)Z]TRIJ2':<:WG]7CU]RJ[KY3.;K.U"T4MK:F[5%%/1D+U
M!3HT_P"INF4:K(:;9B43=XG<':;QO9Y*G[/8%LR9=S=9"V_+V1+/#,&;:P31
M)9W8$6T-5RG?,(2(9S\@N](3K66.Y.!S*=*3=-'E^0<IN<TUE1H41;8ZU391
MIJQ)59!=6T+$J`O82TEJ2>-Y/S*[Y`^.H6U`6F*LZ?MT*2,257:%FSZ%F*@*
M3("6DM6)J;+CF;Y>^8+D?%L73J+Q71*4SQ_E&79*NB2*U1CH*IUN>H\'+M%$
M?DDCD.=0D(UT8IBJA`J28)"5<"G+(/[VEQWXYPM1U#7]6J:E(&4MY9V5V!^X
M4UVL.WN!)Z1*!OZ/%?BCC]1U#9.O6-6BIE(.6=EJ,I^X4E*N.WNBG.:S!V`X
MS$6*H:-AHB*QK0V$97HJ/@X)BVJ4"FWB(>)DXR:C(R/(##9JR834*S>))DV*
M1VT16`.ZF0P1"^1R%5ZE2I?5C4=BS$NVI(*DG74E6*GR)'0Q!E3*9.M4JU:N
M0KM5J,68EVFS,"I)UU)5F4GNK$="1%-^(8,+'YV>44T4R16U&P;7'9%4$"G*
MX?/L>X&KP-7"Q5"]MP4DVZ'K$##TMNWT_P"R+).1J^S\4X*E^:K=,/P%2NT_
M_"/[9Q+65K?M_A7C='7=7O7&IZ`5;EICR](_MG'%^6_(I\X9.XY>/;'TF=Q9
M,E9'K5BRB,:4CAQ6H)54K.N$>%-LB;LQSR1G'*)CD,DWCVRI@$BQ1UD^/+(8
MNQS7,+Q)4*%%EI3_`#-U:7XA4![EF'41D^+;`8;'<@YW?4Y6]M;NE&>@=NKR
M_$)3!EJ68=08O2@(*(J\%"UF`8-XJ"KL3'04)&-"`DUCHB(9HQ\:P;)%^%-N
MS9MR)D*'H!2@&HJK5:E>K5KUG+578LQ/4DF9)^IB%Z]:K<UJUQ7<M6J,68GJ
M68S)/F29QRVL<8H:0AI"&D(:0C__UM_C2$-(17]R?PL$`UFLIU*,?.XUN@O)
M6JNP46^EI-)0G4HXEH6(BV[EZ^37WW7013,=,^ZH`*8G[?JME-:I3HAE#,9`
MLP4?BS$`#S)A3MVN*U.E39%9C*;,J*/,LQ"J/$DB*KI[.-H`3-*%@7+=SDQ`
M`1-+1;'',`)S>A2.)FY.V3I$!'[3%9*D*'J(AZ;]/;\?M/OR/(K*A2[[6-=_
MP6D"#_W@8ZJTXI8:5,OR['6M#OL=KFI^"40P/T+@QAF=IO-C+P*M)BZT?C]5
MG)1(I'TM5]8[F"1P*(E<S:!D"@LG\7WC&08@/V"40^+6\M[[@6%D]"PN,E=C
M\U624OP4ST\G1_KVCIK3)_%O'-M2VQ=UF+]>C5PM.C/R0ST/@].I]>T9`X[\
M-\480RA2<M3$C;,AW2I6Z%MJ<Q/29FR))",D47JCQM'1YD3KN5`(8?TUP\*)
MQWUY\SS_`#&5M*V.HT:-MCW0H419DJ1+:6:<A_*JQYL_\K\@S5E6Q5O;V]GB
MG0H:=-)DH="I9I@"6GH5(V/+?$1-]I:P(1L7;&SEFC-P3-Z\<-HJ4>)("ZB1
M5=M%$E2MESG+N.X%$IMC?#OJ.P9&(W.HBM^>R_DN(</J^T;1N-@;'.T>0M5K
MS*N+MSIF$.V9WVE9@IB_D,#@.K?JW'T'6<*IUZQA+-TZ1B@>1-.IN*>5Q9"8
M6N=NK&.Z[D"Q5B$>(S-L3B(2ULXMR]D@6=@#!-)6Q(G5,Y.4X-RG5*!BIB`[
MS'<>R.2N,:JTO:MKBK[:5'!"%MI:0,O5HIE*8G(3$XZ;"<4R^9KXZFM`T;2[
MK"DE:H&6F6DS24RFQDIEM!&Z0)$XH7M?('E3S#G'-!PY2[:6$=F[1ZAC2/EI
M:378N#@B0;=9F;=(X,E!/T*=7L6!@-LH0WVC-V.XIQ;A]%+_`"MS3>Z'^I5D
M`"/^73UU\/O?P,?1V'X+PC@%O3RF<O*56^77W:\@`PU_HTM?5W$O<J>!'2)D
M<?/"+FJTBPG,VG2J+!02JFJC22:MWVP"`@A,2_2]<--A`043:,E^H@[D<%-]
MF@SGRO03?0P-MO;_`)M02'U5.I\BQ'FICG.2?-M-/<MN+6.]NGOU@0OU2D/4
M?(N5UZH1%N43PLPSQEQ^_DIS(^,,)TN&!F$W-/&[5G'>X<G!O'_.K+8IZ%>2
M4D^6."3?W!U7"ZABII@8P@7455[[-\EOE%0U[N]:>U0"Q`ZG:BB2@=3(`#J8
MA"ZN^2<PR2?N*UQ?9%I[5`+D#J=B*)(HZG:H4#4Q'S)%(J>9L:W^6XQ\YL/1
MT9CI-BED^W*5.3?_`$PA87:T=`J$L$;8)-&"8RIV;P`?IL70A[?K153`IE"[
MW%8TX?(6@Y'QFYJM6F:5/<%#%1-IJ1-R)KZ2RC63`SE'2X/`#`92Q_\`=W$K
MNX>O,T*6Y45R@W-N0B;E9KZ"ZC63*TP(K4A?#]F&9M"TK<<W8:M-87_=>0FJ
M)D'YW<)HKH3NC@:.N\?5G+%^NB4QEE7'?.F?\U-?UVD.[^4\5;V8I8K%U?W0
M](1PJHLM/R,TP.RK*8[K$K9#YJPEICQ0P6'JF^7T+3<(E-):?Z;ON`[*LIC\
MRQUK-62L:\-!=XCPAC%5GE,$$"REVN,"[6<L!63#VTBQ=3C4BUG?+`?N("V(
M2'3,8#$!8.M$//A</F^9%<KR3)D8J9E1IL%W>(8*?0O8[B:A_AT:/'QW`\H^
M0=N9YCFF3`S,K:DX3>!U5U0_TU'0[R:I'Z=&C/GC]\6=YY&VE#D-RZ2GD,>N
MGP3#2I3KI\WN&4GY!**9YY85$I&"J*0D`BA0,D\<E)V4NPF'<U7E'/K'#6QP
MG%@GO(-N]0/;I#P3L[>>J@Z^HS`S\P^3L9@;3_V[PI:7NTUV>Z@'M41X4A]K
MOW+:H#K-VF!M5QL='P\<PB(EDUC8J+9-8Z,CF#=)JQCX]B@FV9LF;5`I$6S5
MJV2*FFF0H%(0H````:@IW>H[U*C%JC$DDZDDZDD]R3'SC4J/5J/5JN6JL222
M9DDF9)/<DZDQ]NK8LAI"&D(:0B!/DXCLGS?"+-]?Q%6IVV6^PQ=?A%(6LQKF
M9GG%:D+9!I6X(Z)9I+O)`ZE;]RFHFBF=0$5#F*&Y=PZW@SV-+E&+K9&NE.W1
MF;<Q"J&"-LF3H/5*4])RCM_CFIC:/,<-7RMPE*TILS;G(50X1MDV,@/7(@D@
M3`$8W\?]-Y30N#\!4ZZ4^$XZXZQE56K.4JCP&]JRKE*5%20<NW<RBNT:0V*:
MW)/GXO%FO;?3RR^Y3JLPZNY[>7W.!JY3+7-M<O>WM>H2''HI4AH`%U+56`$@
M9K3`[-VV'.;OC5;,YR[L[M[^_N:I(<32C170`+J6K.`-H::TP-0'[=!J^)<M
MY2\MEMSW<\>6*$PW@_$R^/\`$UNL$4I'Q]@GCL6;.2/`E=B"KU-22O%C42>)
M$%$[=$FQ]S`&O77R&/L/CVWQ-M>(V2NKCW*J*9E5F2-TNFB4Y@ZS,>ZYRF+Q
MOQ=:X.TOZ;Y>]NO=KHIF569(W2Z:4Z4U.H).D<_YB*GF?(_%B%QCA?'EJR'*
M7S+5.C+(RJK-Q(N&$#&MIF=:N)!JU'J2C5++&,`.Y7V9MA*!E3D,*8ZP_'%Q
MC++/5;[)WE.C3HV[E2YD"Q(4R)[[2V@U/:>L8/B>ZQ&/Y-5R68OZ5O2H6M0H
M7(`+$JI`)[["T@/4>@!UCOS7"'(_)G$/(F&[NUHV+F\[QN)B/%V*X:2<665K
M<O'TX(:.D\C9+(5O'OG,@NU0;+LHMB9FS;"H/N7AQZ@\C93"V/(K/)6K5:Y2
M]]ZK58;0P+[B*=+J)3)#,TR9>E1'@;,\?QW*K#+6;5KEDR'OUJS`(KJ:FXBE
M1Z@`$D,[;F,O2@B&_`G-?*/C1AV(XH7;@GR`LUVQ[,65*N6"NL*]$8]DXFQ6
M.2L>\SD&<?Q]3;':RLLZ(#IJY?IK-RIFWZMP'I>6XO!9S)5.06O*[-+6LJ[E
M8L:@*J%]--07,P!H0I!G'7<WP_&N0Y:MR>SYK8T[.X1-ZN7:J&1`GII*"YF%
M!D0I!GVBWG#3;/;@D_9<ZR5)CGD^:.^G,8T%LXD(;'K!G[X5R2-[DTVLK>+'
M,>Z2]VL5HPCV_MB$;(#NHJK'62;$@T:&*2J52>ZK4,C4)ETIB811(R$V8S]1
MZ`15EFPBFA;X6G69$GOK52`U4F4I4Q-::+([1N9C,EFZ`9NUJXT\:]ODGR#,
MK^1KAO!5_&=QS*.`ZL.<9*AT%D:7LK\SJUN7SH(N*`3=Y_%M\=,7@EZ0%4AD
MR[CZ=,P<)LZ8X9R2K6OJ=M^[J>P*E0R420`3/@?<9?+6)V^/;"BO`.6UZ^1H
MVG[ZK^V%2J=J"2`#<W@QJLOEK$W[]9<]\Z<42&+\>8GRGQ9H%_0:1.2<FYWC
M(FL7KZ*>]9;+6L=XWA+!-S;N4G&A1:*O9=2+:$:+*`0JQE/N^7M*&)XID$OK
MS(4+^\HDFG2H$M3WC[6J5&55`4ZA4#&8'26O&V-OA.%Y-,E?Y2VR=]0):E1M
MBST_<'V/5K,JJ%4^H*@=BP$R):YON/$2G-N%EUXAXF;-ZS"/L46.E5-Q)+J&
M`;(^8N73&P69ZU;&7=KR=H,5W)+)H[G[BG0F`=)`U=MR*Y;DUKR+(,7JBX5W
M`_2"`54$Z2711/PF>\::TY3=MR^SY5E&-2LMTE1P!^0$`J@)D))Z4!.DA,]X
MKL\>N7LR<3<1(\5,R<0.3[ZZ4FS6IU6IK'6/&=II-AA[#+NIL0/=W,_#U-FL
MA,/'!`7%X9F9N9,PJE'J*'9<PQV-Y!D3G\;R.Q%K51`RU*A5U*@+]@4N=`--
MLYSTCON>8K$<GRK<GQ/*\:MG6IH'6K5*5%9%"_Y85G,U`TV[IST[Q,WCQQ@N
MCCD-D3FGR':1C/+UUBD*?C7'4=))3T?A+&;5,J",,O-(!\NEKM+H)@:1<LMV
MB*B[HB"BA'*@ZYG,YVU7#6?&<,S''4FWU:A&TUZI[A>H0?E#:F2S`*B.1SW(
M[-<#8<0P+,<51;W*U4C:;BL?S;3JM-?R!O40%+`%1$5_*OBS.#7+?$/E;AV@
MV;*[;`%P5=VRE5AB]FY5%%.QUBP1SUE!1S5Y(+-II*-=LWKE),XM1(V,8O3N
M8N_X#?XML?R+`9*[2W-W3DCL0H^UE(+$@36890>OJCIOC+)X9L7RKC.6OJ=J
MU]1DE1R%6>QU(+$@36:LH)U]7?KD7.5"SWY`<%7SYEBZ?PC2&^.K(^Q9B3)#
MEBQR'DG+RT*X)7)^^,&3Q>.J-2K1USDAV+M7W:LN=.1<D0(U;%/XL5=XCB&5
MM-E^EU=&LHJUJ8)ITZ.[U+3)$W=OSL!()-%)+-&OPU[A.#9JQ]O)4[R\-P@K
M5Z0)I4J`8;UI$@%W>7]1E&T4YTU+%F(P_P"/C,W*RK\?:QQ88</<DUS)>-`L
M5;1R=E%@XI&%XMF_L<W+M)Z><22;:R3KJ)"2%,T;"(/3R)D2G*X;)K"HCLN8
M8S`5\Q7SS\CH/8U]K>U2.^L2%4%5`FJ@R^YRNV?1B)';<[Q'&+G.W/)7Y9;U
M,=<;7]FB14N"0BJ54":*&E/?4*[)D;6(D;2<2<>H+$^++'06LT^GK/?U[18L
MG9)DVR1)^^9#NJ"A;+=))JBK[=H*JJA2,V*1P08LD$6Z8]*?4/!Y#,5LA?T+
MMJ02A1"K2I@^FG33[4![^;'5F))ZQ&N4SM;*9*WO6HJEM0")1I`^FG2IGT4P
M>I\68ZLQ+'4Q2_P%L/*+Q_1^1N,.0^&V;LH)R>1I6ZTV\XDAV4O5)5=[%P58
M>&=VF4=1=;:03UM6V;ILLNZ2>(%64(X;D$O223.6T<%R][+.V?);6@5HA'2L
M2'$BS"2@%BP+$$`$&0()[R[SBAQOG-3'\DL.6V=L5MUIU*==BKK(LXDBAG+`
MNRD!2ID"K'O<WAY?D?9YV0O&96-1QE5W4,>/JV$:ZZ0N,_&.7#UF[^IL@Y'*
MDV8.K$W:MCM4HR%1^6-R.%3*.7JG9.C&F2&%H4DM<8U2O7#3:NPV*1(C;3I]
M0LS,LYW&0DJB<XCRJX"VHI9XEZMS<AYO<./;4@`C92I3)"DF9>H=YD`%03!@
M#2\094RSY:[QR(NE!ME=Q)@O&KG'>);-8X52-C[-.ECR0DD,$9Z5)5_%G>76
MR.D':)3I*$[8E/\`%MKKKG(V&/\`CVUPUM=TWR-U7%2JJM,JL]PW2Z&24P0=
M>L=S>97&8OXNL\#9WU*IE+VY%6NB-,HL]PW2Z-*G2!4R(UTBX?4<1%$-(11S
MY","YPJ7,CCOSNQ%C:?S-`XS904'D.AU!`9*WMH^`E["[</H:%0`9"2"7K]H
M<HI&;IN!;/&Q#*D[:FI2X?EL7<<;S/%,C>I;5:Y9J=1]$)8*`"W02903.4P3
M(S$3+P3-X:ZXEG^%97():5KEF:E5J&5,EE0`,W0;60$S(FI,C,1(?*F0,T\X
M<12N&\+8;S'@:O9/:FK>3<N<@JDQQ\:L8^?*$;VR&J-*/.R5JM]FL\4*\>3]
M&;1B;994QGA#&2,&GL+/&<6R-/)9/)6UW6H'=2HV[FINJ#["[[0J*IDW4M,#
MT]8T&,L<1PW*TLME\M:7U>V.^C0M7-7?5&J,]3:$1$:3'U%R0!L(G$EI2%H_
M"SAY9HZCM5H^HX%PS:Y&'()TQD9![`P$G+G?NUB$226G+'/B=PNH!2%.[<F,
M!2@(`&DIU;KDW(Z#W3`W%W<H#X`,P$A_"JZ#R$<]3K7O+^5V]2\8-=WUV@;P
M`9@LA_"BZ`=E$1H\/N+#8TX-X[D7C8J$WE67LV59A3J4.J["??A%U]TLHJ0A
MQ.O48&//MZEW,(@([B([OY&O_P!]RF\16G2MU6D/+:)L/^^S1T7RMDQD>9Y"
MFC3HVJI17RVB;`?1V:+0-<+$<12;Y=\3YQM=RX7Y5P]C2U9<0P[E"8EYVG5-
MD_?/%'Z\QCNP0*STK!J_-'1CX*>Z:JOE$3)-#*$$_H<`&3_CO(8NWMN36&1O
MJ=N;F@`KN0!*516E,B9&\$+.9B8?BO*8:UM.7XS+9&E:F[ME5:CD`2"U58"9
M$R/<#!09M(RZ1EW)^/.4N;,)96RYFNLM:O9ZMBK(5@X^<6L>23BW*P620I\N
M>H7/(DXT231R)E"OR:B8PD>S0"-C7A2N$2*/NTHAKK"\P.+RF/QV+KFI0J7%
M-;BZJ`)NI[QO2FI_RZ3">]B=S#0D),'4XZ^XUA\QC,7B+@U;:K=4ENKRJ!3W
M4?<7W*=)29TJ++/W&8[W6:DA)ANE>*O%G*[%^"L?4.]X_@<)T2!G[9:;`2SF
M<3>5<FN;([?N(YFG7"&91^+X:,17:E75>G>2CH[/H*V;$4%4WJY]?\?OLK>7
M=I>/=7;HB+M]-*D%`!.[4U6.L@NU1.>YB)1[/DS)\9R6;O[ZROGO+UT1%V26
MC1"``G?J:S&32"[47=/<Q$HQ!R1HW**Q>6O%F3J3@"<R=1L18X8LZG(RSPU/
MQJ5S-5B[)#,S%]=1LG'M%J[=K5[APW;HNI11&/(5%N<PI;['"W6"H_'M_8W6
M72A=7%<EP!OJR5DT6F""=R)($D+-C,C6-MQ^]XW0^+LGCKS.);7MU<$N%'N5
MI*]/TK2!!(:FD@20@+&;#6)=\J<A\G\0Q?%.['QO;\TFJ.4++<,_,>-\1,HM
MOD!J;::U"5UE5WLW(SUAB6I[P5P7W0&0=NH,JZWLCJ(E)SN`L\%D:F?M1>T[
M7W*"I;FY*SW;U9F+!0JD[)::@/(;I&?*\9L..96IR:S_`-PI6?NVR4[8W;+]
MWN([.7"A48^W+3514*C>`9\9D_*]\YR85O>#\.8`S5CLF2XM2H6;)?(NAM\:
M4^DUZ0.W^>R3&(D960M%WL01PG28-HUF*!'9RJ*O&X)=0WV&/M.+9.TRF2R]
MK6]AMZTK>I[KNPGM!(`5%GJQ8SEH%,XR8W&6/#,Q99G+9RSN/V[>XE*UJ^]4
MJ.)[06`"4TGJQ=I[=`C3C@.7O!!_+>.6/XKX$0-*2^*6M6G*O'/%&[1[>)2N
M/'DC9NXLLX28LYRV.I=^^*43E;^]5!(.@A@$N;CO+$I\S?/98[:=P65B)D(&
M`"]IE4"JOCM$]3&?BO-DI<_?DV<.VE=%U<B9%-7`"=IE4"JOCM$]3UZ;Q1YF
M\BD\3X[PC)<#.1[O+N/*A7J`]EYN(98ZQ3(#5(]K7&D_+WVYA'A#E>MF!7#I
M)LQ?F`W7[8JP=!1].?XUACD+S*)RRR&.K5&J`*34JC>2Q44TG.1,@2R]MTM8
M]?)^)8`Y3(9BGS?'C%5ZK50JL:M<;R7*K2ISW2)D"67MNEK&?.2?'/D/R.X7
MYNQ3?[;17V6LA)P=AJM?J,6XAZ)4'%1L5;MD90F,_+*GG+&,JO7#(+S,@5L4
M7#L3E;-T$RIAJ<)F<-A>38O(6EO5&/H[E=G,ZC[U9#4*CTK+=,(L]!+<Q,XT
M?'L_@>/\OPV4L;6N,7;EE=G8-4<.CH:I5?2FT/,4UGHLBS,9Q'7@[R0RYA_`
M]*XUW_A=RH5RUBF(?UIJ:"H#!+'EE:(R#MU!O/UD6.>@:K$%41>IHN5#+K(`
M9,RJ1U0$4R;GE.%QV1RUUF[3DUA_M]PP8[JA]Q3(!A[:JS'H2!('L0.IZ#F?
M'\5ELW><AL>7XS_:[IPYW53[J$@!A[**SMT)`D#J`0.IE3Q)XJ6;'60LO\GL
MYNX29Y(9\>D^>(U]9P^KN,J*S.U+"8UK$J\(B[E46S.+8%?.S)ID7.P;E3+T
MI"JMH.0Y^A>V>.P>*5EPMH/3NT:JYGNJ,!H)DMM';<9]9#F>4<FM\A88GCF&
M1TX_8KZ=T@]:H9[JSJ)A226VK,R#-,ZR$)O)'B7.]+Y@\9^<V*\8S^:*QB:"
MAZI<*13FKN1LS(D/:+=*G>DC&#=](JM9Z*O2Z*;ANV<$:+L@%P!2'()NGX5D
M,3<\<S?%;^^2VKW#ET=R`IFJ"4R0)J4!()$PVFH,=C\?93"7G%.1<+R>2IV=
MQ=.STZE0@(=R(LID@35J8)!(W!O3J#$N0LF8.<]/2J"F(LF\9<"V0J*.3Y?*
MGL*WEW(=9.'5*8[I%1A9*0D:G"65/]&DYV16:KC'JG29MCJ*F60Y[V,=Q6X-
MR,C0OLLG^4*4VHTV[5'=@`[+U6FH(W`%F`$CRO[?%<,NS=#*VV1S=/\`R5HS
M>A2?M5J.P`=DZI30,-P!=@!)OK\B'%R?SIPLLF%,*13!A,U4E.E:%2V*C6%B
M9%C17#<C>FLC*J-H]B08(AR,"*&(W!TB@4YDR;J$MX=GJ.*Y-1R>3J$TJF\5
M',V(-3\Y[GU?=+61/7I%O`N24,+R^WS&8JLU&K[@JU#-F!J`SJ'J3ZONEKM+
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MLHY_S(_MTC$6%(Z$ZI`M4%I1@\D47!SO6YG%CMLP)4W'2OL'68/C#78_(65Q
M][=8C'XJZ6K86EL$!7[=QT('8^E$Z:=NT=Y\HYK%Y"\P>+PMXE;&V-H*89?M
MW$R($M#)$I]-.PZ1;AJ/(BV->FET#FUC_P`H/+*P8UQ$G(-,O1QHF,S/?T9=
MIBVD5"4<566@[4DZ;-4DKY*0<;"!'E@6CE)P=ZGTJJ)HI*GU,-S=\7O."\?H
MWV1VM;&9HTY&J[C<&64_Z88MN]P@C;T!)`B=[R^X=??&_%[?(97:]HVXV]+:
M:U1P'5DD3_25BV[W6!`4Z`D@1]O"##$'>_)MR+RW'R,G<8+C/&FQPKD2P=M>
M?R!F^Q-'L!?;=*N16.B*HO4;(@V09D*S819F#9`$D$D2&MY3DZMIP?#8]T6G
M5OF]SVUT6G04AJ:`?3VR2=6;>QF23%G,<O6LOCGC^+J4UI5LBWN^TNBTK="&
MI(H\)>T26]3/O9IL28V"=1!$%PTA#2$-(0TA#2$?_]??XTA#2$!`!`0$-P'T
M$!]0$!_(.D(AGFCC*E,*.[3CE%!I)J"JYDJP)BH,Y!4PF44<0YSB"+)X<P^J
M!A(@?[2BF(;'RK4[-TC&R=Q$"WS![&/'$?)-'+!\T4,BZ9O$%&SENJ7\Y-9!
M4I%$SAO]@@&LT8H^%55)!)1991-%%%,ZJJJIRII)))E$ZBBBAQ`A$R$`1$1$
M```W'50"Q"J"6)T$556=E55)8F0`ZD^`CH:/E3QYQQ-])Q\N;,RI5Q1;T*G"
M,NX:NE51`Z#"SHB>'C5#.!-W4`.[.0W4(-^L=QZ_&<!SV445ZM`6MI*9J5O1
MIXA?N.G0D!3^J)&P'QERO,(MQ6M198Z4S4N#[>G680^LZ="5"G]7>)V8NYPX
MESU!)/,@<>\H4+NL3$=(95I=,>QRQE"%`[.-3&P/+$_9KI+FZ55XEHD<`,`@
M&Y>K1Y?#+AZ^RAFK6Y8'3V6<D>9.W8"/`.3&BS^%ML#<^U0Y#97CAM/89V(\
MR=GM@@CH*C$?VRR7B1+A^6VR5=Q9@S&].F+Q#2L)./H+$=#J:%HA#(C)2<#.
M.(IBU>2\<^!L*AVKA-1%4R>YB^@#KR7&5S%RM(765N*BTV#*&JNVUAT*S)D1
MV(D1'AN.0YN]%"G=YJ[JK28,@>M48(PZ,NYCM8#H1(B.-RUR'>8(4DZVRHE/
MH%=@DCN6TU*.DF-7-$"!>W*MD6B%?C&#<"B!3@98Y4E`$A_4!#7GIT[B^K*J
M^Y6N7,@!-F8^`ZDF/#.]O[I::)4KWE0R`&YW8^`&K$_VQ'7/W,*\8_L7$/"+
M.00ELW<D,K4R9>,DUSP32AXLE9^-A&CB>CHU)G)NFLI[E==-NH8JAU6+HJAC
M`B5,_2X/BYR5CG,K=U&IV%E2<Z`$O452VQ2=!*0W'7[EEUF.SXUPRIF,9R'-
M9"N]''8^DY.T`FI55&;VU)](E)=QU^Y0.LQBEI@VZY/Y1^2>H9$?2#C!.5<2
MOX.I1KJ53E5&MDA&]<E&MCKE;]R";%6JVV0?N6_<[`JO0`P@<INX.R_W[%XW
M#<3?&4U_WRVKFI5(7;,$L"KO+U%UV@RG)=-)2C;?^Y\'B,#PM\+23_W+9W!K
M5BJ;=P)<,E2I+U%TV*9;I*93!$HX)RQXQ>++B8:N+2;]SD/D*VC)Y^BNH69N
M5J:Q"3=5JBTCD/:,4&<.VE3((CLV;)NGRAS*B(>MM1^3_(V35EI+[-&8!`VT
MJ0;K-C,DF6OW,9:"0TQ5GYG\LY.F5H)[5&8!`V4*"OJ=S&;$M(3$V=I:+(2%
M8]EKO/;FJY+!4?#]SQ1AN4620"3LS*1ID#,,U5B(IN)RWSC6,-9"JF6*(L(L
MBJ0!MU)JBF*VNVL;7A7"*?[N^R%.\S*]ED[*W@B`D)_.Y!\")[8D/%X[XZ^-
M:(O\EDZ60Y"O0)MJ,K>%.F"5I_\`F5&!\&6>V+:>$WB2H^&SP]QS$12Z6R&6
M5<Q3*7,FHQCGBQR&7<QD0W>/HZ#05[*>YRJ+OUQ)N*R"?4B?A.2\]RF>-6A0
M_P#3X]M"BGU,!T]QY`MW](DNO0D3B-^7?)6;Y0:UO2'[/$MH:2'U.!T]VI(%
MQU](VIKJ"1.+K$446R*3=NDD@W02310013*DBBBD4"))))$`I$TDR%`"E```
M`#8-<'$=Q^ND(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(H;XDR!,V>8CFEE8
M2JNX?%5/<XQA506(Z9QTG#R%/Q^)FJH@<$BR04N97*5,0`3.%1W'<=Y8Y"AQ
M?QQQG']*EQ4%5NQ(8/4U^F]!^`B;.44SA_B?B&,G*K=5O>;L2&%2KK]/<IC7
MP$7R:B>(3AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI".LW6WP&/:;;+[:WO
MRZKTBM3MNL<AVE%_8P-;BW4Q+NP11*9586S!FH<"$`3&VV`!$=9[6VK7ES;V
MENNZO5=44>+,0`/Q)CT6=I7O[NUL;5-US6J*B#Q9R%4?B2(JOSWG2B^1+&$7
MQEXJ6AY;D,N2=/=YHOS"$GHV+PMB.+F6%GGE9R1DV3!B2^V)S$)1;&#W76=$
M6<&5*F@3O:[W$XJ[X;?5,YGZ`IFW5Q1IEE)K5BI5=H!)]M02S/H!(2F=(DO"
M86]X%DJG(N36PI-:K4%O2+*3<5RI1=H!)]I`Q=JF@$E`FQE%K-6K4-3*S7:?
M769(^OU2"B*W!,$_V-C#P4>WBXQF3T#X&S)J0@?WBZX"O7JW->M<UFW5JCEF
M/B6,R?Q)B,KFXK7=Q<7=P^ZO5=G8^+,22?Q)CG=8HPPTA#2$-(0TA#2$-(0T
MA#2$-(0TA#2$-(0TA#2$-(0TA#2$14YE\IX;AUA"4S/-4V>O:32:B*ZR@8-P
MWCRJ2DV+D&*\S,.472<)"@HU%-1R#=R<%E$B%2,8X;;_`(U@:G),I3QE*Y2D
M2I8LPGHLIR`EN;7I,:`F>D=-Q+C5;EF9I8BC=I0)1F+,"=%E/:HEN;68$QH"
M9B4=(RKS)I$GC)%#C'::SFG-V3H$6^&Z729:.L+XDI,HD;-KA<6K4[@*E3*8
M=V#R5=2Q6B"0-Q;F$%SE)KU6'&KI+XG.6[VN+H/_`%G<%1(:E$)^]WE)`DR9
MSZ"<>S&<3O*>1)Y%;5+/#VSSKU*BE1)=33IDRWU*DMJ*FXF>[[03'<^%_&&)
MXFX*@,:(O23EOD';RXY0MH=75;,BV$$5I^3()R)&".9@BDQ9%Z$S>S:I&4`5
MC*G-YN39VIR#*UKXKLM@`E)/T4U^T?4ZLWF3+20CR<NY'5Y1FJ^1*;+50*=%
M/T4DT5?J=6;4^IC+20$K]<_',0TA#2$-(0TA#2$?_]#?XTA#2$-(0TA&*,J8
M:IV6X5U&3Q7\1)*MA;LK;6U&3&TQ'KU%.Q?/&,BT5`FX[).F[A`.H1Z.K80S
M6];V*J5325U!^UI[3Y&1!_L(C+0J)1K4ZST$JA3]KSVGR.TJ9?0B*JLI>+IN
M_7.^F)Z_9VA4CE61AK3D&>9`W.D(J=X]1AWL!67*@_"`]@AA5Z`^Y*'H/3V_
M+\C9@C&T+6U8_FIT4W2\-[AW_P#%'46_-\SC5(PMM963&8W4;>G[DCV]RH*E
M3Z>J>IC&\#ANH8C44BH#&T-07B8&2<)-:TWA)1;80*;WKDS5&1>&'I`!,J<X
MB`!Z[`&M9>Y;)Y,[K_(5:W\SD@?03D/P`CG\GG<UF'W97*7%P9]'=F`^BD[5
M^@`CI]BSQAFJM`>363J6B4X;H-6<\QF)1W\0DV80T.J_EY`W6&VR""@[Z]5K
MQW.WC[+?$UR>Y*%5'U9I*OXD1Z[+B7)\A4]NUP-T2.I:FR(/YG<*B_XF$8B#
ME-F5]-1SWC/@RW34E'/6[Z-O^3&"]$I!5&ZH*%=M64JZB)2PQRA`Z5$P69JG
M*)B@0WV#OZ'%\/9#W.2\BHTO&E0(K5?H2H94/X,/..LM.%<?QDJ_,>76U"76
MA:L+BO\`RL4#I3/X.OB1%WU9N6&N36.JQ"Y]IF,W5G3)%R\W0+<E'V>!A[<U
M1W.]J4I9(QF5]V%14!!=%-)V1(QBG``$1/QXN:V,O:]7#WM9*<V57']-V0]F
M"L>NDQ,C_AQR9%\5D;FM@,E7ITYLJ5/\IVID]&"L1K(369&@/T[W*X%X]GR*
M]SU(U^!;9&7?0ZSW(SF>=A(D4@V31M$1Z;Y[**,XV.;-&J>S-`J+<XB8YB"9
M0YC6?OLE7M:6-%>HUFD]M,3VZDDG:-"9_F()[3D!%#?Y6ZL[?%"YK-8TYE:2
MD[)DDEMBZ,T_S$%N@G(`1PTO.<?ZA:W%RBP+9;]).'ZY6].E).POGCEZD=-T
MD=C'R2D&W*XZA*8JQ2B(FWV'UUY-M3[&!$O$1K&4(Y#@AQV[_P!D=49T[*60
M'T#(M:13<21U<C4X6LV"8AF=@R-#5](Q2%CHJ2DT%IB-(*:9!%/]`$#$WZQ]
M!'.;EUIU*-.L_M.9LH,E8^)427Z=8])O+D4JEO1KU$MG,V4&2L>DRBR7Z:&7
MC&?Z=BJNU-R$NX7DK5:3E$%K5:':DM+`)@`%"LCN!,G&HF^P`2`#B7X3',`:
M\I8GR$>4*!KWC)NK8NAI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(ZC5L
M?T.C&E#TJDU&GGG'9W\T>K5N&KYIA\JX=.U'LH:)9-!D':CM\LJ917K.*BQS
M".YS"/HKWEW=>V+JZJ5`@DNYF:0D!(3)D)`"0[`1ZKF^O;P4Q>7E6J$$EWNS
M;1("0W$R$@!(=@/".W:\\>6&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(X6
MQUNOW"!F*K:X2*LE:L$>ZB9R`G&#:4AY>,>I&1=L)&.>)K-7C1PD82G34*8I
M@'[-9:->M;5J=Q;U62NA!5E)!!'0@C4&,UO<5[2O2N;6LU.XIL&5E)5E(U!!
M&H(\1'"T+&^/L65]"J8TI%4H-:;G%5*"I\!&5V+[YB$(HZ49Q39JBL\6*F'<
M6.!E5!#<QA'UUEN[V\OZQN+ZZJ5JY_,[%C])DG3RZ1FOLA?9*NUUD;RK7N#^
M:HQ=I>$V)T\!T$=TUY8\<-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2
M$-(0TA#2$<+8JW7;?"2-:MD#"VBN2[<6LM`6*+8S<)*-1,4XMI&*DD'+%ZW$
MY`'H53,7<`';TUEHUJUO52O;U6IUE,PRDJP/B")$?A&:A<5[6M3N+6N].X0S
M5E)5@?$,""#]#'3,;86Q#AQDYCL3XPH.-V;T0,^2I53@ZV:0.4PF*>16BF35
M>0.01^$RQCB4-@#8``->F]R>1R3*^0OJU9ATWNS2^DR9?A'KR&7RN6=:F4R5
M>X<=/<=GE]-Q,OPC)NO#&NAI"&D(:0AI"&D(:0C_T=_C2$-(0TA#2$-(0TA&
M.<G?\W3_`.CG\X_^D[_F[^QC^?\`XW^%_BZN7KW_``BAZ=HK%FOI;ZBE.[_-
M3][W9#_1[^N+YY^SFW]S[/\`<'?JV[W^V[;?#OK:59_MJ7_[/;[I;.G;_AY1
M[+B7[2C_`/L=%^Z?M]/R_P#]?*.B2'MNZ'MOE_1U*?Y/^:]K;J#IW^;??=.W
MYOY=OSO77CC5QA[)'R+H9_//UH^W]G(=7ZM_UC=?;[K#J]Y^KO\`=/WG7T^W
MZ?O>GN[?#U:W6(]_>_L_LIS'_P"Q[4NAZ>[I+Q[3EWE'1<?_`'.^I^W_`-NW
M;E__`&_8E.3=/?TE^J?IGMGK*,)<;?U9_K@7^0?ZN[I]^'1^L+^=Q_.%_P#0
M?MS]9?WOO=MNON?D[7]_7;Y_]W_LJ?NO]YW[?R?M_P!EWZ?M_3+_`.L2?R?]
MY_[<I_O?]_\`=V?D_:_[=WZ?M/Z>WP_Q1L18=Z?E:_1^J#HZ2]/ZI^[[7IZQ
MZ??][[[N[?G=?Q=>^_KJ)V_'\8A5>G;\(S/JR+H:0AI"&D(:0AI"&D(:0AI"
M&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:
M0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"
3&D(:0AI"&D(:0AI"&D(:0C__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g176457g51p54.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g176457g51p54.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0D\4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````.P```)L````&`&<`-0`Q
M`'``-0`T`````0`````````````````````````!``````````````";````
M.P`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````!I\````!````<````"L`
M``%0```X<```!H,`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``K`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#TCJ&5<QU>'B1]LRMWIN<);6QD>MDV-_.;5O8UE?\`A;[::_97ZEM=
M.SIV+B9G3A0"[,?:XW93O=<^L56NN=D6>USZ76NI9L_F*;'XWI55^G0K/36^
MO?E=0?S:\T4^5-!=4/\`MS(^T7?]<K_T:,S$?^T+,RUX=^C%6.P`C8TGU+R=
M?<^^QM>[^112DIM))))*4D@,HN9F67>J746L:/1,^U[2[WUNGZ-C'>]FW_!H
MZ2FMF9^/AA@LW.MN.VFFL%UCSR=C&_N_X2QWZ*K_``J$[J60QH>_IV4UO+R/
M1>6CSKIR;+7_`/666J'2F-R7V]5?[GY)+,=W[N,P[:?3_DY.W[9_UZNNS^8K
M5YEM;W/:QP<:SM>`9VN@/VN_==L>QR2D>+F8V8QS\=^\,<6/;!:YCA]*NVM^
MVRJS^18U'6=G,;1U#"S&#:^RS[->X?G5N;8^IMG[_I9+:_2_T7JW_P"EM6BD
MI22222E))))*?__0](Z+_P`CX)(@NQZG._K.8USR?H_2<5//SV8;&`-]7(O=
MLQL<&'6/_';6QOZ2^W_`U>]";THU.L^RY=^+78XO]&OTG,:]QWV/K^T47O9Z
MCO\`![_2_P"#1<7IV/C6NOEUV4\;7Y%IW/+9W;&_1935N]WHT,JI_P"#24YV
M)D=1JZ5BT&]N1U'-ML:W(>/T;9==D/M],;7>CCTMV8]'_$4665_SRS,3/<WJ
M%N1C/R,]];[<:G&-Q!R+:W>C?;L<]N(UE&R^VW)]&C$K];%P\?T[:GU6='^R
M\`TFBREMM)L=<&6>\->\N<_9OG9N]2S_`+<]/^;1ZL?'IGT:F5R&M.QH;HP;
M:V^W]QOM8DIR,SZP-;EXU=.^K&97?E]0NMJ>S91CL;OK#;VU?I'W9%'T-_IU
MLL_?WK3.4+.G_;*9`?3ZM8<(=!;ZC-S'?G*G]8<7&R>G.KOI;<7OKI870"WU
MWLQ7.:_\WVW+3<UKVEKA+7""/(I*:>$^K%Z/0]TMJIQVN=/(:U@<[<J/2>I8
M[,"KT669N1>#?<<=A<PV7?K%FW*?Z>+L_2;*=^1_-?HUFY?2_M?0;<F[+M-M
M%#L9N.\5/H9?1.([TF7X]K]]F15_/[_5_P!%Z:W_`-G9&P,/4<F!S`QP2/W?
M9BMV_P#6]B2FC?EYV;U'%QJ\-K/LSOM5[;;@',&VRFAMK,9F57NLLL]2G]-_
MVGM5PGKQ;HW$:Z>-UA`;_F,W.5G#PL?"J-5#8#G%]CG$N>]Y^E9;8_<^RS3Z
M;T=)30#>N=[,7Y,L_P#2J1;UW\U^(?(LL'_HQROI)*:##US:=[<7=V@V1_U*
M9KNO@^YF(1Y/L'_HMRT$DE/_T?54DDDE*22224Y^>\7YF)@,,NWMR;P((;54
M=U3G_N^IEMI]']_T[MG]'M6@JF-_3LS^8YK_`)K^>^A_VL_]$?\`!*VDIR\S
MI>2^\OQ+*VTY%U%V55:TD32^I[K:7-_PEM%#<=];_P!%_-7_`*/]-]JU$DDE
M*22224I))))2DDDDE/\`_]D`.$))300A``````!5`````0$````/`$$`9`!O
M`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P````$P!!`&0`;P!B`&4`(`!0`&@`
M;P!T`&\`<P!H`&\`<``@`#8`+@`P`````0`X0DE-!`8```````<`"``!``$!
M`/_N``Y!9&]B90!D0`````'_VP"$``$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$"`@("`@("`@("`@,#`P,#`P,#`P,!`0$!
M`0$!`0$!`0("`0("`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`__``!$(`#L`FP,!$0`"$0$#$0'_W0`$`!3_Q`!W
M``$``04!``,`````````````"`0&!PD*!0$"`P$!````````````````````
M`!````<``@$#`@,&`PD``````0(#!`4&!P`($1(3%"$5(C07,4$C,S4646,8
M87&1,D)28E-D$0$`````````````````````_]H`#`,!``(1`Q$`/P#ODG)N
M&K,+,62Q2L?!5^OQ<A-SLW+.T(^*AX:*:+/Y.5DW[HZ39E'Q[)N=9990Q4TT
MR"8P@`"/`A57:!)=P'+;3-T@I%GU].HF_P`:ZX61H[CVEUBOQ&C=<[&59T"!
MY][86QRNH"C3")V%?:'1=R[,]@]M&##U.K54K^<ZIVSS+,:_!4_%:1H69-ZO
M2*PT90]6HM\GL3HUEO\`6:A5HH4H:GUEU!RM<FQCV;=H@>7FI!Z*0JO%5E0F
MKP'`<!P'`<#'FA:YE&1LHZ2U?3L\S&.F'I(V(?Z%=*W2V4I(J*MT",(YU9)*
M-0?/3KNTB`DD8QQ.J0/'DP>0L:,[6=79JQ150ANR6!RULGC`2#J\9L6>/[%,
MG%P@T`L5"M;$K)2)A=.DDO"*1Q]Q0I?VF`!#/G`<!P'`<!P'`<!P/__0[,]S
M:CMVP9[UE#^/0XB.C-\[$H%$3)2M,AK(NPQC+)4A1*8(C6],KC^1?)G]QK)P
M5'E8ITF="2.'`DY>+K5,VIMKT*]3C*LTNCUV9MELL4D8Y&$)7:_'N)28E'8I
M$56%!DP:J*&`A3G,!?!2F,(`(84ZJ56T0^7N+MH,*_KVF[E<;-N.@0$NN+B=
MJSZ^.434O.Y]<BJS1::Q_)XRNTU=1L(-535_UI!Z#`(A)3@.!\#Y\#X`!'P/
M@!'P`C^X!$`$0#S_`+!X&+<2U6)VW*Z9IT0R7APLT6<9JLO5TUY:DW&'>.H&
M]Y]8#)$3(G9\]ND6_A)1+TE%&08+$$`$OC@93X&#M_UB3RBF1IJA!,[?JNAV
MF*S/&J2_?JQC"TZ-86TC(-_O,@V;O'S"G4NKPDI9[(Y:H.GC.LP4BX;MW*Z2
M;=4/-QKKQ6,N>/[U/NRZ7O5M9I):-NMDBVQ+?91`07_MRN)&6?\`Z=Y3#.A-
M]FJ<6N6+CBF.L?Y4BX?2#L,RV>JUB[P$G5+G7(&W5>;;_$F:W9X>/GX"7:>X
M17XLG#RK=W'/V_NIE-Z%4SE]10'QY`.!"^[9G/=1Z_.ZSUS6F%LHI4<_M.B]
M4%UW\Y3'=)AFJK^R.^M;-0KZ3R&_P<,T,O$5:+,2CS2B!H_[9&/)`9UH$WXJ
M4CIR+C9N'>MY*)F&#.4BY%HH59J_CI!NF[9/6RI?PJMW398IR&#Z&*8!X%?P
M'`<!P'`<!P/_T>T?JLD-I+MNZ/$U`?;/MMV3AA7,\4^)FN-2"F&YRA%G?M6C
MA"O6:/S]S;D$"E%$KNU.E$S&!83F"3<W`05E8?:K'"Q-@BP?1,H$;-QS.58!
M)P$LRGH*1^&_17;_`#H6<C6SUHMZ?<;.VZ:R8E4(4P!ZASD3(910Q2)D*8YS
MG,!2$(4!,8QC&$"E*4H>1$?H`<"G8OF4HR9R<8\:R,=(M6[Z/D&+A%VR?,G:
M)'#1XS=MSJ(.6KE!0ITU"&,0Y#`("("`\"Q;QKV39BYAV>DZAG>>N["+TL`U
MO%UK53<SAHUFO(R(0Z$])L%9,6$>U577]@#^TBF8YO!2B(!>\;)1TS',)>(?
MLI6)E6362BY2-=(/HZ2CGR";ID_8/6JBK9XR>-E2J)*IF,10A@,41`0'@4\7
M!0D&,D,+#Q4.,S*NIV8&+CVD>,K-OBHD>S$D+1%$7TJ\(W3!5PKZUE`(4#&'
MTAX#U>!$\R0WGNJ=-Z4AXGKMUZB)>%2%-!TU>WCLO=[7$2$D<3/53QUCH5,Z
M]?&;'!LBK]NNKLH*G37,0`DQ8K!"5*OSMJLTHSA*Y68>3L%@FI!8K>/B(2%9
M+R4K*/ES?A09L&#9154X_0I""/[N!;N8W"0T'.J3>Y6I35#>W.L0UH4I=D]!
M;+5TIUBC)M82RH)D(FRL<>T<D3?MBB<K5V"B(**`0%#!?!R$5(=)4A%$U"&(
MHF<H'(<AP$IR'(8!*8ABCX$!^@AP(F]#5A/TRZR-BK).6L-C5'K,4[1;I-2/
M8*JP[>M5]\"*!$VQ3/82*;JF%(A$CF.)B%*00*`2TX#@.`X#@.`X'__2[2^B
M($_T1]/S%:Q[)1;K#A#EVUBG)7S!&1=9A5W$F5N^(X>?/`9%543+F66.N<1.
M8YS&$PA*W@:V>_>E3MRRS=>NV12)R3L;B5YN78>YQZRY$,IR1.F34O\`V8G)
M,3I+LM;W5BS4B85!%9!Y"0B[ZPBH11I%MI0,Q6B3N6!8=U\PG-/M,EL5L9T7
MK]G4K8FZ\C5:](57-I&9MVEVUDP6BWDK`T:A4"5DTV*:C$)R638Q/RF`R)7:
M`:W=WQ6DS/8UITVJ*4G<]5G,3KNRZYKFA,F5NMUJ=ZG=-"HD5V*V2RJL65><
MUCK/$Y/9W=-I*S9.J!?;'5@AXB/901W$:$T,M[EYG5SS,*_J$AG/4JKQ=8J7
M63?VD+8IG*M/K],ARURW$)/0L9),*3"U^=CTV5;>3!F+.XQY?G0BT@U`50#!
MD7W1.OM_=SMS;K[;HCH/T?Q`E-09QT(Z9U[0-$6IU+WG1]$CX=^SB;E;+5`5
M27CH&+241-!F;O45HMPX6D'WQ@W$\"+N%$8NMF[JRH,3HRS7>Z#4'$@J90QG
ML/$=3^N5JBFZ`&,)",V,C?)`2@4`_C+*B/D1X%M]VIB%7S6D9-896+A8+L'K
M]-RJUOY^12B:VKET4QL&S;S`V*26<,T645<>OV26J%$YEDR^[(I@(B`^D0]4
M>YV.SHJ(Y"UT;L2Y$%RL76"YS9[Y1I-RW))>ZQ;;:+.*P!J^(XBE$#IO+6U%
M)<Q"J>CUE$0PWOO:/M)4*"J^SSJI'5:X7.=1S#+8G>-TH\!9YS3+<`1%(&'J
MF(P_8R)GXYI(J+S,H1>8CRQ]7B)"1=J($;*$*%QY/EW='/<BR')Z[:NJV;QF
M8Y]4,_*H^I.N;R<8BD0497(A)LNA?.M@.G"\7&%!5R=%`I53>HK<2AZ!#(TK
M2.ZS]V8C#L?UOA(@Z90$K+J#H;JPIJ`7\1V\O*=RWT(4IC?4"J1*O@/IY$?K
MP*=OEO;LI1!UVTI:Q_/X3-^LD4V*!?`?02*:L[$P^?W^H/\`=P/LMEO;@R8@
MW[94U)7R'I.MUGB5TP#S]?*1-3;F,(E_9^,/`_\`#@4?Z>=XV10+%]INO+\!
M_P"=2Y].;G+K>/J/\(U0[@9\B3ZC_P!29_H'^/D>!=9:MW`".%(^Z=;#2WH,
M`/2]4M0+'`H(#Z#C%CW,.Y$A3?42_,`1#Z>H/V\"U0J7?9`QE![!=0I4H#ZB
MM`Z>[-`&.`#Y]HTA_KELH)BH'T]?Q3^C]OH-^P`KOLW>7V?'ZC=4/D?#]/K_
M`$6U_P!G[A\_U>Y[?Z^>OX?VO\'H]7K^1^/U^C^'P/_3[-:_G/8'"YF;K^+,
MLKTS%[#9)^W0M1U+0KCF%IQU_:)9:>L=9J5BK.6:^QO6>O9Z1=O(F->-(9Q7
M"K&9(NW4>#)M'!Z$E&=RM&*YKTG(8QULKRXF1?7'+;98^P.H/(Y1T\243I_Z
MCX]D.?YU8`8E;JI2,G$7=HDJ=5(8X_I3<\#)=<Z^Y55,JM&-0U><$IEX8VMK
M>5'\W-S%JO#Z],5X^XV6Y7:7?OK;:+A8V[DP.I5\\7?*>"![@%33*4+5#KZ:
MUY7C]0UF[6"P:3D"4(\B-FHDA,9W:U;A#UF1I3ZYM2-):5*W5N%;EGB<K%O%
M)*,7%ZJ4R:@$1.0+1;="^J'S'4O/9-'WJR38D->;9HLW9KW9M6]CY7P6VPRM
MFF9%35X6$!\L2(BI\'\3!(*BA&-6;<"I%"7:""+9%%LV12;MVZ2:""""9$D4
M$4B`FDBBDF!2)I)D*!2E*```!X#@:TNZG6C.;E,T`74S9HQ'L#VAZV,]0S@T
M^_>91L:N86.L7YW_`'KG[IM(P\E*R&88@$(Z.3XK>1BFJ"3\KDK1I[(;,N!K
MKN;KLY#[!VOH'6`V,N-#LB'6[=(Y]N9[S&T:O0U^JF@8I8RIK4>ORTE8K0BK
MU?9*-VHJ)-FR<B"ZYC`0C9T$)9K"^RCSMSUC9;%CN)=A-%:Y]V!VHCW:^Z>E
MW*G*26<R^#YXWG*_1F/0BMY+F<[3R[B48I*N4^//(^M1R^>?,:I+.`VL2E@[
MB+)-6\)D?6F-6<N447DO*=BM1FTH9F80^0_:UUIU=KY[*Y1*'@C,\I$D4$?(
MN4_'@0_3-\%EHV\_K+M5X1UW9D8I[`5N38UM2FYOE5=E/C?>H3(,]<S]N=UI
M6SF9(GFI>1EY>=E3)D1,\2CT6L>V"27`<!P'`<!P'`<#_]3OXX#@.`X#@.!%
M/;3EF^PG3"I-4HY>3@M%UW;GA7:3I=\UJ5*Z_P"BX[*R$61`H(M%4K7V+@6Z
MKE<_MD2="B!#*+D,F$K.!#KL*\;XYK&.=HGZS:/H,!'VG#MZEW)6[6/JV::A
M(5F:J&KV&1]1'!8?+]5ID:P=K+B$;"5ZX3<P\.@V8K+%"Y$DY&=[IO53N6WV
MG*^KT6FW:`9$7@2._:O+F>.3$]KY!6PMNM:!2CZ_08P#^'R'G@2AX#@.`X#@
M.`X#@.`X'__5[^.`X#@.`X%,\>,XYFZD)!TV8L&+9=X^?/%TFK-FS:I&7<NG
M3E<Q$6[9NB0QSG.8"D*`B(@`<"(N%/7&XZI;>T7QW*.;?VDCD?6TS]N*+BPT
M%280L^F[,P270;OH^`V:V1D,TBD5`,1]!4V.ETCBC*D(F$P^!3/&;.19NX^0
M:-G[!^V79OF+Q!)TS>,W21D'+1VV7*=%PV<(G,11,Y1*<HB`@(#P,%X]UAQ3
M`[!;[+E-7EJU(7:OT:H2C1S?=$L]<AZ;F;JZ/:#2:!3[=:YZI992*HZT.9.S
MAJRRB(Q(7YP]@0*F!`S[P'`<!P'`<!P'`<!P/__6[^.`X#@.`X%#*?TR1_(?
MD'?]4_IGY=3^H_\`P?\`N_R_/`J&WY=O_(_D)?EOR_\`++^7_P`C_L_\?'`_
3;@.`X#@.`X#@.`X#@.`X#@?_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g176457prx_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g176457prx_001.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`)@`H`P$1``(1`0,1`?_$`'\```,!`0$`````````
M``````@)"@8$!P$!`0$!`0```````````````@$``P00```&`@$#`P,%`0``
M``````(#!`4&!P$(%!$3"0`2%187&"$B(U,*)!$``0,"!00"`@,`````````
M`0`1`B$Q05$2(C)AD:$#\''!(]%2$__:``P#`0`"$0,1`#\`NMM^X*ZH>O9!
M:=K25+$X1&24XW-V4E*E0\GKE9#>V-S>@0D*7!T=G5Q5%)TJ5.48<>>8$``Y
MSGU0'HLI7?)GY7]SQVY5U%:EJU$6ESLQM-H3"E:_CWSFQ<=9PO2E?%V*Y'5T
M1KX?1T5E\03IWET6.AZ1T1M2TLG+9@1:A0%C38!S\[*B+@RD6'SN>B3$B\A'
MD@<RK+H.D=HI1;.QED3XVP;?LFMWP@=(ZJMP34@G5B9;"X)S2\*$IK<4->X8
M.5(BE)1@",J50LX%>5`QEX"6F,6G*GKPSD4W#37_`$2V')=DI57]J)&JU=8J
MFI%:XV5?<58@,8T=B1=,0I=)*U&'JAIW2,R0PDY*B2&&]U0H'@9`\D8+$9-(
MD6C8"Z)C*$09<B:#%E5W0=[U=LW3M>WS2\G32^L[/C3?*8H^)P&)S#D#@5@>
M4CB@/P!6TO+:?[DZQ&>$"A(I+&48$(PYQZYJ$$%C=*MVFV6K>3;K5%3[BAV;
MGB.OY>DC4B@%.PZ?YK/+W,$7Q^)C<,A*;&2**&.#&N9"LHHIX$LZD=2$YXC.
MV/I$;:.Z-R]&Z_A(R\Q3?"83LS:T7V2OU-3]"2M9%E4<U"U)CX/RBVT[#"TH
M2Y%<LX2]J3GQIW6(U"0@I28%$04#.`JA&F"('@VFIID%T@Y.T/(8FP2P[,KZ
M5*:;;"]D547\5'CS(-*61C5RO4X7#9S84Q`E[OMEJ,.$\FE+\Y8SU$H?1$H4
M0C?>)`02/D!I%*[8>500);=_MSP"%^61EUN>HPFQN&BT<\9T*7EJ,2*5F&*;
M#O1X0"P0%08<LXBRUI^^*<"$G0(P":T!G]PBS,BG(?U]:H(C-^?O/8)]/^;#
M>N5*-A)+JP6%IKS42;05U)U5KN3N)@)*9-ZU6Y>)B[Q=0)*`F1NTT:7]8YRL
MT0\8$Y82X3_H`P&8:U%(X+3CI%2_LQ^>$VV2,E\OF]3$AD.VE:U:R,=KK)JA
MJZ#PAJ53FS4$`2'SEZB[RXS%X=GM4@6QUD4<PAA0!492X&8$0/;[L,G9>C+S
MAM1HY0];NT/MS(]J7"7:):HU?*K5LZL("_S;R$7X]Q[$,@32C:3&MGA-<$//
M8D,@<(_'@#-!A$26G%A3G"TT)N?=Z(D!2(KFN@`(_83IR"GXL^&T7KCL`YQV
M>H;(\O7E#/5("3XR_H'!;2%6.BQ,A<V\Q>QMPES8L9D[:[$+"TA0CFLI,HP>
M:,DL6<YVUZ;IIC68X0]/DH9MF41J.;M\_P#)-:*C8S9K)"-OJ[Q_4&X8Q#JT
M`I2EFLT=LUZBXE#/`VPKD`*&QQXM2]K,!`$2@9`B300W>=99)1XMZ=L,9%>E
M^*8*Y;YD=/3MB8>X2*PQ2U0"*555Q?9CVMP&E@>A0PM]9&52%&RM43-",Y<V
MX'G#<1G*E?DU4<847B22\KMV5DW^?Z^+W.*L;\@5+2ZO+@3WI0>I-/63/+#1
M$DO-M2*10JM'6-REF*)2-J>12$,.>9[($JQO+[Q.4BG!A?9,+#C'[>J@:,!N
M7FD,R1%!G2D=VUO78-E@&S/DD21-9$XA++2'J/J@W0UK=$T`BXFWY,4HFEC-
M<PM1V1<]_1(CS1D(FY=A4#)96#"PB#I#,A^B49`C;$MF?PL;Y<F1#%J@K":5
MM:=.^-UJL=PEN-K[A*@L<A]SSF$PUL8XO`XG"6:,)")(^S3";VI$YQ&<J4S>
MG(Q@T@C'4,B]6+!(,2'!G+`8*5R0SV'4]$C#]5XN[:\0B3E'`/W"OE("0[I[
M$94!-`L#0,$")0YUY&Y#WL=7%M"FZ!.,`<[&C*P7F6M3KBNS&7-B<AQ'VGK_
M`.5'2V1NMA6KOV1)Q,]8H$DFH-B@Z\CYF5RR7!.CTBD4EEK\L0@2)C&OD$&E
MA;3#,=Y1@L9PNV<')L*(>TN1$W"LTO7%49J"P\7EEN#4N8L[8G@G/Y#C!CV4
MIG/R'XC`GCE8)Z]GAXRK[OM[/\GM]8.]+KFIWZ@A%6'6D['>&Z\='VD"=H7+
MYT2R5F?+KN7H2AC.=H_+&XQ97S"4TJ5!9!7-?W4L6#C,9R6$>`#PP7CD$2X.
MYS]T6\@METS+K@KMJV_UWUIJ/9!`_/*;6V7R>5ZU3FP),AP,`+"<(/$[CM/)
M\-59?NV)O#%U[T=DK.?V!*",!AE?^4HNQT\>EEW;A5EJ3)6=F=M\]BK%KR@H
M;&71/*XPKCAR\5O82D1DA]<9FH;Z9FF8ZSNHTJ<]I3Q%P9W!.>I6%I1Y-P,9
M4HD"<!5.KU4_&O\`'NK/Q`^W7XX_2Z/[6?:KA?1/T_U'T^.X7Z\SE=SF\C_M
-YG=Y/\_<]10N];K_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g176457prx_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g176457prx_002.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`)P`H`P$1``(1`0,1`?_$`(````,``@,`````````
M``````@)"@0%!@<+`0$!`0$!```````````````!`@`#!!```04!`0`"`P`!
M!`,`````!`(#!08'`0@3"0`2%!$A,2(5)!88$0`!`P($!00"`P`````````!
M`!$"(3%!41(#\&%Q(C*!P4)2D:&QT2/_V@`,`P$``A$#$0`_`+C/06ZUCSIF
M4WIMI@[M:QXM0PL?4LWJ<M=[Q994YY`X477ZS",$'FO..K_9US]>-#,)6ZZI
M*$=[^(#K*07[//:OM?T)K]:P_!KUHL)/Y]$QUPWK%,M/-S2@XC:6)3ECJ,?Z
M)]0"S,?5PH$2L?\`6&ST(&8:9_V*EQ_S!(=2[RPQ\1QS5``!YX\4&/JDCPUA
MW?0&]IQGS7K4]NEWU:3&L?KKU5'2$U7O.N8Q\+'D1/8K-9626&"EN&BR2@US
MZ&V5/!I%:C$K7\#@M/(N(U)N<!T28PBTIAHBPQ/5,5\9_<MZNIGHK$,AR+5Y
M7<?('G#.^UST-H&DL0S%9LU9@X=4>U;A+"]$LDUT.I-!LM0RQC$ORZ><42HA
M*%*>&$Y-'Q%R@QT0,YTG(T''`5B?UW?8E@_V4XA(;7ACLJ"-7+G.4&YU"Q=C
MTV6J6.&<2Z.F1;C#3Q%1UDA"!I2->2Y_Y`!;2U)0KJD)YGE9!C*-)70+;GZ,
MIE\^P3.:Z-A/IO:'\NM$EE?PP%?D*OBE/)F2%P%JOUE3=YNHP&B2->D_D4(B
M-;D^OB,<^%7%*YW\MAIQ=0'U5(;]I*GW,C9-6O4-TKGL+T#;K'G']59?PWZU
M/*D9V(M6L?!7Q415@UDNNM%3$BBQ'@N-C<(;ZO@+:6VQROCZI(&T]Q]`ND-7
MPC7[%+BUK/+Q:\I@YKVY8JU]:/@")3_9F/BS'F1'MEUUF.$=8';EJ^*]PVQS
M[S2V$OGS3SZ!D%_$^D);;/>40?G2.200)-M]^[F<$,\]!7/TWE1(>5Y]&^"_
MK(HQB"Y31KH0\U/:TH5S@PATS.R/!9;8;?+DM+4)&QC3X#+_`'O._+UMWGX5
MD/KMI>,).>_?/Z13_3S[9=P?W_@0>/'*QSPARQ%^=+O(7Q9R@M9M&J\0J%L=
MJ(&ZD9S5#KC&QA@Q/^H\##L*9*=:8(XET-:1\`F<6B\Z[IKT']*G^NT[=9CV
MU!N7SV71JO#5K7;M<XO'<MRB$H<K?@Z.?.6DFK7JSWS1M>N$^,W$@*3(-5X>
MMJ);;<7U+25<;:LOIO1><:7I&N;_`,673_N/"?9,]Z;E)CP5Y-SFQ:EI^74F
M5T'WCMTC!C4JAP[L<:'`TFC'V$9BSW06LB#-$C`,,G#1OS_L1%D]=6[^0)`>
M(]5;`^9+#`*?C<\Z\_\`E3=7X_T6_I'VM_9=-=@S1<M?%.D,EIIMEC6):H_W
MP("9V/.@R(23&<CP.\E4O!*#>&BXQAUE]+V@_:2L:Y!@VWMH=_543:3#X76/
MMKVDAFQ-!-F9']>GGT\$2SAQ[S"U!"SS0!<K6,'K#BN);)/+[+V(I*>LN.?T
MM(;_`#'/<_"J!^.P*8R/%4($H2=.[-YREM^Q]V'S9Z]4J/S;Q7E0Y0MH>S,N
MPAJ.='K_`,;TQ_18U.\2RJ0_GEK43^R&UBC=20W)=QJMDJBPB1`U:LCGQZ!7
MG^[<A(Q+?G=BP_Q32=2TG2T/SH.M#NYEGLI!VW]?AF!9K19J)(MP3Q*D\-4L
M-?RD-/K2G_/4*_.D"XL\EY2[UD1%#)GU5^Q/T1KM'JOI'[`Z[Y9K<#%V#16,
M-\O`4^9U#N>UP85ZVOV#4]>K]CLEABP%O-);.!B.B,ODIX\E[GZ(_"46J:'(
M*HRBS1!/,K;?9=GUDK_GJGWKQ\/Y[\7Z!8[H5FFU>H[/3*3GXL'YOH]"0#72
MZR3&P\:V7(#N$5V,A@PQ>M+&&?0R-_AIE#9'5\:!(TD_Z.3@!BI+F[9C66-V
MBZ>1X]6YWYDLDG3/LS]>-MIH$3/IXIF2>PFBVKD@U:[2VVE"!32VIB1YSC"T
MCB_X[U(&'C?,KJTI4W*1PB/=%C]`GE'0/7'V91F\P6FF35>\MRPNE[MH&CBN
M3=_TV2NP=CC(*)$@)[^@J%CKB0(6RT8Z^DP(0%YQ/..=0S^2,PG<($-!%\K!
MO=>B+MM1SB_9M9*9J<NF`J5D"<B2IMJU.T>5BWRD*;8-K]M%.C9"`G1U=_8<
MD9]M]"N?\>_[_F#X+@6Q4VL!D%/\V>FIA/UFF?79M6[-4RTE7:^7WTL1L/IL
M.DNG1O\`[U%V;!JGPG2K+7FRVQ.DE,W,`=1?Q<=88[U/.V\2&L5FDP,C(Q>P
MX]EC:KJ_@6_QL?9OLSQ6&R6.C+L_)9);/9M?T?\`^>-%G9B)KD?H-=S3#9K:
M=`NE`'C&:)"O]-EX4:''D)#JVV.FG<X62!Q50>T;UM=<C]/8AXZW[.\A@;WZ
M?\:8/C;DDMRJ:EI%4\G5".E6%DR:*G&>?JCLO)!B"DF($D5HUQ^OAG.&"((!
M,2TXXTHZK1)JP>G--E^LK&OKQP3%YG-/KWO>,:96H2PI5K%YS#4:7KUIL6A$
EA-.O2.IVZIS,T[VR/A=3T<0A;+8@O4MC,ML\XG\E,M3]SNO_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
